endocrine neoplasm: A benign or malignant neoplasm arising from the epithelial cells of an endocrine organ. Representative examples include pituitary gland adenoma, pituitary gland carcinoma, thyroid gland carcinoma, carcinoid tumor, and neuroendocrine carcinoma.
Benign neoplasm of other and unspecified endocrine glands
DOID EFO Endpoint Browser PheWeb
CD2_BENIGN_ENDOCRINE_OTH
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
5729 |
4. Check minimum number of eventsNone |
5729 |
5. Include endpoints |
5887 |
6. Filter based on genotype QC (FinnGen only) |
5671 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10-D36
- Name in latin
- Neoplasmata benigna glandularum endocrinarum aliarum et non specificatarum
Benign neoplasm of other and unspecified endocrine glands
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 26190 | 15605 | 10411 |
| Only index persons | 24177 | 14637 | 9540 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.38 | 0.45 | 0.29 |
| Only index persons | 0.47 | 0.54 | 0.36 |
| Median age at first event (years) | |||
| Whole population | 59.28 | 58.64 | 60.45 |
| Only index persons | 59.12 | 58.33 | 60.32 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5671 | 3383 | 2288 |
| Unadjusted period prevalence (%) | 1.14 | 1.20 | 1.05 |
| Median age at first event (years) | 60.39 | 58.34 | 63.43 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 5887
- Matched controls
- 58870
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E26.0
ICD-10 Finland
Primary hyperaldosteronism
31.1
307.7
242
81
N04BC06
ATC
cabergoline; oral
85.0
307.7
419
53
BC1AD
NOMESCO Finland
CT of adrenal glands
74.2
307.7
786
122
H02AB09
ATC
hydrocortisone; systemic
19.3
307.7
875
529
BC1CD
NOMESCO Finland
Very extensive CT of adrenal glands
81.7
307.7
273
35
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
111.6
307.7
327
31
ZXC86
NOMESCO Finland
Use of endoscopic device
28.4
307.7
222
81
101
Kela drug reimbursment
Anterior pituitary hypofunction
47.6
307.7
408
92
D44.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pituitary gland
238.0
307.7
294
13
E22.1
ICD-10 Finland
Hyperprolactinaemia
52.1
307.7
475
99
D35.1
ICD-10 Finland
Benign neoplasm: Parathyroid gland
667.3
307.7
376
6
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
96.9
307.7
925
113
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
125.1
307.7
263
22
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
16384.0
307.7
3155
*
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
69.6
307.7
827
138
E23.00
ICD-10 Finland
Panhypopituitarism
155.9
307.7
393
27
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
1050.9
307.7
655
7
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
13242.4
307.7
1857
*
D35.31
ICD-10 Finland
Cyst in Rathke's pocket
2915.7
300.3
288
*
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
134.2
286.2
144
11
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
11.3
259.4
277
257
AA4DG
NOMESCO Finland
Very extensive MRI examination of sella turcica with high intensity magnet
97.9
258.1
134
14
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
5.8
254.5
488
899
102
Kela drug reimbursment
Diabetes insipidus
61.9
250.7
139
23
BC4WT
NOMESCO Finland
Selective blood sample from adrenal gland with radiological guidance
106.9
204.0
105
10
E23.05
ICD-10 Finland
Lack of TSH
27.9
193.6
131
48
G02CB03
ATC
cabergoline; oral
22.8
183.9
134
60
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
7.6
179.5
258
351
G02CB01
ATC
bromocriptine; systemic
7.2
164.8
248
355
E21.0
ICD-10 Finland
Primary hyperparathyroidism
6.4
161.9
277
454
E22.0
ICD-10 Finland
Acromegaly and pituitary gigantism
190.9
160.7
167
9
E23.2
ICD-10 Finland
Diabetes insipidus
29.9
151.3
100
34
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
3.6
145.0
519
1548
BCA30
NOMESCO Finland
Unilateral adrenalectomy
43.2
135.7
81
19
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
6.4
135.4
227
364
H53.4
ICD-10 Finland
Visual field defects
5.5
130.4
257
482
H03AA01
ATC
levothyroxine sodium; systemic
2.0
115.3
1643
9476
E24.9
ICD-10 Finland
Cushing syndrome, unspecified
51.3
114.7
66
13
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
16.6
113.3
95
58
C03DA01
ATC
spironolactone; oral
2.4
112.5
923
4278
I15.2
ICD-10 Finland
Hypertension secondary to endocrine disorders
30.0
112.0
74
25
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
8.1
107.8
145
182
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
105.4
1742
10516
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.9
101.7
311
830
2273A
ICD-9 Finland
Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)
+∞
101.3
97
*
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
100.0
1009
5081
H01AC01
ATC
somatropin; parenteral
23.2
98.1
71
31
XCK00
NOMESCO Finland
Perimetry
2.8
95.6
504
1879
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
95.4
1257
6984
E23.09
ICD-10 Finland
Pituitary insufficiency NOS
49.5
93.1
54
11
WX402
NOMESCO Finland
General anaesthesia
1.9
92.7
1536
9216
D35.30
ICD-10 Finland
Craniopharyngoma
+∞
89.8
86
*
D35.4
ICD-10 Finland
Benign neoplasm: Pineal gland
881.7
88.9
87
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.4
88.1
657
2900
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
84.5
3001
22324
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
81.9
1083
5992
D35.59
ICD-10 Finland
Other paragangliom
+∞
79.3
76
*
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
6.0
79.1
141
240
E23.03
ICD-10 Finland
Lack of ACTH
17.3
79.0
65
38
ZXC95
NOMESCO Finland
Use of surgical navigator
5.4
75.8
150
282
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
74.6
1528
9684
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
3.3
74.2
296
939
D35.9
ICD-10 Finland
Benign neoplasm: Endocrine gland, unspecified
+∞
72.0
69
*
E24.0
ICD-10 Finland
Pituitary-dependent Cushing disease
128.3
71.0
76
6
BBA20
NOMESCO Finland
Exploration of parathyroid gland
12.7
70.9
69
55
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
70.3
2244
15984
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
69.7
3688
29742
H01CB03
ATC
lanreotide; parenteral
13.0
65.7
63
49
A10BA02
ATC
metformin; oral
1.7
65.2
1727
11672
E24.8
ICD-10 Finland
Other Cushing syndrome
91.2
65.0
72
8
Z3231
NOMESCO Finland
Registered nurse
1.7
64.4
1649
11039
C08CA01
ATC
amlodipine; oral
1.6
63.9
2337
17102
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
26.1
63.4
44
17
N02BE01
ATC
paracetamol; systemic, rectal
2.1
63.4
5339
48243
H01CB02
ATC
octreotide; parenteral
12.8
63.1
61
48
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.1
63.1
668
3387
E260, I152,
ICD-10 Finland
133.5
62.0
66
5
G47.3
ICD-10 Finland
Sleep apnoea
1.7
59.2
1455
9601
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
59.0
744
4012
2542
FHL
Transasal hypophysectomy
584.0
58.8
58
*
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
6.1
58.1
102
171
AA1AD
NOMESCO Finland
CT of head and brain
1.6
57.4
1749
12173
E27.5
ICD-10 Finland
Adrenomedullary hyperfunction
151.5
57.0
60
*
A02BC02
ATC
pantoprazole; systemic
1.6
56.7
4099
34685
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
56.4
1765
12353
E26.9
ICD-10 Finland
Hyperaldosteronism, unspecified
18.1
56.0
45
25
BC1BD
NOMESCO Finland
Extensive CT of adrenal glands
102.8
55.9
61
6
E66.8
ICD-10 Finland
Other obesity
2.4
55.5
398
1715
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
6.3
55.5
93
149
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
4.8
55.0
126
269
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
53.5
4208
36022
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
53.4
1492
10129
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
53.1
1340
8867
UJF32
NOMESCO Finland
Coloscopy
1.6
52.4
1580
10921
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
52.3
2072
15253
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.7
52.3
1162
7431
J01DB01
ATC
cefalexin; oral
1.7
50.4
4836
43041
R51.80
ICD-10 Finland
Headache
1.8
50.2
958
5867
301
Kela drug reimbursment
Growth hormone
71.8
50.1
57
8
N02AX02
ATC
tramadol; systemic, rectal
1.5
49.3
2515
19479
D35.50
ICD-10 Finland
Carotid body
+∞
49.0
47
*
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
47.6
1545
10824
T90
ICPC
Diabetes non-insulin dependent
1.6
47.4
1464
10137
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
46.9
1189
7841
22620
ICD-8 Finland
Benign neoplasm of endocrine glands, Pituitary gland and craniopharyngeal duct (pouch)
+∞
45.9
44
*
C07AB07
ATC
bisoprolol; oral
1.5
45.8
2776
22146
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
45.0
1984
14829
E87.6
ICD-10 Finland
Hypokalaemia
2.6
43.0
250
975
E89.30
ICD-10 Finland
Postprocedural hypopituitarism
151.1
42.8
45
*
E66.01
ICD-10 Finland
Obesity due to excess calories
1.9
42.8
584
3218
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
6.9
42.8
66
97
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.9
42.7
542
2915
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.1
42.6
449
2261
E21.2
ICD-10 Finland
Other hyperparathyroidism
7.7
42.4
59
77
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
41.7
778
4713
T73
ICPC
Neoplasm endocrine other/unspecified
15.7
41.7
36
23
B01AB05
ATC
enoxaparin; parenteral
1.5
41.6
1823
13556
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.9
41.5
620
3515
C03CA01
ATC
furosemide; systemic
1.5
40.8
1601
11624
205
Kela drug reimbursment
Chronic hypertension
1.5
40.8
1418
10030
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
8.7
40.5
51
59
P01AB01
ATC
metronidazole; oral, rectal
1.5
40.4
2269
17691
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
40.2
2100
16145
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.8
40.1
616
3521
E66.00
ICD-10 Finland
Metabolic syndrome
2.2
39.8
369
1768
E23.6
ICD-10 Finland
Other disorders of pituitary gland
88.7
39.8
44
5
9350/1-C75.2
ICD-O-3
Craniopharyngioma, NOS, of craniopharyngeal duct
+∞
39.6
38
*
105
Kela drug reimbursment
Adrenal cortical hypofunction
11.5
39.6
41
36
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.9
39.1
581
3285
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.8
39.0
651
3814
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.1
38.9
387
1905
J01MA02
ATC
ciprofloxacin; systemic
1.5
38.8
2180
16961
N07BA03
ATC
varenicline; oral
2.3
38.6
311
1408
R06.0
ICD-10 Finland
Dyspnoea
1.5
38.5
1563
11405
R5140
NOMESCO Finland
Monitoring the use of the aid
1.8
38.3
675
4018
Z71.8
ICD-10 Finland
Other specified counselling
1.5
37.3
1941
14860
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.8
37.1
586
3374
C02AC05
ATC
moxonidine; oral
2.3
36.9
302
1376
WX882
NOMESCO Finland
High dependency care
2.8
36.5
186
678
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
4.8
36.4
82
173
R03AC02
ATC
salbutamol; inhalant
1.4
36.2
3083
25749
R03BB04
ATC
tiotropium bromide; inhalant
1.8
35.5
572
3314
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.7
34.5
185
692
WZC30
NOMESCO Finland
Teaching
1.6
34.5
997
6732
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
34.3
1302
9333
H47.2
ICD-10 Finland
Optic atrophy
7.1
34.3
51
72
E83.50
ICD-10 Finland
Hypercalcemia
3.6
33.6
112
317
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
33.1
2324
18671
G02CB04
ATC
quinagolide; oral
63.7
33.0
38
6
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
32.9
2456
19928
UKC02
NOMESCO Finland
Cystoscopy
1.6
32.8
873
5776
R53
ICD-10 Finland
Malaise and fatigue
1.5
32.6
1392
10201
22680
ICD-8 Finland
Benign neoplasm of endocrine glands, Other specified endocrine glands
+∞
32.3
31
*
M79.6
ICD-10 Finland
Pain in limb
1.4
31.8
2524
20650
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
3.4
31.7
115
344
JN4AD
NOMESCO Finland
Body CT examination
1.7
31.6
687
4320
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
31.5
1293
9393
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
3.4
31.2
111
328
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.0
31.1
379
2005
ZXE00
NOMESCO Finland
One hour or less
1.4
30.7
2079
16538
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
4.1
30.4
82
200
2271A
ICD-9 Finland
Benign neoplasm of other endocrine glands and related structures, Parathyroid gland
+∞
30.2
29
*
D35.6
ICD-10 Finland
Benign neoplasm: Aortic body and other paraganglia
+∞
30.2
29
*
CS494
NOMESCO Finland
Other visual field testing
2.6
29.9
175
685
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
29.8
1028
7195
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.0
29.5
352
1848
J01FF01
ATC
clindamycin; systemic
1.4
29.2
1487
11230
D01
ICPC
Abdominal pain/cramps general
1.6
29.2
696
4476
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.6
29.2
802
5337
ZYC01
NOMESCO Finland
Remote contact by phone
1.9
29.1
374
2015
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
5.7
29.1
54
96
2370A
ICD-9 Finland
Neoplasm of uncertain behaviour of endocrine glands and nervous system, Pituitary gland and craniopharyngeal duct
293.4
28.8
29
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
28.4
750
4942
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.9
28.1
362
1951
E22.9
ICD-10 Finland
Hyperfunction of pituitary gland, unspecified
282.9
27.8
28
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
27.7
1309
9735
S18
ICPC
Laceration/cut
1.4
27.5
2664
22315
N91.1
ICD-10 Finland
Secondary amenorrhoea
3.7
27.4
88
243
BB1BQ
NOMESCO Finland
Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT
5.9
27.4
49
84
R42
ICD-10 Finland
Dizziness and giddiness
1.4
27.4
1265
9369
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
27.3
1668
12978
A10BH01
ATC
sitagliptin; oral
1.7
27.3
534
3260
R4110
NOMESCO Finland
Physiotherapy
1.4
27.2
1533
11762
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.3
27.2
202
883
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.7
27.1
596
3753
Z3226
NOMESCO Finland
Physiotherapist
1.5
27.1
975
6874
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
27.0
703
4614
N06AX21
ATC
duloxetine; oral
1.6
27.0
680
4429
H02AB06
ATC
prednisolone; systemic
1.3
26.8
2627
22014
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
26.8
1458
11115
N06AX11
ATC
mirtazapine; oral
1.4
26.7
1864
14818
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.6
26.6
641
4127
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
26.6
1007
7170
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
26.6
718
4753
E21
ICD-10 Finland
Hyperparathyroidism and other disorders of parathyroid gland
9.2
26.5
32
35
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.1
26.3
262
1290
N03AX16
ATC
[U] pregabalin
1.4
26.2
1267
9453
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.7
26.2
537
3320
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.7
26.2
474
2833
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.8
26.1
131
474
2522
FHL
Removal of parathyroidism or multiple parathyroidism (including removal of adenoma or total removal)
36.9
26.1
33
9
KH1AD
NOMESCO Finland
CT of urinary organs
2.2
26.0
220
1016
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
2.4
25.8
172
716
I15.9
ICD-10 Finland
Secondary hypertension, unspecified
4.3
25.8
67
159
R02
ICPC
Shortness of breath/dyspnoea
1.6
25.5
754
5091
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.6
25.4
633
4109
A28
ICPC
Limited function/disability NOS
1.5
25.2
936
6631
A02BC05
ATC
esomeprazole; systemic
1.3
25.1
2239
18442
A10BJ06
ATC
semaglutide; parenteral
1.9
24.8
322
1740
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
24.5
739
5010
N06AB10
ATC
escitalopram; oral
1.5
24.5
1050
7648
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
24.5
2410
20119
C08CA13
ATC
lercanidipine; oral
1.5
24.4
804
5554
Y28
ICPC
Limited function/disability (Y)
5.8
24.4
44
76
T99
ICPC
Endocr/metab/nutrit disease other
3.0
24.4
111
381
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.7
24.4
447
2679
C09CA01
ATC
losartan; oral
1.4
24.4
1418
10905
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
2.7
24.1
126
466
D64.9
ICD-10 Finland
Anaemia, unspecified
1.6
24.1
576
3700
2270A
ICD-9 Finland
Benign neoplasm of other endocrine glands and related structures, Adrenal gland
+∞
24.0
23
*
C10AA05
ATC
atorvastatin; oral
1.3
23.9
2328
19381
R31
ICD-10 Finland
Unspecified haematuria
1.6
23.8
535
3385
N06AX16
ATC
venlafaxine; oral
1.5
23.7
760
5217
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.5
23.6
894
6351
L28
ICPC
Limited function/disability (L)
1.4
23.5
1030
7526
H02AA02
ATC
fludrocortisone; oral
4.2
23.2
61
146
N28.1
ICD-10 Finland
Cyst of kidney
3.0
23.2
101
338
A11CC03
ATC
alfacalcidol; systemic
2.5
23.2
145
587
C10AA01
ATC
simvastatin; oral
1.3
23.2
2148
17734
C74.0
ICD-10 Finland
Malignant neoplasm: Cortex of adrenal gland
28.3
23.1
31
11
SPAT1262
SPAT
Handing over of treatment supplies
1.5
23.1
913
6541
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
22.9
971
7050
N03AX12
ATC
[U] gabapentin; oral
1.5
22.6
880
6281
H05BX01
ATC
cinacalcet; oral
4.4
22.6
56
128
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
22.4
594
3906
S10
ICPC
Boil/carbuncle
1.8
22.4
339
1921
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
22.4
1300
9971
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
22.4
2828
24341
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
22.4
648
4348
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
4.4
22.4
55
125
SPAT1254
SPAT
Administration of medicine
1.5
22.3
732
5046
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
22.3
723
4971
G44.2
ICD-10 Finland
Tension-type headache
1.5
22.2
731
5043
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.0
22.0
254
1318
ZX120
NOMESCO Finland
Intravenous
1.6
21.8
499
3168
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
21.6
939
6841
N06AB04
ATC
citalopram; systemic
1.4
21.6
1084
8108
A10BK01
ATC
dapagliflozin; oral
1.7
21.5
447
2768
J45.9
ICD-10 Finland
Asthma, unspecified
1.4
21.5
1025
7593
Z3229
NOMESCO Finland
Other healthcare associate professional
1.7
21.4
431
2648
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.7
21.4
416
2532
E23.0
ICD-10 Finland
Hypopituitarism
43.5
21.4
26
6
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.0
21.3
239
1228
J01MA12
ATC
levofloxacin; systemic
1.4
21.2
960
7045
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.8
21.2
305
1703
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
2.0
21.0
216
1077
ZXA10
NOMESCO Finland
Bilateral
1.4
20.9
945
6929
E89.6
ICD-10 Finland
Postprocedural adrenocortical(-medullary) hypofunction
28.1
20.9
28
10
E23
ICD-10 Finland
Hypofunction and other disorders of pituitary gland
28.1
20.9
28
10
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.4
20.9
1462
11535
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.6
20.9
585
3894
WZC00
NOMESCO Finland
Treatment plan or consultation
1.3
20.9
2017
16683
D352, E221,
ICD-10 Finland
+∞
20.8
20
*
BDA10
NOMESCO Finland
Operation on carotid body
+∞
20.8
20
*
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.9
20.6
247
1299
8700/3-C74.1
ICD-O-3
Pheochromocytoma, NOS, of medulla of adrenal gland
110.4
20.6
22
*
25320
ICD-8 Finland
Diseases of pituitary gland, Chromophobe adenoma, pituitary
110.4
20.6
22
*
R10.0
ICD-10 Finland
Acute abdomen
2.1
20.5
190
910
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
6.5
20.4
33
51
R60.0
ICD-10 Finland
Localized oedema
1.5
20.4
691
4790
C74.1
ICD-10 Finland
Malignant neoplasm: Medulla of adrenal gland
41.8
20.4
25
6
C74.9
ICD-10 Finland
Malignant neoplasm: Adrenal gland, unspecified
25.6
20.4
28
11
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.4
20.3
1405
11059
N05CF01
ATC
zopiclone; oral
1.3
20.3
1667
13463
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.5
20.2
833
6004
WX725
NOMESCO Finland
Noninvasive ventilation
1.8
20.1
315
1803
A10BK03
ATC
empagliflozin; oral
1.6
20.1
565
3762
321
Kela drug reimbursment
Paricalcitol and cinacalcet
4.1
20.0
54
132
A46
ICD-10 Finland
Erysipelas
1.5
20.0
775
5518
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.5
20.0
120
477
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
20.0
575
3851
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
6.8
19.9
31
46
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.3
19.9
2997
26234
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.3
19.9
149
655
C09CA03
ATC
valsartan; oral
1.6
19.8
503
3273
2530A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Acromegaly and gigantism[ACROMEGALIA]
+∞
19.8
19
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
19.5
918
6776
K86.2
ICD-10 Finland
Cyst of pancreas
3.0
19.2
82
272
M54.5
ICD-10 Finland
Low back pain
1.3
19.1
1968
16371
R11
ICD-10 Finland
Nausea and vomiting
1.6
19.1
454
2908
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
19.0
1160
8940
Z2221
NOMESCO Finland
Medical doctor
1.3
18.9
1379
10921
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.5
18.9
534
3561
TAB00
NOMESCO Finland
Lumbar puncture
1.9
18.7
236
1263
A10BJ02
ATC
liraglutide; parenteral
2.2
18.7
166
783
E23.08
ICD-10 Finland
Hypopituitarism
27.9
18.7
25
9
XF400
NOMESCO Finland
ECG with 12 standard connections
1.4
18.7
762
5476
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
18.6
813
5918
LCA06
NOMESCO Finland
Biopsy of endometrium
1.5
18.6
593
4058
N05BA04
ATC
oxazepam; oral
1.3
18.5
1351
10697
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.5
18.5
522
3478
N05AH04
ATC
quetiapine; oral
1.4
18.5
876
6469
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
18.4
1887
15665
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.3
18.3
1520
12260
A04
ICPC
Weakness/tiredness general
1.4
18.2
805
5868
V04CD01
ATC
metyrapone; oral
44.1
18.2
22
5
E23.7
ICD-10 Finland
Disorder of pituitary gland, unspecified
44.1
18.2
22
5
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
18.2
406
2560
K05.31
ICD-10 Finland
Periodontitis pronounced
1.5
18.2
594
4085
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
2.0
18.1
192
968
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
18.0
1620
13208
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
4.8
18.0
40
84
J01AA02
ATC
doxycycline; systemic
1.3
17.9
4320
39891
106
Kela drug reimbursment
Hypoparathyroidism
5.1
17.9
37
73
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
17.8
1317
10437
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
2.7
17.7
92
340
AA4DM
NOMESCO Finland
Very extensive MRI examination of sella turcica with 3 Tesla magnet
+∞
17.7
17
*
E27.2
ICD-10 Finland
Addisonian crisis
20.1
17.7
26
13
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
17.6
1510
12220
WX892
NOMESCO Finland
Monitored bed care
1.6
17.6
383
2399
A08
ICPC
Swelling
1.7
17.6
316
1883
JAH01
NOMESCO Finland
Laparoscopy
1.9
17.5
237
1298
N20.0
ICD-10 Finland
Calculus of kidney
2.4
17.4
122
521
D06
ICPC
Abdominal pain localized other
1.6
17.4
480
3182
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
3.0
17.4
76
256
L17
ICPC
Foot/toe symptom/complaint
1.3
17.4
1659
13621
A10BH05
ATC
linagliptin; oral
1.8
17.4
266
1514
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.6
17.4
399
2534
ZXD05
NOMESCO Finland
Urgent procedure
1.3
17.3
1481
11982
WX704
NOMESCO Finland
Intubation
1.6
17.2
431
2796
C08CA02
ATC
felodipine; oral
1.6
17.1
466
3081
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
17.0
708
5101
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
2.2
17.0
140
641
C10AA07
ATC
rosuvastatin; oral
1.3
16.9
1851
15459
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
16.9
434
2830
SPAT1263
SPAT
Sampling
1.3
16.8
2126
18073
XCK10
NOMESCO Finland
Photography of fundus of eye
1.5
16.8
471
3134
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.9
16.7
202
1067
JN4BD
NOMESCO Finland
Extensive body CT
1.5
16.7
524
3571
M48.0
ICD-10 Finland
Spinal stenosis
1.5
16.6
637
4518
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
6.5
16.6
27
42
R93.0
ICD-10 Finland
Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified
6.5
16.6
27
42
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
16.6
2436
21082
A02BA02
ATC
ranitidine; systemic
1.4
16.5
945
7191
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.8
16.5
256
1464
A12BA01
ATC
potassium chloride; oral
1.9
16.4
191
997
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.6
16.3
342
2123
WF002
NOMESCO Finland
Radical radiotherapy
1.7
16.3
292
1739
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.4
16.2
691
4999
C09AA02
ATC
enalapril; systemic
1.4
16.2
924
7027
M03BX02
ATC
tizanidine; oral
1.3
16.1
3360
30242
WX290
NOMESCO Finland
Other blockage of nerve
1.3
16.1
2447
21236
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.6
16.0
377
2407
A01
ICPC
Pain general/multiple sites
1.5
16.0
542
3750
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.7
16.0
329
2031
A02BC03
ATC
lansoprazole; oral
1.3
16.0
1446
11760
2533
FHL
Unilateral removal of additional egg
47.6
16.0
19
*
8700/3-C74.9
ICD-O-3
Pheochromocytoma, NOS, of adrenal gland, NOS
47.6
16.0
19
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
16.0
526
3619
A02BC01
ATC
omeprazole; systemic
1.3
16.0
1373
11092
N06AA09
ATC
amitriptyline; systemic
1.5
15.8
484
3283
XG466
NOMESCO Finland
Sleep oxymetry
2.0
15.7
163
816
N17
ICPC
Vertigo/dizziness
1.4
15.7
666
4813
D35.3
ICD-10 Finland
Benign neoplasm: Craniopharyngeal duct
+∞
15.6
15
*
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
1.8
15.5
214
1181
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
3.4
15.4
55
164
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
15.4
347
2194
N20.1
ICD-10 Finland
Calculus of ureter
1.9
15.4
191
1019
WVA30, ,
SPAT
1.6
15.3
356
2266
A06AD11
ATC
lactulose; oral
1.4
15.2
692
5064
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
17.8
15.1
23
13
GD1AD
NOMESCO Finland
Thorax CT examination
1.6
15.1
335
2109
A10AE04
ATC
insulin glargine; parenteral
1.5
15.0
470
3200
B01AB04
ATC
dalteparin; parenteral
1.7
15.0
260
1534
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
14.9
1279
10314
Z72.0
ICD-10 Finland
Tobacco use
2.1
14.9
141
683
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
14.9
497
3429
K02.1
ICD-10 Finland
Caries of dentine
1.2
14.9
3123
28011
XA800
NOMESCO Finland
Neuropsychological investigation
1.8
14.9
216
1211
E66.9
ICD-10 Finland
Obesity, unspecified
1.9
14.9
189
1016
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.4
14.9
611
4389
Z01.7
ICD-10 Finland
Laboratory examination
1.4
14.8
868
6625
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.8
14.8
229
1309
M01AB05
ATC
diclofenac; systemic, rectal
1.2
14.7
3573
32546
N02AA05
ATC
oxycodone; systemic
1.4
14.7
911
7011
ZYC06
NOMESCO Finland
Real-time text-based remote transaction
5.3
14.6
29
55
J01DA01
ATC
[U] cefalexin
1.2
14.6
3232
29127
EBA00
NOMESCO Finland
Extraction of tooth
1.3
14.6
1857
15731
D35.7
ICD-10 Finland
Benign neoplasm: Other specified endocrine glands
+∞
14.6
14
*
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.5
14.6
409
2720
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.6
14.6
314
1963
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.4
14.5
717
5319
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.6
14.5
300
1856
N06AX12
ATC
bupropion; oral
1.6
14.5
334
2123
D11
ICPC
Diarrhoea
1.4
14.5
585
4188
H47.4
ICD-10 Finland
Disorders of optic chiasm
150.4
14.5
15
*
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
14.5
3570
32549
XX9XW, ,
NOMESCO Finland
3.7
14.4
45
123
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.6
14.4
306
1907
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
12.5
14.3
25
20
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
2.2
14.3
115
522
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
2.4
14.3
95
397
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
2.3
14.3
104
453
C07AA05
ATC
propranolol; systemic
1.3
14.3
981
7665
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
14.2
1466
12098
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
2.3
14.2
102
442
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.2
14.2
2526
22210
M25.5
ICD-10 Finland
Pain in joint
1.3
14.2
1760
14858
J01CA04
ATC
amoxicillin; systemic
1.3
14.1
4473
41907
S06.0
ICD-10 Finland
Concussion
1.5
14.1
518
3643
XKD00
NOMESCO Finland
Uroflowmetry
1.4
14.0
729
5454
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
3.9
13.9
40
103
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.7
13.9
270
1645
M54.4
ICD-10 Finland
Lumbago with sciatica
1.3
13.8
941
7342
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
1.8
13.7
208
1181
M01AE02
ATC
naproxen; oral, rectal
1.2
13.7
2957
26499
C09DA01
ATC
losartan and diuretics; oral
1.4
13.7
550
3932
C09CA06
ATC
candesartan; oral
1.3
13.7
1257
10216
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.8
13.7
208
1183
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
3.9
13.7
39
100
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
6.5
13.6
22
34
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.4
13.6
643
4731
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
13.6
974
7653
E27.0
ICD-10 Finland
Other adrenocortical overactivity
14.7
13.5
22
15
B01AB10
ATC
tinzaparin; parenteral
1.4
13.5
572
4130
2532A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Panhypopituitarism[PANHYPOPITUITARISMUS]
140.3
13.4
14
*
C03AA03
ATC
hydrochlorothiazide; oral
1.5
13.4
430
2941
K57.2
ICD-10 Finland
Diverticular disease of large intestine with perforation and abscess
2.2
13.4
112
517
K59.1
ICD-10 Finland
Functional diarrhoea
1.6
13.4
289
1807
A55
ICPC
General and Unspecified, Local injection/infiltration
2.6
13.4
73
278
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.7
13.3
249
1501
121
Kela drug reimbursment
Severe hypofunction of sexual glands
2.2
13.3
105
474
R20.2
ICD-10 Finland
Paraesthesia of skin
1.5
13.3
361
2385
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
13.3
795
6081
Z2446
NOMESCO Finland
Social worker
1.6
13.2
298
1885
R4110, ,
SPAT
1.4
13.2
718
5408
R07.3
ICD-10 Finland
Other chest pain
1.4
13.2
526
3755
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
13.2
798
6112
J01FA10
ATC
azithromycin; systemic
1.2
13.2
2971
26702
UDM02
NOMESCO Finland
Sinoscopy
2.1
13.1
120
575
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
4.3
13.1
33
77
N01
ICPC
Headache
1.4
13.1
516
3676
B01AF02
ATC
apixaban; oral
1.4
13.1
662
4928
K30
ICD-10 Finland
Functional dyspepsia
1.4
13.1
583
4247
WX002
NOMESCO Finland
Sedation and analgesia
1.3
13.0
953
7508
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
1.7
13.0
219
1284
R35
ICD-10 Finland
Polyuria
1.5
12.9
346
2280
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.8
12.8
198
1132
T82
ICPC
Obesity
1.8
12.8
207
1199
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.4
12.8
620
4582
I50.9
ICD-10 Finland
Heart failure, unspecified
1.4
12.8
599
4402
WX302
NOMESCO Finland
Thoracal epidural anesthesy
1.6
12.7
264
1636
R4120
NOMESCO Finland
Occupational therapy
1.6
12.7
328
2142
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.7
12.7
236
1421
N02BF01
ATC
gabapentin; oral
1.4
12.7
548
3969
-50
ICPC
Medication/prescr/renewal
1.8
12.6
193
1100
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
2.0
12.6
139
714
R5110, ,
SPAT
1.5
12.5
446
3115
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.3
12.5
949
7505
R4190
NOMESCO Finland
Nutritional therapy
1.8
12.5
195
1117
D35.8
ICD-10 Finland
Benign neoplasm: Pluriglandular involvement
+∞
12.5
12
*
R04.2
ICD-10 Finland
Haemoptysis
1.9
12.5
166
907
N30.0
ICD-10 Finland
Acute cystitis
1.3
12.4
856
6679
AA4AD
NOMESCO Finland
CT of sella turcica
130.3
12.4
13
*
N04BC01
ATC
bromocriptine; oral
20.1
12.4
18
9
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
4.2
12.4
32
76
A98
ICPC
Health maint/preventive medicine
1.6
12.4
5627
54806
E66
ICD-10 Finland
Obesity
1.6
12.3
271
1705
R93.8
ICD-10 Finland
Abnormal findings on diagnostic imaging of other specified body structures
3.4
12.3
44
132
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
2.4
12.3
83
351
C07AB02
ATC
metoprolol; systemic
1.3
12.2
907
7150
ZXA05
NOMESCO Finland
Left side
1.3
12.2
1178
9614
L72.1
ICD-10 Finland
Trichilemmal cyst
1.5
12.2
343
2283
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
1.9
12.2
152
814
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
12.2
3875
35933
SPAT1153
SPAT
Removal of sutures
1.2
12.1
1587
13432
R55
ICD-10 Finland
Syncope and collapse
1.4
12.0
521
3774
SPAT1240
SPAT
Therapeutic discussion
1.4
12.0
455
3216
2520A
ICD-9 Finland
Disorders of parathyroid gland, Hyperparathyroidism
18.1
12.0
18
10
A03FA01
ATC
metoclopramide; systemic, rectal
1.3
12.0
1117
9073
K07
ICPC
Swollen ankles/oedema
1.7
12.0
234
1428
OAB50, ,
SPAT
1.5
11.9
419
2919
TKC20
NOMESCO Finland
Catheterisation of bladder
1.6
11.9
309
2022
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
2.7
11.8
64
243
ZXA00
NOMESCO Finland
Right side
1.3
11.8
1275
10546
N75
ICPC
Benign neoplasm nervous system
11.7
11.8
21
18
R06AE07
ATC
cetirizine; oral
1.2
11.8
2250
19805
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.7
11.7
193
1124
R51
ICD-10 Finland
Headache
1.6
11.7
262
1654
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.5
11.7
394
2722
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.6
11.7
291
1884
Z00.8
ICD-10 Finland
Other general examinations
1.5
11.7
380
2608
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
11.7
2073
18106
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
11.6
415
2900
EBA15
NOMESCO Finland
Extraction of multiple teeth
1.7
11.6
191
1112
Z00.0
ICD-10 Finland
General medical examination
1.3
11.6
943
7524
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
1.8
11.6
172
972
I152, E260,
ICD-10 Finland
65.1
11.6
13
*
N20.9
ICD-10 Finland
Urinary calculus, unspecified
2.0
11.6
126
644
JEA01
NOMESCO Finland
Laparoscopic appendectomy
1.8
11.6
176
1002
N03AX11
ATC
topiramate; oral
2.0
11.6
117
583
DCB00
NOMESCO Finland
Excision of lesion of middle ear
22.9
11.6
16
7
A03
ICPC
Fever
1.3
11.5
805
6289
KBE12
NOMESCO Finland
Transluminal endoscopic extraction of calculus of ureter
2.7
11.5
62
235
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
2.2
11.5
94
431
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
11.5
614
4608
AA4BM
NOMESCO Finland
MRI examination of sella turcica with 3 Tesla magnet
+∞
11.5
11
*
AA4BD
NOMESCO Finland
Extensive CT of sella turcica
+∞
11.5
11
*
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.4
11.5
534
3918
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
11.4
1338
11174
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
3.2
11.3
44
139
R03AK07
ATC
formoterol and budesonide; inhalant
1.3
11.3
1047
8494
R52.9
ICD-10 Finland
Pain, unspecified
1.4
11.3
519
3798
P03
ICPC
Feeling depressed
1.4
11.3
438
3110
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.7
11.3
187
1092
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
3.5
11.3
37
105
H53.1
ICD-10 Finland
Subjective visual disturbances
1.5
11.3
351
2388
RD211, ,
NOMESCO Finland
1.7
11.3
212
1282
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
2.2
11.2
91
416
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
2.2
11.2
87
391
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
11.2
1147
9422
SPAT1301
SPAT
No procedures
1.2
11.2
1504
12746
R60.9
ICD-10 Finland
Oedema, unspecified
1.6
11.2
285
1857
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
1.9
11.2
145
787
M01AH05
ATC
etoricoxib; oral
1.2
11.1
3366
30903
2531A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Other and unspecified anterior pituitary hyperfunction[HYPERPROLACTINAEMIA]
25.0
11.1
15
6
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
2.3
11.1
83
367
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
1.8
11.0
163
921
-1, ,
NOMESCO Finland
1.2
11.0
1584
13516
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.3
11.0
712
5501
Z31.5
ICD-10 Finland
Genetic counselling
1.6
11.0
250
1586
G96.0
ICD-10 Finland
Cerebrospinal fluid leak
9.2
11.0
22
24
207
Kela drug reimbursment
Chronic arrhythmias
1.3
11.0
732
5682
J01DA09
ATC
[U] cefadroxil
1.3
11.0
1272
10600
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
10.9
1211
10037
L03
ICPC
Low back symptom/complaint
1.2
10.9
1502
12755
N03AX09
ATC
lamotrigine; oral
1.7
10.9
216
1324
L13
ICPC
Hip symptom/complaint
1.3
10.9
1003
8130
M01AH01
ATC
celecoxib; oral
1.3
10.9
876
6978
C09DA03
ATC
valsartan and diuretics; oral
1.6
10.9
233
1457
N02BF02
ATC
pregabalin; oral
1.5
10.8
346
2366
N06AB03
ATC
fluoxetine; oral
1.4
10.8
575
4312
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.4
10.8
436
3120
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
10.6
10.7
20
19
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.2
10.7
1350
11350
C08CA05
ATC
nifedipine; systemic
1.6
10.7
260
1675
E83.51
ICD-10 Finland
Hypocalcemia
3.1
10.7
43
139
C10AC01
ATC
colestyramine; oral
1.9
10.6
137
742
D44.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Parathyroid gland
12.9
10.6
18
14
E89.39
ICD-10 Finland
Postprocedural hypopituitarism, other or several procedures
60.1
10.6
12
*
R01AD09
ATC
mometasone; nasal
1.2
10.6
2314
20569
L14
ICPC
Leg/thigh symptom/complaint
1.4
10.6
403
2852
J01FA06
ATC
roxithromycin; oral
1.2
10.6
1984
17379
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
3.9
10.5
30
77
C09BA02
ATC
enalapril and diuretics; systemic
1.5
10.4
361
2509
E22
ICD-10 Finland
Hyperfunction of pituitary gland
+∞
10.4
10
*
M14.5*E22.0
ICD-10 Finland
Arthropathy associated with acromegaly
+∞
10.4
10
*
H01AX01
ATC
pegvisomant; parenteral
+∞
10.4
10
*
P06
ICPC
Sleep disturbance
1.3
10.4
621
4739
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.4
10.4
438
3157
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.6
10.4
214
1325
S29
ICPC
Skin symptom/complaint other
1.3
10.4
1038
8492
J20
ICD-10 Finland
Acute bronchitis
1.4
10.4
502
3706
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
1.9
10.4
125
663
R50.9
ICD-10 Finland
Fever, unspecified
1.3
10.3
719
5611
H02AB07
ATC
prednisone; oral
1.3
10.3
636
4876
N91.4
ICD-10 Finland
Secondary oligomenorrhoea
4.2
10.3
27
65
2159
FHL
Other measure in this category
16.0
10.3
16
10
B01AA03
ATC
warfarin; systemic
1.3
10.3
805
6381
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
2.0
10.3
114
587
160
Kela drug reimbursment
exenatide
2.1
10.3
99
485
M01AG02
ATC
tolfenamic acid; oral, rectal
1.3
10.3
705
5492
K35.9
ICD-10 Finland
Acute appendicitis, unspecified
1.5
10.2
314
2130
RD210, ,
NOMESCO Finland
2.2
10.2
84
387
G04CA02
ATC
tamsulosin; oral
1.3
10.2
1022
8362
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
1.6
10.2
204
1255
C08CA10
ATC
nilvadipine; oral
2.1
10.2
93
447
R95
ICPC
Chron obstructive pulmonary disease
1.8
10.1
146
819
R03BA05
ATC
fluticasone; inhalant
1.3
10.1
849
6793
E29.1
ICD-10 Finland
Testicular hypofunction
2.4
10.1
65
269
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.4
10.1
477
3506
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
1.8
10.1
143
798
A12AA04
ATC
calcium carbonate; oral
2.3
10.1
77
344
G93.0
ICD-10 Finland
Cerebral cysts
3.9
10.1
29
75
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.3
10.1
922
7459
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
2.1
10.1
89
422
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
1.8
10.1
148
836
PD5AD
NOMESCO Finland
CT of aorta
1.9
10.0
122
649
R04
ICPC
Breathing problem other
1.7
10.0
193
1176
L86
ICPC
Back syndrome with radiating pain
1.5
10.0
309
2100
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.0
9.9
108
553
ZX114
NOMESCO Finland
Intramuscular
2.4
9.9
68
290
A10BJ05
ATC
dulaglutide; parenteral
2.0
9.9
104
526
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.3
9.9
686
5349
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.3
9.9
638
4927
J02AC01
ATC
fluconazole; systemic
1.2
9.9
1960
17236
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
1.8
9.8
137
761
D44.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified
12.2
9.8
17
14
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.6
9.8
248
1615
K92.1
ICD-10 Finland
Melaena
1.6
9.8
237
1528
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
2.4
9.7
63
262
KAT00
NOMESCO Finland
Extracorporeal shock wave lithotripsy of pelvis of kidney
2.6
9.7
53
203
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.5
9.7
355
2494
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
1.8
9.7
129
707
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
1.9
9.7
121
650
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.2
9.7
1370
11647
OAB42
NOMESCO Finland
Guidance related to known health problem
3.8
9.7
28
73
BBA50
NOMESCO Finland
Total parathyroidectomy
13.4
9.7
16
12
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
2.9
9.6
43
148
C09DA06
ATC
candesartan and diuretics; oral
1.4
9.6
362
2558
LC2HE
NOMESCO Finland
Hystero-salpingography with ultrasound
1.6
9.6
200
1243
104
Kela drug reimbursment
Thyroid insufficiency
1.5
9.6
335
2334
Z2445
NOMESCO Finland
Psychologist
1.7
9.5
164
969
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.3
9.5
694
5450
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.6
9.5
234
1514
H25.1
ICD-10 Finland
Senile nuclear cataract
1.2
9.5
1254
10580
B01AC04
ATC
clopidogrel; oral
1.3
9.5
755
6000
XF402
NOMESCO Finland
ECG with work load test
1.4
9.5
491
3667
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.6
9.4
212
1342
8680/3-C75.5
ICD-O-3
Paraganglioma, NOS, of aortic body and other paraganglia
100.2
9.4
10
*
C07AG02
ATC
carvedilol; oral
1.5
9.4
259
1718
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
1.7
9.4
151
876
D352, E220,
ICD-10 Finland
+∞
9.4
9
*
9350/1-C75.1
ICD-O-3
Craniopharyngioma, NOS, of pituitary gland
+∞
9.4
9
*
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
1.7
9.4
155
907
SFA30
NOMESCO Finland
Three-surface restoration
1.2
9.3
2194
19565
E27.8
ICD-10 Finland
Other specified disorders of adrenal gland
21.7
9.3
13
6
H53.2
ICD-10 Finland
Diplopia
1.7
9.3
158
930
WVA20, ,
SPAT
1.7
9.3
177
1076
J01FA09
ATC
clarithromycin; systemic
1.2
9.3
1531
13209
S04
ICPC
Lump/swelling localized
1.4
9.3
532
4035
K59.09
ICD-10 Finland
Constipation, unspecified
1.5
9.2
332
2325
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
2.3
9.2
65
281
E0000UV, ,
ATC
1.2
9.2
2103
18698
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
2.0
9.2
98
499
G43.9
ICD-10 Finland
Migraine, unspecified
1.5
9.2
265
1776
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
2.3
9.2
66
288
3051, ,
Kela drug reimbursment
2.4
9.2
58
239
N06AB06
ATC
sertraline; oral
1.4
9.2
519
3929
R01AD08
ATC
fluticasone; nasal
1.2
9.2
1388
11872
I11
ICD-10 Finland
Hypertensive heart disease
3.3
9.1
33
100
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.4
9.1
495
3722
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
1.8
9.1
126
699
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
1.8
9.1
128
714
T28
ICPC
Limited function/disability (T)
2.5
9.1
53
210
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.5
9.1
325
2274
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.5
9.1
282
1919
E27.9
ICD-10 Finland
Disorder of adrenal gland, unspecified
11.5
9.0
16
14
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.2
9.0
1061
8832
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.2
9.0
1384
11848
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
3.4
9.0
31
91
D30.0
ICD-10 Finland
Benign neoplasm: Kidney
2.6
9.0
52
205
N05BA01
ATC
diazepam; systemic, rectal
1.3
9.0
591
4573
N06AX22
ATC
agomelatine; oral
1.9
9.0
106
559
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.4
9.0
435
3212
K04.0
ICD-10 Finland
Pulpitis
1.4
9.0
401
2922
L02.8
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of other sites
2.1
9.0
82
395
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.5
9.0
307
2131
E03.89
ICD-10 Finland
Other specified hypothyroidism
1.6
9.0
196
1234
R04.0
ICD-10 Finland
Epistaxis
1.4
8.9
348
2474
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
8.9
2204
19722
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.4
8.9
434
3209
BAA60
NOMESCO Finland
Total thyroidectomy
1.8
8.9
118
647
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.5
8.9
259
1741
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
4.3
8.9
22
51
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.4
8.8
436
3229
G03DB01
ATC
dydrogesterone; oral
1.3
8.8
552
4240
U04
ICPC
Incontinence urine
1.5
8.8
274
1865
DFF00
NOMESCO Finland
Pure tone audiometry
1.4
8.8
498
3768
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.3
8.8
621
4852
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
1.8
8.8
133
759
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.4
8.8
416
3061
A10BX07
ATC
[U] liraglutide
2.3
8.8
63
275
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
10.7
8.8
16
15
I50.0
ICD-10 Finland
Congestive heart failure
1.5
8.8
289
1991
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.2
8.8
1108
9296
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.3
8.7
695
5520
L20
ICPC
Joint symptom/complaint NOS
1.6
8.7
180
1117
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
2.3
8.7
66
295
WVA20
NOMESCO Finland
Medicine administration
1.8
8.7
132
754
8240/3-C25.9
ICD-O-3
Neuroendocrine tumor, NOS, of pancreas, NOS
14.0
8.7
14
10
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.4
8.7
463
3473
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.3
8.6
495
3756
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
2.4
8.6
55
228
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
2.4
8.6
54
222
S97
ICPC
Chronic ulcer skin
1.5
8.6
288
1991
M04AA01
ATC
allopurinol; systemic
1.3
8.6
575
4461
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.5
8.6
247
1656
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
8.5
3501
32630
162
Kela drug reimbursment
liraglutide
2.4
8.5
57
241
N30.9
ICD-10 Finland
Cystitis, unspecified
1.5
8.5
305
2135
R83
ICPC
Respiratory infection other
1.2
8.5
1168
9878
R01AD58
ATC
fluticasone, combinations; nasal
1.2
8.5
1188
10065
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.5
8.5
252
1700
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.3
8.5
606
4745
N05CF02
ATC
zolpidem; oral
1.3
8.4
822
6695
BC5AQ
NOMESCO Finland
Chromaffine tissue SPECT with low dose CT
90.2
8.4
9
*
PDQ20
NOMESCO Finland
Insertion of endovascular graft into common iliac artery
3.9
8.4
24
62
S21
ICPC
Skin texture symptom/complaint
1.3
8.4
749
6035
C09DA07
ATC
telmisartan and diuretics; oral
1.6
8.4
194
1239
2397A
ICD-9 Finland
Neoplasm of unspecified nature, Endocrine glands and other parts of nervous system
12.8
8.4
14
11
T92
ICPC
Gout
1.9
8.3
99
524
E87.8
ICD-10 Finland
Other disorders of electrolyte and fluid balance, not elsewhere classified
4.6
8.3
19
41
XG410
NOMESCO Finland
Flow-volume spirometry
1.6
8.3
173
1076
D44.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Craniopharyngeal duct
+∞
8.3
8
*
E2300, D352,
ICD-10 Finland
+∞
8.3
8
*
D350, E260,
ICD-10 Finland
+∞
8.3
8
*
2549, ,
FHL
+∞
8.3
8
*
2550C
ICD-9 Finland
Disorders of adrenal glands, Cushing's syndrome[SYNDROMA CUSHING E HYPERSECRETIO HYPOFYSEOS]
+∞
8.3
8
*
AN1
HP
Coronary angiography
1.3
8.3
469
3548
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
1.6
8.3
166
1023
XW000
NOMESCO Finland
Bone marrow biopsy
1.6
8.3
187
1187
ZZC00
NOMESCO Finland
Graft of fascia
8.5
8.3
17
20
C08DB01
ATC
diltiazem; oral
1.6
8.3
203
1314
SGA02
NOMESCO Finland
Opening and preparing the root canals
1.3
8.3
592
4635
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.7
8.3
153
924
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.5
8.3
271
1866
K08.3
ICD-10 Finland
Retained dental root
1.4
8.3
369
2689
R06.5
ICD-10 Finland
Mouth breathing
1.4
8.2
414
3076
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
3.1
8.2
33
107
SPAT1252
SPAT
Overall medication plan or its review
1.5
8.2
288
2009
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
2.3
8.2
62
277
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.4
8.2
394
2906
SFA20
NOMESCO Finland
Two-surface restoration
1.2
8.2
3042
28079
R52.2
ICD-10 Finland
Other chronic pain
1.6
8.2
181
1143
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
1.9
8.2
97
513
J01CA08
ATC
pivmecillinam; oral
1.2
8.2
1964
17492
C07BB07
ATC
bisoprolol and thiazides; systemic
1.6
8.2
176
1104
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
1.8
8.2
110
606
XJH00
NOMESCO Finland
Transanal ultrasonography
1.5
8.2
235
1575
N03AX14
ATC
levetiracetam; systemic
1.7
8.2
132
768
K43.2
ICD-10 Finland
Incisional hernia without obstruction or gangrene
2.8
8.1
39
140
D02
ICPC
Abdominal pain epigastric
1.4
8.1
298
2096
XCH00
NOMESCO Finland
Eye pressure measurement
1.5
8.1
225
1496
M70.6
ICD-10 Finland
Trochanteric bursitis
1.3
8.1
661
5263
D12
ICPC
Constipation
1.6
8.1
173
1083
X14
ICPC
Vaginal discharge
2.0
8.1
85
431
E78.29
ICD-10 Finland
Other mixed hyperlipidaemia
2.4
8.1
52
216
A97
ICPC
No disease
1.2
8.1
969
8074
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
1.7
8.1
134
785
ZY010
NOMESCO Finland
Hospital outpatient
1.5
8.1
223
1481
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
2.8
8.1
40
146
A10BB12
ATC
glimepiride; oral
1.5
8.1
263
1808
G04BD08
ATC
solifenacin; oral
1.4
8.1
299
2107
E24
ICD-10 Finland
Cushing syndrome
33.4
8.1
10
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
2.1
8.1
73
351
ZYC03
NOMESCO Finland
Remote contact, text-based
3.0
8.1
35
119
X59
ICD-10 Finland
Exposure to unspecified factor
1.2
8.0
901
7454
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
1.8
8.0
107
588
C09AA05
ATC
ramipril; oral
1.2
8.0
1148
9746
J01MA06
ATC
norfloxacin; oral
1.3
8.0
584
4584
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
3.6
8.0
25
69
U05
ICPC
Urination problems other
1.5
8.0
250
1706
M01AH03
ATC
valdecoxib; oral
1.5
8.0
282
1971
XX3DW
NOMESCO Finland
Time consuming IT work
1.3
8.0
517
3993
R05
ICPC
Cough
1.2
7.9
1234
10561
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.6
7.9
185
1184
R03BA02
ATC
budesonide; inhalant
1.3
7.9
833
6841
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
4.3
7.9
20
47
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
1.6
7.9
174
1098
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.4
7.9
362
2649
M54.3
ICD-10 Finland
Sciatica
1.4
7.9
284
1991
JF2BD
NOMESCO Finland
Extensive colon CT
2.6
7.9
44
171
G04BD12
ATC
mirabegron; oral
1.3
7.9
582
4575
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
3.7
7.9
24
65
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.3
7.9
447
3386
A10AB05
ATC
insulin aspart; parenteral
1.4
7.9
338
2448
P01
ICPC
Feeling anxious/nervous/tense
1.3
7.8
504
3888
E21.5
ICD-10 Finland
Disorder of parathyroid gland, unspecified
6.1
7.8
20
33
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.7
7.8
140
839
A05
ICPC
Feeling ill
1.5
7.8
241
1641
SPAT1059
SPAT
Spirometry at the office
1.5
7.8
228
1535
R61.9
ICD-10 Finland
Hyperhidrosis, unspecified
2.2
7.8
63
290
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
1.9
7.8
90
473
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
2.2
7.8
62
284
B02AA02
ATC
tranexamic acid; systemic
1.3
7.7
667
5350
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
1.8
7.7
117
669
K57
ICD-10 Finland
Diverticular disease of intestine
1.8
7.7
107
596
BCA41
NOMESCO Finland
Endoscopic bilateral adrenalectomy
45.0
7.7
9
*
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
7.7
1199
10262
D09
ICPC
Nausea
1.6
7.7
193
1257
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
2.7
7.7
38
139
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.2
7.7
1016
8554
358
Kela drug reimbursment
liraglutide
3.1
7.7
30
96
R74
ICPC
Upper respiratory infection acute
1.2
7.7
1533
13426
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
2.7
7.6
39
145
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
2.0
7.6
83
427
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
1.8
7.6
107
598
SPAT1260
SPAT
Consultation of another employee
1.3
7.6
799
6559
SPAT1216
SPAT
Assessment of functional ability
1.3
7.6
679
5468
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.5
7.6
238
1624
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
2.0
7.6
79
400
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
1.7
7.6
144
876
WZA90
NOMESCO Finland
Other medical or dental certificate
1.2
7.6
1106
9401
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.4
7.6
272
1906
E66.0
ICD-10 Finland
Obesity due to excess calories
2.3
7.6
52
223
J96.1
ICD-10 Finland
Chronic respiratory failure
1.9
7.6
89
470
H01
ICPC
Ear pain/earache
1.3
7.6
534
4172
K85
ICPC
Elevated blood pressure
1.2
7.6
821
6767
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
1.8
7.5
109
615
A10BD07
ATC
metformin and sitagliptin; systemic
1.6
7.5
190
1239
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
1.6
7.5
177
1136
SFA10
NOMESCO Finland
One-surface restoration
1.2
7.5
2831
26090
AA1BD
NOMESCO Finland
Extensive CT of head and brain
1.8
7.5
111
631
J45
ICD-10 Finland
Asthma
1.3
7.5
482
3719
PA2AD
NOMESCO Finland
CT angiography of brain
2.4
7.5
49
206
T78.4
ICD-10 Finland
Allergy, unspecified
1.5
7.5
192
1258
M02AA07
ATC
piroxicam; topical
1.2
7.4
1729
15331
C02CA01
ATC
prazosin; oral
2.2
7.4
62
289
WX722
NOMESCO Finland
PEEP
1.5
7.4
201
1331
D07AC01
ATC
betamethasone; topical
1.2
7.4
1810
16112
KA1AE
NOMESCO Finland
Kidney ultrasound examination
1.7
7.4
116
670
JLC00
NOMESCO Finland
Excision of lesion of pancreas
80.2
7.4
8
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
1.8
7.4
97
531
PD7ZT
NOMESCO Finland
Stent grafting of abdominal aorta
3.5
7.4
24
68
R03AL11
ATC
formoterol, glycopyrronium bromide and budesonide; inhalant
2.5
7.4
43
171
SPAT1310
SPAT
Counselling related to known health issue
1.2
7.4
1495
13099
R4140
NOMESCO Finland
Psychotherapy
3.1
7.4
29
93
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.5
7.4
45
183
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
7.4
1167
9998
M01AB55
ATC
diclofenac, combinations; oral
1.4
7.4
292
2085
M43.1
ICD-10 Finland
Spondylolisthesis
1.6
7.4
184
1198
J01DC02
ATC
cefuroxime; systemic
1.5
7.3
241
1663
A29
ICPC
General symptom/complaint other
1.3
7.3
639
5134
D35
ICD-10 Finland
Benign neoplasm of other and unspecified endocrine glands
+∞
7.3
7
*
23990
ICD-8 Finland
Neoplasm of unspecified nature of other and unspecified organs, Glandulae pituitariae et ductus craniopharyngice
+∞
7.3
7
*
8272/3-C75.1
ICD-O-3
Pituitary carcinoma, NOS, of pituitary gland
+∞
7.3
7
*
E24.1
ICD-10 Finland
Nelson syndrome
+∞
7.3
7
*
J01CF05
ATC
flucloxacillin; systemic
1.4
7.3
324
2361
SPAT1058
SPAT
PEF monitoring instruction
1.4
7.3
360
2670
J01DA06
ATC
[U] cefuroxime
1.3
7.3
646
5200
N03AX18
ATC
lacosamide; systemic
2.6
7.3
39
149
E21.1
ICD-10 Finland
Secondary hyperparathyroidism, not elsewhere classified
4.1
7.3
19
46
L15
ICPC
Knee symptom/complaint
1.2
7.3
1263
10916
WF099
NOMESCO Finland
Other radiotherapy
2.8
7.2
34
121
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.3
7.2
540
4252
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
1.5
7.2
238
1642
E23.02
ICD-10 Finland
Neurosecretory dysfunction of the growth hormone
15.7
7.2
11
7
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.5
7.2
211
1422
SGB10
NOMESCO Finland
Root filling of tooth with one root canal
1.3
7.2
566
4488
R03AK08
ATC
formoterol and beclometasone; inhalant
1.5
7.2
206
1382
C09AA04
ATC
perindopril; oral
1.5
7.2
211
1423
NGC00
NOMESCO Finland
Exchange of a loose part of prosthesis in knee joint
3.0
7.2
30
100
K63.5
ICD-10 Finland
Polyp of colon
1.7
7.2
112
647
Z02.7
ICD-10 Finland
Issue of medical certificate
1.4
7.1
332
2438
H53.9
ICD-10 Finland
Visual disturbance, unspecified
1.6
7.1
176
1143
E26
ICD-10 Finland
Hyperaldosteronism
20.0
7.1
10
5
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
2.3
7.1
53
236
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
2.1
7.1
66
321
N19
ICD-10 Finland
Unspecified kidney failure
1.6
7.1
154
970
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.1
7.1
64
308
K04.08
ICD-10 Finland
Other specified pulpit
1.4
7.1
336
2475
S76
ICPC
Skin infection other
1.4
7.1
251
1757
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.4
7.1
262
1849
OAB72
NOMESCO Finland
Weight control and weight loss guidance
2.4
7.1
44
181
R33
ICD-10 Finland
Retention of urine
1.4
7.0
329
2418
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
1.6
7.0
139
856
N06AX26
ATC
vortioxetine; oral
1.4
7.0
322
2360
N20.2
ICD-10 Finland
Calculus of kidney with calculus of ureter
2.7
7.0
35
129
M01AE01
ATC
ibuprofen; systemic, rectal
1.2
7.0
4991
48266
H54.7
ICD-10 Finland
Unspecified visual loss
2.6
7.0
39
152
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.3
7.0
690
5623
U07
ICPC
Urine symptom/complaint other
1.3
7.0
401
3043
WX723
NOMESCO Finland
CPAP therapy
1.5
7.0
202
1358
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.3
7.0
588
4702
D13.7
ICD-10 Finland
Benign neoplasm: Endocrine pancreas
7.0
7.0
16
23
N64.3
ICD-10 Finland
Galactorrhoea not associated with childbirth
3.4
7.0
24
71
K96
ICPC
Haemorrhoids
1.7
6.9
129
782
C09CA07
ATC
telmisartan; oral
1.4
6.9
342
2537
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.4
6.9
279
2000
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.3
6.9
490
3832
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
6.9
1899
17048
PC5CG
NOMESCO Finland
Extensive MRI examination of kidney vasculature with high intensity magnet
5.4
6.9
19
35
R03DC03
ATC
montelukast; oral
1.2
6.9
772
6382
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
1.7
6.9
120
715
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
1.9
6.9
81
429
M54.6
ICD-10 Finland
Pain in thoracic spine
1.4
6.9
334
2470
J01EA01
ATC
trimethoprim; systemic
1.2
6.9
1193
10302
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
2.0
6.9
68
339
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.3
6.9
441
3402
J01MA14
ATC
moxifloxacin; systemic
1.3
6.9
403
3069
KH1AA
NOMESCO Finland
Urinary tract X-ray examination without contrast
2.0
6.9
65
319
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
1.7
6.9
120
716
ZXD20
NOMESCO Finland
Day surgery
1.3
6.9
566
4515
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
6.9
1912
17183
Z01.2
ICD-10 Finland
Dental examination
1.2
6.8
2352
21473
H81.3
ICD-10 Finland
Other peripheral vertigo
1.7
6.8
127
770
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
1.9
6.8
83
445
H05.2
ICD-10 Finland
Exophthalmic conditions
4.1
6.8
18
44
R13
ICD-10 Finland
Dysphagia
1.4
6.8
327
2415
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
1.7
6.8
127
772
EBA30
NOMESCO Finland
Extraction of root of tooth
1.4
6.8
266
1898
U02
ICPC
Urinary frequency/urgency
1.2
6.8
701
5745
E22.88
ICD-10 Finland
Other hyperfunction of pituitary gland
40.1
6.8
8
*
25300
ICD-8 Finland
Diseases of pituitary gland, Aeromegalia
40.1
6.8
8
*
ZXF05
NOMESCO Finland
Interruption of procedure for other patient related reason
2.7
6.7
34
126
P29
ICPC
Psychological sympt/compl other
1.4
6.7
300
2189
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.5
6.7
213
1461
ACC51
NOMESCO Finland
Release of median nerve
1.4
6.7
345
2578
D44.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pineal gland
22.5
6.7
9
*
AA4WT
NOMESCO Finland
Selective blood sample from sinus petrosus inferior
22.5
6.7
9
*
C09DX01
ATC
valsartan, amlodipine and hydrochlorothiazide; oral
1.8
6.7
92
513
M02AA10
ATC
ketoprofen; topical
1.2
6.7
742
6130
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
1.8
6.7
94
528
XFE00
NOMESCO Finland
Epicardial ultrasonography
1.8
6.6
90
499
A07AA02
ATC
nystatin; oral
1.4
6.6
253
1796
M10.9
ICD-10 Finland
Gout, unspecified
1.4
6.6
306
2247
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.3
6.6
393
3000
S20.2
ICD-10 Finland
Contusion of thorax
1.4
6.6
233
1631
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
1.7
6.6
124
755
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
1.9
6.6
82
443
PD1AD
NOMESCO Finland
CT of abdominal aorta and branches
2.4
6.6
41
169
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
1.6
6.6
148
942
H93.1
ICD-10 Finland
Tinnitus
1.4
6.6
322
2386
PDQ05
NOMESCO Finland
Insertion of endovascular graft into infrarenal abdominal aorta
2.8
6.6
31
111
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.3
6.6
387
2950
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.3
6.5
482
3789
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
8.7
6.5
13
15
C07AB12
ATC
nebivolol; oral
1.6
6.5
133
826
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.4
6.5
302
2217
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
1.8
6.5
96
546
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.4
6.5
262
1878
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.5
6.5
192
1297
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
6.5
125
766
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
1.8
6.5
89
496
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
3.6
6.5
20
55
K61.0
ICD-10 Finland
Anal abscess
2.0
6.4
69
355
I48.1
ICD-10 Finland
Persistent atrial fibrillation
1.5
6.4
187
1261
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
1.6
6.4
132
823
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
1.6
6.4
128
792
UJF32, ,
SPAT
1.5
6.4
163
1068
C10AX09
ATC
ezetimibe; oral
1.2
6.4
829
6959
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.2
6.4
937
7962
JN3AE, ,
SPAT
1.5
6.4
178
1189
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
2.0
6.4
66
335
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
2.0
6.4
61
301
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
2.0
6.4
68
349
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.5
6.4
209
1443
G44.0
ICD-10 Finland
Cluster headache syndrome
2.2
6.4
51
235
R06AX22
ATC
ebastine; oral
1.2
6.4
780
6510
A11
ICPC
Chest pain NOS
1.3
6.4
407
3140
Z71.9
ICD-10 Finland
Counselling, unspecified
1.3
6.4
366
2781
ZX050
NOMESCO Finland
Stereotactic radiotherapy
2.4
6.3
41
172
N05BA12
ATC
alprazolam; oral
1.3
6.3
441
3441
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
1.9
6.3
78
420
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.5
6.3
204
1404
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
1.7
6.3
119
725
M79.1
ICD-10 Finland
Myalgia
1.2
6.3
699
5771
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.4
6.3
337
2532
SPAT1097
SPAT
Recording of ECG
1.2
6.3
650
5324
R01AD12
ATC
fluticasone furoate; nasal
1.2
6.3
1492
13222
J01FA15
ATC
telithromycin; oral
1.3
6.3
439
3428
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
9.2
6.3
12
13
T83
ICPC
Overweight
1.7
6.3
99
575
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
2.1
6.3
54
256
D25.2
ICD-10 Finland
Subserosal leiomyoma of uterus
1.8
6.3
80
436
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.5
6.3
162
1065
25200
ICD-8 Finland
Diseases of parathyroid gland, Hyperparathyroidism
18.0
6.3
9
5
G04CA01
ATC
alfuzosin; oral
1.3
6.3
508
4045
PA5DT
NOMESCO Finland
Embolisation of a tumor of carotis externa area
+∞
6.2
6
*
C75.1
ICD-10 Finland
Malignant neoplasm: Pituitary gland
+∞
6.2
6
*
E260, D350,
ICD-10 Finland
+∞
6.2
6
*
E220, D352,
ICD-10 Finland
+∞
6.2
6
*
2534
FHL
Remove both eggs
+∞
6.2
6
*
D352, E2300,
ICD-10 Finland
+∞
6.2
6
*
2533A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Pituitary dwarfism[NANISMUS HYPOPHYSARIUS]
+∞
6.2
6
*
N40
ICD-10 Finland
Hyperplasia of prostate
1.2
6.2
905
7680
J31.0
ICD-10 Finland
Chronic rhinitis
1.3
6.2
385
2955
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
2.0
6.2
66
338
K57.1
ICD-10 Finland
Diverticular disease of small intestine without perforation or abscess
2.0
6.2
67
345
25310
ICD-8 Finland
Diseases of pituitary gland, Panhypopituitarismus
26.7
6.2
8
*
L12
ICPC
Hand/finger symptom/complaint
1.2
6.2
821
6903
OAB93, ,
SPAT
1.4
6.2
266
1928
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.6
6.2
149
964
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.2
6.2
1049
9033
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
2.5
6.2
36
144
N05CD07
ATC
temazepam; oral
1.3
6.2
470
3713
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
1.7
6.1
102
601
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.4
6.1
320
2395
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
2.0
6.1
64
326
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
2.3
6.1
42
181
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
2.0
6.1
65
333
XF600
NOMESCO Finland
Bloodpressure measurement
1.4
6.1
262
1899
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
1.4
6.1
295
2181
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
1.7
6.1
96
557
C07AB03
ATC
atenolol; systemic
1.4
6.1
230
1630
ENB99
NOMESCO Finland
Other excision of pharynx and adjacent structures
7.7
6.1
13
17
KAE12
NOMESCO Finland
Retrograde ureteronephroscopic lithotripsy in pelvis of kidney
2.6
6.1
34
133
XQ848
NOMESCO Finland
Dermatological photography
1.6
6.1
128
802
PA6AD
NOMESCO Finland
CT of neck arteries
1.5
6.1
173
1161
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
2.8
6.1
28
99
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
1.8
6.1
78
426
D38.58
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other respiratory organ
12.5
6.1
10
8
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
1.4
6.1
221
1557
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.3
6.1
341
2582
K80.8
ICD-10 Finland
Other cholelithiasis
1.9
6.1
76
412
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
1.5
6.1
162
1073
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.4
6.1
258
1869
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.5
6.1
153
1001
GD1LA
NOMESCO Finland
GD
2.0
6.0
63
321
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
1.3
6.0
362
2767
T07
ICPC
Weight gain
1.9
6.0
70
370
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
1.8
6.0
77
420
C03DB01
ATC
amiloride; oral
6.7
6.0
14
21
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
1.6
6.0
141
907
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Endocrinology
46 [38004485]
46 [38004485]
1.1e+00
2.5e+00
2.8e+00
9.1e+00
3.8e+00
3.6e+00
3.0e+00
cases:10.25%
controls:3.55%
cases:19.85%
controls:2.04%
cases:7.12%
controls:0.45%
cases:60.61%
controls:0.02%
cases:16.27%
controls:0.42%
cases:42.51%
controls:2.06%
cases:43.96%
controls:3.85%
595
2055
5208
55890
1152
1181
4651
56764
413
260
5390
57685
3517
10
2286
57935
942
245
4847
57564
2388
1157
3229
54904
2050
1795
2613
44785
Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
47845-3 [3048821]
47845-3 [3048821]
2.5e+00
5.2e+00
7.3e+00
1.0e+50
—
3.8e+00
3.7e+00
cases:1.76%
controls:0.14%
cases:4.53%
controls:0.03%
cases:11.79%
controls:0.01%
cases:0.09%
controls:0.00%
—
—
cases:2.01%
controls:0.05%
cases:3.86%
controls:0.10%
102
84
5701
57861
263
15
5540
57930
684
5
5119
57940
5
0
5798
57945
—
113
26
5504
56035
180
48
4483
46532
Prolactin [Units/volume] in Serum or Plasma
15081-3 [3021387]
15081-3 [3021387]
1.2e+00
3.0e+00
5.9e+00
1.0e+50
4.5e+00
3.6e+00
3.1e+00
cases:2.33%
controls:0.70%
cases:4.93%
controls:0.25%
cases:6.91%
controls:0.02%
cases:0.17%
controls:0.00%
cases:1.92%
controls:0.02%
cases:7.28%
controls:0.21%
cases:13.08%
controls:0.67%
135
405
5668
57540
286
142
5517
57803
401
12
5402
57933
10
0
5793
57945
111
12
5678
57797
409
115
5208
55946
610
312
4053
46268
Cortisol [Moles/time] in 24 hour Urine
32310-5 [3020911]
32310-5 [3020911]
2.3e+00
4.5e+00
5.1e+00
—
1.0e+50
4.9e+00
4.2e+00
cases:0.59%
controls:0.06%
cases:1.36%
controls:0.02%
cases:1.36%
controls:0.01%
—
—
cases:1.16%
controls:0.00%
cases:2.05%
controls:0.02%
cases:2.17%
controls:0.03%
34
33
5769
57912
79
9
5724
57936
79
5
5724
57940
—
67
0
5722
57809
115
9
5502
56052
101
16
4562
46564
cabergoline; oral
G02CB03 [21602460]
G02CB03 [21602460]
3.7e+00
5.3e+00
—
1.0e+50
—
6.2e+00
5.5e+00
cases:1.34%
controls:0.03%
cases:1.72%
controls:0.01%
—
—
cases:1.05%
controls:0.00%
—
—
cases:4.33%
controls:0.01%
cases:6.37%
controls:0.03%
78
20
5725
57925
100
5
5703
57940
—
61
0
5742
57945
—
243
5
5374
56056
297
13
4366
46567
cabergoline; oral
N04BC06 [21604478]
N04BC06 [21604478]
3.7e+00
5.3e+00
—
1.0e+50
—
6.2e+00
5.5e+00
cases:1.34%
controls:0.03%
cases:1.72%
controls:0.01%
—
—
cases:1.05%
controls:0.00%
—
—
cases:4.33%
controls:0.01%
cases:6.37%
controls:0.03%
78
20
5725
57925
100
5
5703
57940
—
61
0
5742
57945
—
243
5
5374
56056
297
13
4366
46567
3-Methoxytyramine [Moles/volume] in Serum or Plasma
50140-3 [3030408]
50140-3 [3030408]
2.4e+00
4.6e+00
7.5e+00
—
—
3.5e+00
2.4e+00
cases:2.05%
controls:0.18%
cases:6.10%
controls:0.06%
cases:13.54%
controls:0.01%
—
—
—
—
cases:2.51%
controls:0.07%
cases:2.66%
controls:0.24%
119
107
5684
57838
354
36
5449
57909
786
5
5017
57940
—
—
141
42
5476
56019
124
111
4539
46469
Extensive MRI examination of sella turcica with high intensity magnet
AA4CG [2001300145]
AA4CG [2001300145]
3.1e+00
5.2e+00
—
1.0e+50
1.0e+50
6.2e+00
6.0e+00
cases:0.86%
controls:0.04%
cases:2.07%
controls:0.01%
—
—
cases:2.53%
controls:0.00%
cases:0.50%
controls:0.00%
cases:5.16%
controls:0.01%
cases:9.63%
controls:0.03%
50
22
5753
57923
120
7
5683
57938
—
147
0
5656
57945
29
0
5760
57809
290
6
5327
56055
449
12
4214
46568
Normetanephrine [Moles/volume] in Serum or Plasma
25489-6 [3026179]
25489-6 [3026179]
2.4e+00
4.6e+00
7.5e+00
—
—
3.6e+00
2.5e+00
cases:2.03%
controls:0.19%
cases:5.98%
controls:0.06%
cases:12.87%
controls:0.01%
—
—
—
—
cases:2.53%
controls:0.07%
cases:2.66%
controls:0.23%
118
110
5685
57835
347
37
5456
57908
747
5
5056
57940
—
—
142
40
5475
56021
124
108
4539
46472
Metanephrine [Moles/volume] in Serum or Plasma
25473-0 [3009340]
25473-0 [3009340]
2.4e+00
4.6e+00
7.0e+00
—
—
3.5e+00
2.6e+00
cases:1.84%
controls:0.17%
cases:5.14%
controls:0.06%
cases:10.55%
controls:0.01%
—
—
—
—
cases:2.05%
controls:0.06%
cases:2.34%
controls:0.18%
107
99
5696
57846
298
32
5505
57913
612
6
5191
57939
—
—
115
35
5502
56026
109
86
4554
46494
Hyperprolactinaemia
E22.1 [45600649]
E22.1 [45600649]
4.0e+00
4.9e+00
1.0e+50
1.0e+50
—
5.5e+00
5.4e+00
cases:1.72%
controls:0.03%
cases:2.26%
controls:0.02%
cases:0.98%
controls:0.00%
cases:3.36%
controls:0.00%
—
—
cases:4.36%
controls:0.02%
cases:6.15%
controls:0.03%
100
18
5703
57927
131
10
5672
57935
57
0
5746
57945
195
0
5608
57945
—
245
10
5372
56051
287
14
4376
46566
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
14675-3 [3036481]
1.1e+00
2.7e+00
5.6e+00
—
4.1e+00
3.1e+00
2.6e+00
cases:4.72%
controls:1.62%
cases:9.84%
controls:0.72%
cases:18.20%
controls:0.09%
—
—
cases:5.74%
controls:0.10%
cases:13.62%
controls:0.73%
cases:22.45%
controls:2.20%
274
938
5529
57007
571
415
5232
57530
1056
50
4747
57895
—
332
58
5457
57751
765
410
4852
55651
1047
1023
3616
45557
Neoplasm of uncertain or unknown behaviour: Adrenal gland
D44.1 [45571621]
D44.1 [45571621]
4.0e+00
5.9e+00
—
1.0e+50
—
4.7e+00
4.3e+00
cases:2.64%
controls:0.05%
cases:8.20%
controls:0.02%
—
—
cases:1.41%
controls:0.00%
—
—
cases:2.87%
controls:0.03%
cases:2.47%
controls:0.03%
153
28
5650
57917
476
14
5327
57931
—
82
0
5721
57945
—
161
15
5456
56046
115
16
4548
46564
Primary hyperaldosteronism
E26.0 [45586152]
E26.0 [45586152]
2.0e+00
4.3e+00
4.2e+00
1.0e+50
—
4.6e+00
3.5e+00
cases:0.41%
controls:0.05%
cases:1.71%
controls:0.02%
cases:0.71%
controls:0.01%
cases:1.64%
controls:0.00%
—
—
cases:3.13%
controls:0.03%
cases:2.12%
controls:0.07%
24
31
5779
57914
99
13
5704
57932
41
6
5762
57939
95
0
5708
57945
—
176
19
5441
56042
99
31
4564
46549
Lutropin [Units/volume] in Serum or Plasma
10501-5 [3009214]
10501-5 [3009214]
9.8e-01
2.8e+00
5.2e+00
—
4.3e+00
2.9e+00
2.3e+00
cases:1.38%
controls:0.52%
cases:2.71%
controls:0.18%
cases:3.03%
controls:0.02%
—
—
cases:1.02%
controls:0.01%
cases:2.92%
controls:0.17%
cases:5.13%
controls:0.54%
80
301
5723
57644
157
102
5646
57843
176
10
5627
57935
—
59
8
5730
57801
164
94
5453
55967
239
253
4424
46327
Neurosurgery
14 [38004459]
14 [38004459]
2.9e-01
1.1e+00
2.0e+00
6.8e+00
3.3e+00
2.6e+00
1.4e+00
cases:3.65%
controls:2.76%
cases:3.26%
controls:1.06%
cases:1.28%
controls:0.18%
cases:7.08%
controls:0.01%
cases:4.54%
controls:0.18%
cases:11.98%
controls:1.03%
cases:9.91%
controls:2.76%
212
1598
5591
56347
189
612
5614
57333
74
104
5729
57841
411
5
5392
57940
263
102
5526
57707
673
579
4944
55482
462
1287
4201
45293
Observation for other suspected diseases and conditions
Z03.80 [2000503756]
Z03.80 [2000503756]
1.4e+00
3.1e+00
3.9e+00
1.0e+50
4.0e+00
2.9e+00
2.0e+00
cases:1.22%
controls:0.31%
cases:2.55%
controls:0.12%
cases:0.86%
controls:0.02%
cases:0.57%
controls:0.00%
cases:0.66%
controls:0.01%
cases:1.57%
controls:0.09%
cases:1.54%
controls:0.21%
71
179
5732
57766
148
70
5655
57875
50
10
5753
57935
33
0
5770
57945
38
7
5751
57802
88
48
5529
56013
72
99
4591
46481
Panhypopituitarism
E23.00 [2000501468]
E23.00 [2000501468]
2.6e+00
3.6e+00
—
1.0e+50
—
5.1e+00
5.1e+00
cases:0.29%
controls:0.02%
cases:0.59%
controls:0.02%
—
—
cases:1.26%
controls:0.00%
—
—
cases:3.08%
controls:0.02%
cases:4.68%
controls:0.03%
17
13
5786
57932
34
9
5769
57936
—
73
0
5730
57945
—
173
11
5444
56050
218
14
4445
46566
Visual field defects
H53.4 [45557469]
H53.4 [45557469]
4.1e-01
2.8e+00
4.4e+00
1.0e+50
3.4e+00
3.2e+00
2.5e+00
cases:0.26%
controls:0.17%
cases:0.71%
controls:0.04%
cases:0.72%
controls:0.01%
cases:0.24%
controls:0.00%
cases:0.36%
controls:0.01%
cases:1.69%
controls:0.07%
cases:1.91%
controls:0.16%
15
99
5788
57846
41
25
5762
57920
42
5
5761
57940
14
0
5789
57945
21
7
5768
57802
95
39
5522
56022
89
75
4574
46505
bromocriptine; oral, parenteral
G02CB01 [21602458]
G02CB01 [21602458]
3.1e+00
3.9e+00
1.0e+50
1.0e+50
—
4.7e+00
4.3e+00
cases:1.10%
controls:0.05%
cases:1.03%
controls:0.02%
cases:0.21%
controls:0.00%
cases:0.31%
controls:0.00%
—
—
cases:1.41%
controls:0.01%
cases:2.10%
controls:0.03%
64
30
5739
57915
60
12
5743
57933
12
0
5791
57945
18
0
5785
57945
—
79
7
5538
56054
98
14
4565
46566
bromocriptine; oral
N04BC01 [21604473]
N04BC01 [21604473]
3.1e+00
3.9e+00
1.0e+50
1.0e+50
—
4.7e+00
4.3e+00
cases:1.10%
controls:0.05%
cases:1.03%
controls:0.02%
cases:0.21%
controls:0.00%
cases:0.31%
controls:0.00%
—
—
cases:1.41%
controls:0.01%
cases:2.10%
controls:0.03%
64
30
5739
57915
60
12
5743
57933
12
0
5791
57945
18
0
5785
57945
—
79
7
5538
56054
98
14
4565
46566
Other primary hyperparathyroidism
E21.09 [2000501463]
E21.09 [2000501463]
1.8e+00
3.4e+00
—
—
4.2e+00
3.6e+00
3.0e+00
cases:1.03%
controls:0.17%
cases:2.14%
controls:0.07%
—
—
—
—
cases:0.66%
controls:0.01%
cases:1.99%
controls:0.06%
cases:1.87%
controls:0.09%
60
101
5743
57844
124
42
5679
57903
—
—
38
6
5751
57803
112
32
5505
56029
87
43
4576
46537
octreotide; parenteral
H01CB02 [21602716]
H01CB02 [21602716]
—
2.2e+00
2.9e+00
—
3.1e+00
3.6e+00
4.1e+00
—
—
cases:0.16%
controls:0.02%
cases:0.16%
controls:0.01%
—
—
cases:0.19%
controls:0.01%
cases:0.57%
controls:0.02%
cases:0.99%
controls:0.02%
—
9
10
5794
57935
9
5
5794
57940
—
11
5
5778
57804
32
9
5585
56052
46
8
4617
46572
Somatotropin [Mass/volume] in Serum or Plasma
2963-7 [3023709]
2963-7 [3023709]
2.1e+00
4.3e+00
—
—
—
4.5e+00
4.8e+00
cases:0.34%
controls:0.04%
cases:1.36%
controls:0.02%
—
—
—
—
—
—
cases:1.89%
controls:0.02%
cases:3.37%
controls:0.03%
20
24
5783
57921
79
11
5724
57934
—
—
—
106
12
5511
56049
157
13
4506
46567
Primary hyperparathyroidism
E21.0 [45571667]
E21.0 [45571667]
1.6e+00
2.9e+00
3.1e+00
—
3.5e+00
2.7e+00
2.0e+00
cases:0.64%
controls:0.13%
cases:1.69%
controls:0.09%
cases:0.69%
controls:0.03%
—
—
cases:0.71%
controls:0.02%
cases:1.85%
controls:0.13%
cases:1.84%
controls:0.25%
37
76
5766
57869
98
55
5705
57890
40
19
5763
57926
—
41
13
5748
57796
104
74
5513
55987
86
115
4577
46465
Cortisol [Moles/volume] in Saliva (oral fluid)
51844-9 [3039429]
51844-9 [3039429]
2.7e+00
4.4e+00
—
—
—
5.0e+00
3.5e+00
cases:0.97%
controls:0.07%
cases:1.95%
controls:0.02%
—
—
—
—
—
—
cases:2.69%
controls:0.02%
cases:2.64%
controls:0.09%
56
39
5747
57906
113
14
5690
57931
—
—
—
151
10
5466
56051
123
40
4540
46540
Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
29775-4 [3014326]
29775-4 [3014326]
2.4e+00
4.1e+00
—
1.0e+50
—
4.5e+00
4.5e+00
cases:1.07%
controls:0.10%
cases:3.27%
controls:0.06%
—
—
cases:0.09%
controls:0.00%
—
—
cases:5.22%
controls:0.06%
cases:9.11%
controls:0.12%
62
58
5741
57887
190
32
5613
57913
—
5
0
5798
57945
—
293
33
5324
56028
425
54
4238
46526
Chromogranin A [Moles/volume] in Serum or Plasma
25587-7 [3014702]
25587-7 [3014702]
1.2e+00
2.4e+00
4.5e+00
—
2.5e+00
2.2e+00
2.0e+00
cases:0.72%
controls:0.23%
cases:1.45%
controls:0.14%
cases:1.05%
controls:0.01%
—
—
cases:0.28%
controls:0.02%
cases:1.28%
controls:0.14%
cases:2.29%
controls:0.31%
42
131
5761
57814
84
80
5719
57865
61
7
5742
57938
—
16
13
5773
57796
72
80
5545
55981
107
144
4556
46436
Macroprolactin [Presence] in Serum or Plasma
72680-2 [43055514]
72680-2 [43055514]
2.1e+00
4.0e+00
—
—
—
4.6e+00
3.8e+00
cases:0.36%
controls:0.04%
cases:0.93%
controls:0.02%
—
—
—
—
—
—
cases:0.87%
controls:0.01%
cases:1.46%
controls:0.03%
21
25
5782
57920
54
10
5749
57935
—
—
—
49
5
5568
56056
68
15
4595
46565
Prolactin monomeric/Prolactin.total in Serum or Plasma
50366-4 [3031309]
50366-4 [3031309]
2.4e+00
4.0e+00
—
1.0e+50
—
4.4e+00
3.7e+00
cases:0.48%
controls:0.04%
cases:1.17%
controls:0.02%
—
—
cases:0.09%
controls:0.00%
—
—
cases:1.14%
controls:0.01%
cases:1.93%
controls:0.05%
28
25
5775
57920
68
13
5735
57932
—
5
0
5798
57945
—
64
8
5553
56053
90
22
4573
46558
Prolactin monomeric [Units/volume] in Serum or Plasma
78994-1 [21491979]
78994-1 [21491979]
2.4e+00
3.9e+00
—
1.0e+50
—
4.4e+00
3.7e+00
cases:0.48%
controls:0.04%
cases:1.14%
controls:0.02%
—
—
cases:0.09%
controls:0.00%
—
—
cases:1.16%
controls:0.01%
cases:1.93%
controls:0.05%
28
25
5775
57920
66
13
5737
57932
—
5
0
5798
57945
—
65
8
5552
56053
90
23
4573
46557
desmopressin; nasal, oral, parenteral, sublingual
H01BA02 [21602700]
H01BA02 [21602700]
8.0e-01
1.8e+00
2.2e+00
—
3.8e+00
3.4e+00
3.3e+00
cases:0.28%
controls:0.12%
cases:0.40%
controls:0.07%
cases:0.14%
controls:0.02%
—
—
cases:0.83%
controls:0.02%
cases:2.19%
controls:0.07%
cases:2.72%
controls:0.11%
16
72
5787
57873
23
40
5780
57905
8
9
5795
57936
—
48
11
5741
57798
123
40
5494
56021
127
49
4536
46531
Estradiol (E2) [Moles/volume] in Serum or Plasma
14715-7 [3026725]
14715-7 [3026725]
4.6e-01
1.9e+00
4.4e+00
—
3.2e+00
2.3e+00
2.1e+00
cases:0.48%
controls:0.31%
cases:0.79%
controls:0.12%
cases:0.97%
controls:0.01%
—
—
cases:0.26%
controls:0.01%
cases:0.84%
controls:0.08%
cases:2.04%
controls:0.25%
28
177
5775
57768
46
68
5757
57877
56
7
5747
57938
—
15
6
5774
57803
47
47
5570
56014
95
116
4568
46464
CT of adrenal glands
BC1AD [2001300798]
BC1AD [2001300798]
3.1e+00
—
1.0e+50
1.0e+50
1.0e+50
5.4e+00
5.4e+00
cases:0.55%
controls:0.03%
—
—
cases:0.76%
controls:0.00%
cases:5.55%
controls:0.00%
cases:0.22%
controls:0.00%
cases:1.92%
controls:0.01%
cases:3.24%
controls:0.02%
32
15
5771
57930
—
44
0
5759
57945
322
0
5481
57945
13
0
5776
57809
108
5
5509
56056
151
7
4512
46573
Insulin-like growth factor [Moles/volume] in Serum or Plasma
25528-1 [3019083]
25528-1 [3019083]
2.3e+00
3.8e+00
—
—
—
3.9e+00
3.8e+00
cases:0.16%
controls:0.02%
cases:0.69%
controls:0.02%
—
—
—
—
—
—
cases:0.71%
controls:0.01%
cases:1.76%
controls:0.04%
9
9
5794
57936
40
9
5763
57936
—
—
—
40
8
5577
56053
82
18
4581
46562
Hyperparathyroidism, unspecified
E21.3 [45581360]
E21.3 [45581360]
1.5e+00
3.5e+00
3.4e+00
1.0e+50
—
2.7e+00
2.3e+00
cases:0.41%
controls:0.09%
cases:1.10%
controls:0.03%
cases:0.31%
controls:0.01%
cases:0.29%
controls:0.00%
—
—
cases:0.64%
controls:0.04%
cases:0.75%
controls:0.08%
24
54
5779
57891
64
20
5739
57925
18
6
5785
57939
17
0
5786
57945
—
36
24
5581
56037
35
35
4628
46545
hydrocortisone; oral, parenteral
H02AB09 [21602737]
H02AB09 [21602737]
5.1e-01
1.5e+00
2.7e+00
—
3.8e+00
2.9e+00
2.0e+00
cases:2.67%
controls:1.62%
cases:2.71%
controls:0.64%
cases:1.65%
controls:0.11%
—
—
cases:4.87%
controls:0.11%
cases:9.81%
controls:0.62%
cases:10.38%
controls:1.59%
155
939
5648
57006
157
368
5646
57577
96
64
5707
57881
—
282
65
5507
57744
551
350
5066
55711
484
740
4179
45840
Testosterone Free [Moles/volume] in Serum or Plasma by calculation
96559-0 [36032269]
96559-0 [36032269]
9.3e-01
2.1e+00
4.4e+00
—
2.1e+00
2.1e+00
1.7e+00
cases:1.07%
controls:0.43%
cases:1.29%
controls:0.17%
cases:1.19%
controls:0.02%
—
—
cases:0.21%
controls:0.02%
cases:1.58%
controls:0.19%
cases:2.92%
controls:0.55%
62
247
5741
57698
75
97
5728
57848
69
9
5734
57936
—
12
14
5777
57795
89
108
5528
55953
136
257
4527
46323
Aldosterone [Moles/volume] in Serum or Plasma
14586-2 [3001788]
14586-2 [3001788]
2.2e+00
4.8e+00
—
—
—
4.1e+00
2.1e+00
cases:1.74%
controls:0.20%
cases:5.41%
controls:0.05%
—
—
—
—
—
—
cases:2.60%
controls:0.05%
cases:2.14%
controls:0.26%
101
113
5702
57832
314
27
5489
57918
—
—
—
146
26
5471
56035
100
120
4563
46460
Metanephrine Free [Moles/volume] in Serum or Plasma
49700-8 [3032155]
49700-8 [3032155]
2.4e+00
4.7e+00
—
—
—
3.6e+00
2.6e+00
cases:1.84%
controls:0.17%
cases:5.41%
controls:0.05%
—
—
—
—
—
—
cases:2.19%
controls:0.06%
cases:2.47%
controls:0.20%
107
101
5696
57844
314
31
5489
57914
—
—
—
123
35
5494
56026
115
91
4548
46489
Follitropin [Units/volume] in Serum or Plasma
15067-2 [3023323]
15067-2 [3023323]
5.4e-01
1.7e+00
4.1e+00
—
3.3e+00
1.9e+00
1.4e+00
cases:1.71%
controls:1.00%
cases:1.96%
controls:0.36%
cases:2.09%
controls:0.04%
—
—
cases:0.60%
controls:0.02%
cases:2.07%
controls:0.30%
cases:4.22%
controls:1.03%
99
580
5704
57365
114
207
5689
57738
121
21
5682
57924
—
35
13
5754
57796
116
170
5501
55891
197
482
4466
46098
Upper gastrointestinal surgery
106 [44777669]
106 [44777669]
4.2e-01
1.6e+00
2.1e+00
4.4e+00
2.1e+00
1.4e+00
6.7e-01
cases:14.99%
controls:10.36%
cases:18.08%
controls:4.10%
cases:4.91%
controls:0.61%
cases:2.83%
controls:0.03%
cases:4.70%
controls:0.59%
cases:14.08%
controls:3.79%
cases:18.72%
controls:10.53%
870
6003
4933
51942
1049
2374
4754
55571
285
354
5518
57591
164
20
5639
57925
272
340
5517
57469
791
2124
4826
53937
873
4904
3790
41676
Very extensive MRI examination of brain with high intensity magnet
AA1DG [2001300120]
AA1DG [2001300120]
6.3e-01
2.9e+00
3.1e+00
1.0e+50
2.8e+00
2.4e+00
1.7e+00
cases:0.48%
controls:0.26%
cases:1.14%
controls:0.06%
cases:0.26%
controls:0.01%
cases:0.36%
controls:0.00%
cases:0.14%
controls:0.01%
cases:0.71%
controls:0.07%
cases:1.35%
controls:0.25%
28
149
5775
57796
66
36
5737
57909
15
7
5788
57938
21
0
5782
57945
8
5
5781
57804
40
38
5577
56023
63
115
4600
46465
Internal Medicine
11 [38004456]
11 [38004456]
3.7e-01
1.3e+00
1.6e+00
5.4e+00
1.8e+00
1.2e+00
8.6e-01
cases:27.55%
controls:20.73%
cases:24.19%
controls:7.95%
cases:6.01%
controls:1.29%
cases:12.11%
controls:0.06%
cases:7.19%
controls:1.23%
cases:21.58%
controls:7.48%
cases:34.55%
controls:18.22%
1599
12010
4204
45935
1404
4605
4399
53340
349
747
5454
57198
703
35
5100
57910
416
710
5373
57099
1212
4194
4405
51867
1611
8487
3052
38093
Renin [Units/volume] in Plasma
30895-7 [3011985]
30895-7 [3011985]
2.2e+00
4.5e+00
—
—
—
3.8e+00
2.1e+00
cases:1.88%
controls:0.22%
cases:5.74%
controls:0.07%
—
—
—
—
—
—
cases:2.69%
controls:0.06%
cases:2.29%
controls:0.28%
109
126
5694
57819
333
38
5470
57907
—
—
—
151
36
5466
56025
107
131
4556
46449
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
2.7e-01
1.1e+00
1.4e+00
5.4e+00
2.3e+00
1.3e+00
7.5e-01
cases:10.94%
controls:8.60%
cases:6.60%
controls:2.23%
cases:1.28%
controls:0.31%
cases:2.17%
controls:0.01%
cases:2.73%
controls:0.29%
cases:6.64%
controls:1.99%
cases:10.89%
controls:5.47%
635
4985
5168
52960
383
1295
5420
56650
74
180
5729
57765
126
6
5677
57939
158
165
5631
57644
373
1117
5244
54944
508
2550
4155
44030
Corticotropin [Mass/volume] in Plasma
2141-0 [3035637]
2141-0 [3035637]
2.0e+00
3.7e+00
—
—
—
3.6e+00
3.1e+00
cases:1.03%
controls:0.14%
cases:3.15%
controls:0.08%
—
—
—
—
—
—
cases:3.33%
controls:0.09%
cases:4.61%
controls:0.23%
60
79
5743
57866
183
47
5620
57898
—
—
—
187
52
5430
56009
215
106
4448
46474
Outpatient Hospital
22 [8756]
22 [8756]
2.1e-01
1.1e+00
1.4e+00
5.6e+00
2.1e+00
1.4e+00
6.5e-01
cases:28.12%
controls:24.11%
cases:16.91%
controls:6.43%
cases:2.96%
controls:0.76%
cases:5.98%
controls:0.02%
cases:5.29%
controls:0.68%
cases:18.27%
controls:5.38%
cases:24.71%
controls:14.64%
1632
13971
4171
43974
981
3727
4822
54218
172
439
5631
57506
347
14
5456
57931
306
393
5483
57416
1026
3017
4591
53044
1152
6819
3511
39761
Inpatient Visit
IP [9201]
IP [9201]
2.3e-01
1.1e+00
1.7e+00
5.3e+00
2.0e+00
1.3e+00
6.0e-01
cases:8.43%
controls:6.80%
cases:8.50%
controls:3.09%
cases:1.98%
controls:0.38%
cases:3.14%
controls:0.02%
cases:2.76%
controls:0.40%
cases:11.14%
controls:3.15%
cases:17.16%
controls:10.19%
489
3943
5314
54002
493
1792
5310
56153
115
219
5688
57726
182
9
5621
57936
160
229
5629
57580
626
1767
4991
54294
800
4746
3863
41834
Testosterone [Moles/volume] in Serum or Plasma
14913-8 [3017446]
14913-8 [3017446]
5.4e-01
1.8e+00
4.1e+00
—
2.4e+00
2.0e+00
1.4e+00
cases:2.76%
controls:1.63%
cases:4.03%
controls:0.72%
cases:4.22%
controls:0.07%
—
—
cases:0.98%
controls:0.09%
cases:5.34%
controls:0.77%
cases:9.44%
controls:2.39%
160
942
5643
57003
234
418
5569
57527
245
41
5558
57904
—
57
54
5732
57755
300
430
5317
55631
440
1115
4223
45465
Benign tumor of the meninges at the base of the brain
D32.02 [2000501309]
D32.02 [2000501309]
1.0e+00
1.6e+00
2.3e+00
1.0e+50
2.7e+00
2.4e+00
2.2e+00
cases:0.26%
controls:0.09%
cases:0.31%
controls:0.06%
cases:0.12%
controls:0.01%
cases:0.24%
controls:0.00%
cases:0.17%
controls:0.01%
cases:0.68%
controls:0.06%
cases:1.03%
controls:0.12%
15
55
5788
57890
18
35
5785
57910
7
7
5796
57938
14
0
5789
57945
10
7
5779
57802
38
34
5579
56027
48
56
4615
46524
Sex hormone binding globulin [Moles/volume] in Serum or Plasma
13967-5 [3004248]
13967-5 [3004248]
8.1e-01
2.1e+00
4.0e+00
—
1.7e+00
2.0e+00
1.5e+00
cases:1.19%
controls:0.53%
cases:1.71%
controls:0.22%
cases:1.26%
controls:0.02%
—
—
cases:0.21%
controls:0.04%
cases:1.85%
controls:0.26%
cases:3.41%
controls:0.78%
69
310
5734
57635
99
128
5704
57817
73
13
5730
57932
—
12
23
5777
57786
104
145
5513
55916
159
362
4504
46218
Perimetry
XCK00 [2001301380]
XCK00 [2001301380]
2.1e-01
1.4e+00
2.8e+00
1.0e+50
3.9e+00
2.5e+00
1.4e+00
cases:1.15%
controls:0.94%
cases:1.05%
controls:0.26%
cases:0.53%
controls:0.03%
cases:0.57%
controls:0.00%
cases:1.07%
controls:0.02%
cases:2.87%
controls:0.25%
cases:2.77%
controls:0.68%
67
546
5736
57399
61
149
5742
57796
31
18
5772
57927
33
0
5770
57945
62
13
5727
57796
161
138
5456
55923
129
318
4534
46262
Benign tumor of the meninges on the outer surface of the cerebrum
D32.00 [2000501307]
D32.00 [2000501307]
8.9e-01
1.5e+00
2.9e+00
1.0e+50
2.8e+00
2.1e+00
1.6e+00
cases:0.33%
controls:0.13%
cases:0.34%
controls:0.07%
cases:0.22%
controls:0.01%
cases:0.19%
controls:0.00%
cases:0.22%
controls:0.01%
cases:0.57%
controls:0.07%
cases:0.90%
controls:0.18%
19
78
5784
57867
20
43
5783
57902
13
7
5790
57938
11
0
5792
57945
13
8
5776
57801
32
38
5585
56023
42
82
4621
46498
Inpatient Hospital
21 [8717]
21 [8717]
2.4e-01
1.1e+00
1.3e+00
5.3e+00
2.0e+00
1.2e+00
5.8e-01
cases:34.46%
controls:29.23%
cases:22.70%
controls:8.65%
cases:4.10%
controls:1.13%
cases:7.93%
controls:0.04%
cases:7.83%
controls:1.10%
cases:21.60%
controls:7.78%
cases:30.11%
controls:19.39%
2000
16940
3803
41005
1317
5014
4486
52931
238
656
5565
57289
460
24
5343
57921
453
636
5336
57173
1213
4360
4404
51701
1404
9033
3259
37547
Outpatient Visit
OP [9202]
OP [9202]
4.2e-01
9.7e-01
1.1e+00
5.3e+00
1.3e+00
1.3e+00
1.1e+00
cases:82.22%
controls:75.18%
cases:75.67%
controls:54.22%
cases:28.16%
controls:11.29%
cases:49.84%
controls:0.48%
cases:31.56%
controls:10.97%
cases:81.11%
controls:53.22%
cases:92.82%
controls:80.41%
4771
43565
1032
14380
4391
31415
1412
26530
1634
6541
4169
51404
2892
281
2911
57664
1827
6341
3962
51468
4556
29837
1061
26224
4328
37454
335
9126
Calcium [Moles/time] in 24 hour Urine
14637-3 [3010838]
14637-3 [3010838]
9.8e-01
2.2e+00
2.8e+00
—
2.3e+00
1.7e+00
1.3e+00
cases:1.09%
controls:0.41%
cases:1.65%
controls:0.18%
cases:0.36%
controls:0.02%
—
—
cases:0.16%
controls:0.02%
cases:0.94%
controls:0.18%
cases:1.61%
controls:0.44%
63
237
5740
57708
96
106
5707
57839
21
13
5782
57932
—
9
9
5780
57800
53
100
5564
55961
75
207
4588
46373
androstanolone
G03BB02 [21602513]
G03BB02 [21602513]
1.0e+00
1.7e+00
1.5e+00
—
2.1e+00
2.4e+00
2.6e+00
cases:1.21%
controls:0.44%
cases:1.50%
controls:0.29%
cases:0.40%
controls:0.09%
—
—
cases:0.71%
controls:0.09%
cases:3.13%
controls:0.29%
cases:4.76%
controls:0.36%
70
254
5733
57691
87
167
5716
57778
23
53
5780
57892
—
41
52
5748
57757
176
165
5441
55896
222
168
4441
46412
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
K57.3 [45567316]
4.2e-01
1.4e+00
1.6e+00
4.6e+00
1.3e+00
9.7e-01
6.4e-01
cases:4.38%
controls:2.92%
cases:4.67%
controls:1.14%
cases:0.79%
controls:0.16%
cases:0.83%
controls:0.01%
cases:0.73%
controls:0.19%
cases:3.06%
controls:1.18%
cases:6.86%
controls:3.75%
254
1690
5549
56255
271
660
5532
57285
46
90
5757
57855
48
5
5755
57940
42
110
5747
57699
172
664
5445
55397
320
1746
4343
44834
5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
50149-4 [3030136]
50149-4 [3030136]
8.7e-01
1.5e+00
3.5e+00
—
1.9e+00
1.7e+00
1.5e+00
cases:0.34%
controls:0.14%
cases:0.45%
controls:0.10%
cases:0.29%
controls:0.01%
—
—
cases:0.12%
controls:0.02%
cases:0.55%
controls:0.10%
cases:0.94%
controls:0.21%
20
84
5783
57861
26
59
5777
57886
17
5
5786
57940
—
7
10
5782
57799
31
58
5586
56003
44
100
4619
46480
General Surgery
2 [38004447]
2 [38004447]
2.8e-01
9.9e-01
1.5e+00
5.2e+00
1.4e+00
9.5e-01
4.1e-01
cases:19.75%
controls:15.68%
cases:11.51%
controls:4.59%
cases:2.74%
controls:0.60%
cases:4.15%
controls:0.02%
cases:2.38%
controls:0.57%
cases:10.08%
controls:4.13%
cases:16.75%
controls:11.73%
1146
9088
4657
48857
668
2662
5135
55283
159
345
5644
57600
241
14
5562
57931
138
330
5651
57479
566
2318
5051
53743
781
5465
3882
41115
Visual field testing with Octopus automated perimetry
CS444 [2001301477]
CS444 [2001301477]
1.7e-01
8.7e-01
3.1e+00
1.0e+50
3.0e+00
2.4e+00
1.4e+00
cases:0.41%
controls:0.35%
cases:0.36%
controls:0.15%
cases:0.31%
controls:0.01%
cases:0.17%
controls:0.00%
cases:0.40%
controls:0.02%
cases:1.74%
controls:0.16%
cases:2.21%
controls:0.55%
24
203
5779
57742
21
88
5782
57857
18
8
5785
57937
10
0
5793
57945
23
12
5766
57797
98
87
5519
55974
103
257
4560
46323
Neurology
13 [38004458]
13 [38004458]
2.5e-01
1.1e+00
1.6e+00
4.6e+00
1.6e+00
9.5e-01
6.7e-01
cases:13.29%
controls:10.62%
cases:12.41%
controls:4.67%
cases:4.34%
controls:0.89%
cases:3.76%
controls:0.04%
cases:3.97%
controls:0.82%
cases:11.00%
controls:4.58%
cases:19.24%
controls:10.88%
771
6156
5032
51789
720
2708
5083
55237
252
514
5551
57431
218
23
5585
57922
230
473
5559
57336
618
2568
4999
53493
897
5068
3766
41512
Macroprolactin [Units/volume] in Serum or Plasma
74953-1 [44816844]
74953-1 [44816844]
1.1e+00
3.0e+00
—
—
—
3.5e+00
3.0e+00
cases:0.65%
controls:0.22%
cases:1.45%
controls:0.07%
—
—
—
—
—
—
cases:2.26%
controls:0.07%
cases:3.80%
controls:0.19%
38
128
5765
57817
84
42
5719
57903
—
—
—
127
38
5490
56023
177
89
4486
46491
androstanolone
A14AA01 [21600917]
A14AA01 [21600917]
9.7e-01
1.5e+00
1.4e+00
—
2.0e+00
2.3e+00
2.4e+00
cases:1.22%
controls:0.47%
cases:1.52%
controls:0.33%
cases:0.41%
controls:0.11%
—
—
cases:0.73%
controls:0.10%
cases:3.24%
controls:0.34%
cases:5.00%
controls:0.45%
71
272
5732
57673
88
190
5715
57755
24
62
5779
57883
—
42
60
5747
57749
182
191
5435
55870
233
211
4430
46369
spironolactone; oral
C03DA01 [21601534]
C03DA01 [21601534]
8.0e-01
1.2e+00
1.2e+00
3.6e+00
1.5e+00
1.3e+00
9.6e-01
cases:4.14%
controls:1.90%
cases:5.31%
controls:1.59%
cases:1.59%
controls:0.50%
cases:0.60%
controls:0.02%
cases:2.09%
controls:0.49%
cases:6.28%
controls:1.74%
cases:7.06%
controls:2.82%
240
1100
5563
56845
308
924
5495
57021
92
287
5711
57658
35
10
5768
57935
121
283
5668
57526
353
976
5264
55085
329
1314
4334
45266
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
7.3e-02
1.2e+00
2.0e+00
3.4e+00
2.0e+00
1.3e+00
6.4e-01
cases:5.22%
controls:4.87%
cases:6.03%
controls:1.98%
cases:1.76%
controls:0.25%
cases:0.53%
controls:0.02%
cases:1.88%
controls:0.26%
cases:6.84%
controls:1.98%
cases:10.87%
controls:6.03%
303
2824
5500
55121
350
1146
5453
56799
102
144
5701
57801
31
10
5772
57935
109
150
5680
57659
384
1111
5233
54950
507
2811
4156
43769
Immunohistochemistry procedure
117617002 [4035726]
117617002 [4035726]
7.0e-02
1.2e+00
2.5e+00
—
3.3e+00
2.3e+00
1.2e+00
cases:1.88%
controls:1.75%
cases:1.98%
controls:0.62%
cases:0.47%
controls:0.04%
—
—
cases:1.11%
controls:0.04%
cases:3.93%
controls:0.42%
cases:4.29%
controls:1.38%
109
1016
5694
56929
115
361
5688
57584
27
22
5776
57923
—
64
23
5725
57786
221
235
5396
55826
200
644
4463
45936
Other hyperparathyroidism
E21.2 [45547640]
E21.2 [45547640]
1.9e+00
3.3e+00
—
1.0e+50
—
2.7e+00
2.4e+00
cases:0.19%
controls:0.03%
cases:0.24%
controls:0.01%
—
—
cases:0.09%
controls:0.00%
—
—
cases:0.25%
controls:0.02%
cases:0.32%
controls:0.03%
11
16
5792
57929
14
5
5789
57940
—
5
0
5798
57945
—
14
9
5603
56052
15
13
4648
46567
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
D38.1 [45605357]
D38.1 [45605357]
5.8e-01
1.7e+00
2.6e+00
—
2.9e+00
1.9e+00
1.3e+00
cases:0.22%
controls:0.13%
cases:0.41%
controls:0.08%
cases:0.12%
controls:0.01%
—
—
cases:0.19%
controls:0.01%
cases:0.45%
controls:0.07%
cases:0.56%
controls:0.16%
13
73
5790
57872
24
45
5779
57900
7
5
5796
57940
—
11
6
5778
57803
25
37
5592
56024
26
73
4637
46507
Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
14688-6 [3016616]
14688-6 [3016616]
1.3e+00
3.6e+00
—
—
—
2.9e+00
2.6e+00
cases:0.43%
controls:0.11%
cases:1.15%
controls:0.03%
—
—
—
—
—
—
cases:0.50%
controls:0.03%
cases:1.12%
controls:0.08%
25
66
5778
57879
67
19
5736
57926
—
—
—
28
16
5589
56045
52
39
4611
46541
Otolaryngology
4 [38004449]
4 [38004449]
3.3e-01
7.7e-01
1.3e+00
4.7e+00
1.6e+00
1.1e+00
5.9e-01
cases:15.46%
controls:11.59%
cases:8.74%
controls:4.23%
cases:2.17%
controls:0.61%
cases:2.38%
controls:0.02%
cases:3.09%
controls:0.62%
cases:11.18%
controls:4.18%
cases:19.11%
controls:11.62%
897
6714
4906
51231
507
2450
5296
55495
126
354
5677
57591
138
13
5665
57932
179
358
5610
57451
628
2344
4989
53717
891
5411
3772
41169
Sodium [Moles/time] in 24 hour Urine
2956-1 [3002079]
2956-1 [3002079]
1.6e+00
3.4e+00
—
—
—
3.6e+00
1.7e+00
cases:0.41%
controls:0.09%
cases:1.12%
controls:0.04%
—
—
—
—
—
—
cases:0.59%
controls:0.02%
cases:0.64%
controls:0.11%
24
50
5779
57895
65
21
5738
57924
—
—
—
33
9
5584
56052
30
53
4633
46527
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
7.9e-02
1.1e+00
1.8e+00
3.5e+00
2.0e+00
1.3e+00
5.8e-01
cases:7.74%
controls:7.19%
cases:8.06%
controls:2.86%
cases:2.03%
controls:0.34%
cases:0.81%
controls:0.02%
cases:2.44%
controls:0.33%
cases:8.94%
controls:2.66%
cases:13.66%
controls:8.13%
449
4167
5354
53778
468
1658
5335
56287
118
198
5685
57747
47
14
5756
57931
141
193
5648
57616
502
1491
5115
54570
637
3787
4026
42793
Cell count panel - Cerebral spinal fluid
34563-7 [3044290]
34563-7 [3044290]
2.1e-01
1.5e+00
2.8e+00
—
3.4e+00
1.8e+00
7.6e-01
cases:0.47%
controls:0.38%
cases:0.60%
controls:0.13%
cases:0.22%
controls:0.01%
—
—
cases:0.26%
controls:0.01%
cases:0.77%
controls:0.13%
cases:1.05%
controls:0.49%
27
219
5776
57726
35
76
5768
57869
13
8
5790
57937
—
15
5
5774
57804
43
72
5574
55989
49
230
4614
46350
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
4.2e-01
9.7e-01
1.1e+00
4.9e+00
1.4e+00
8.4e-01
5.5e-01
cases:26.83%
controls:19.45%
cases:22.70%
controls:10.03%
cases:4.79%
controls:1.64%
cases:10.43%
controls:0.08%
cases:6.37%
controls:1.62%
cases:21.79%
controls:10.72%
cases:37.25%
controls:25.51%
1557
11268
4246
46677
1317
5813
4486
52132
278
953
5525
56992
605
48
5198
57897
369
934
5420
56875
1224
6011
4393
50050
1737
11881
2926
34699
Hypogonadotropic hypogonadism
E23.04 [2000501472]
E23.04 [2000501472]
1.4e+00
2.5e+00
—
—
—
3.6e+00
2.6e+00
cases:0.29%
controls:0.07%
cases:0.50%
controls:0.04%
—
—
—
—
—
—
cases:0.94%
controls:0.02%
cases:1.39%
controls:0.11%
17
40
5786
57905
29
23
5774
57922
—
—
—
53
14
5564
56047
65
50
4598
46530
Pancreatic polypeptide [Moles/volume] in Serum or Plasma
55226-5 [40758355]
55226-5 [40758355]
2.0e+00
3.1e+00
1.0e+50
—
—
2.3e+00
2.8e+00
cases:0.17%
controls:0.02%
cases:0.33%
controls:0.02%
cases:0.10%
controls:0.00%
—
—
—
—
cases:0.20%
controls:0.02%
cases:0.47%
controls:0.03%
10
14
5793
57931
19
9
5784
57936
6
0
5797
57945
—
—
11
11
5606
56050
22
13
4641
46567
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
2.4e-01
1.1e+00
2.0e+00
3.3e+00
1.8e+00
1.0e+00
7.0e-01
cases:14.34%
controls:11.67%
cases:17.94%
controls:6.64%
cases:7.12%
controls:1.03%
cases:0.91%
controls:0.03%
cases:5.99%
controls:1.08%
cases:16.81%
controls:6.67%
cases:29.81%
controls:17.45%
832
6762
4971
51183
1041
3850
4762
54095
413
598
5390
57347
53
20
5750
57925
347
626
5442
57183
944
3738
4673
52323
1390
8130
3273
38450
testosterone; oral, parenteral, rectal, sublingual, transdermal
G03BA03 [21602510]
G03BA03 [21602510]
9.5e-01
1.4e+00
1.3e+00
—
2.0e+00
2.2e+00
2.3e+00
cases:1.83%
controls:0.72%
cases:2.05%
controls:0.51%
cases:0.57%
controls:0.16%
—
—
cases:1.11%
controls:0.15%
cases:4.42%
controls:0.51%
cases:6.20%
controls:0.67%
106
415
5697
57530
119
293
5684
57652
33
90
5770
57855
—
64
89
5725
57720
248
287
5369
55774
289
313
4374
46267
Excision of lesion of parathyroid gland
BBA30 [2001300785]
BBA30 [2001300785]
1.2e+00
2.8e+00
—
1.0e+50
—
3.8e+00
2.2e+00
cases:0.22%
controls:0.07%
cases:0.43%
controls:0.03%
—
—
cases:1.69%
controls:0.00%
—
—
cases:1.14%
controls:0.02%
cases:0.60%
controls:0.06%
13
41
5790
57904
25
15
5778
57930
—
98
0
5705
57945
—
64
14
5553
56047
28
30
4635
46550
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
1.7e-02
1.1e+00
1.8e+00
3.7e+00
1.7e+00
1.1e+00
5.0e-01
cases:10.65%
controls:10.49%
cases:11.55%
controls:4.35%
cases:3.29%
controls:0.55%
cases:1.05%
controls:0.03%
cases:2.88%
controls:0.53%
cases:11.79%
controls:4.10%
cases:19.04%
controls:12.52%
618
6079
5185
51866
670
2521
5133
55424
191
321
5612
57624
61
15
5742
57930
167
308
5622
57501
662
2298
4955
53763
888
5833
3775
40747
Neoplasm of uncertain or unknown behaviour: Kidney
D41.0 [45581311]
D41.0 [45581311]
3.2e-01
2.0e+00
2.3e+00
—
2.7e+00
1.8e+00
1.1e+00
cases:0.38%
controls:0.28%
cases:0.97%
controls:0.14%
cases:0.43%
controls:0.04%
—
—
cases:0.47%
controls:0.03%
cases:0.80%
controls:0.13%
cases:0.88%
controls:0.28%
22
160
5781
57785
56
80
5747
57865
25
25
5778
57920
—
27
18
5762
57791
45
74
5572
55987
41
132
4622
46448
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
1.4e-01
1.3e+00
1.8e+00
3.4e+00
1.7e+00
1.2e+00
6.4e-01
cases:7.01%
controls:6.18%
cases:9.51%
controls:2.89%
cases:2.41%
controls:0.43%
cases:0.76%
controls:0.03%
cases:2.21%
controls:0.43%
cases:7.98%
controls:2.61%
cases:12.93%
controls:7.29%
407
3582
5396
54363
552
1672
5251
56273
140
247
5663
57698
44
15
5759
57930
128
246
5661
57563
448
1461
5169
54600
603
3396
4060
43184
Neoplasm of uncertain or unknown behaviour: Other digestive organs
D37.7 [45552349]
D37.7 [45552349]
6.8e-01
1.7e+00
2.4e+00
1.0e+50
2.5e+00
1.8e+00
1.4e+00
cases:0.43%
controls:0.22%
cases:0.72%
controls:0.13%
cases:0.41%
controls:0.04%
cases:0.34%
controls:0.00%
cases:0.35%
controls:0.03%
cases:0.93%
controls:0.15%
cases:1.27%
controls:0.32%
25
127
5778
57818
42
75
5761
57870
24
21
5779
57924
20
0
5783
57945
20
17
5769
57792
52
83
5565
55978
59
147
4604
46433
More than three and less than five hours
ZXE20 [2001311408]
ZXE20 [2001311408]
2.6e-01
1.3e+00
2.1e+00
1.0e+50
3.4e+00
2.0e+00
1.1e+00
cases:2.40%
controls:1.86%
cases:1.34%
controls:0.36%
cases:0.26%
controls:0.03%
cases:0.43%
controls:0.00%
cases:0.79%
controls:0.03%
cases:1.99%
controls:0.27%
cases:2.34%
controls:0.82%
139
1075
5664
56870
78
211
5725
57734
15
18
5788
57927
25
0
5778
57945
46
16
5743
57793
112
154
5505
55907
109
380
4554
46200
cinacalcet; oral
H05BX01 [21602792]
H05BX01 [21602792]
1.9e+00
2.3e+00
2.5e+00
—
—
1.8e+00
1.4e+00
cases:0.22%
controls:0.03%
cases:0.40%
controls:0.04%
cases:0.17%
controls:0.01%
—
—
—
—
cases:0.27%
controls:0.05%
cases:0.30%
controls:0.08%
13
20
5790
57925
23
23
5780
57922
10
8
5793
57937
—
—
15
26
5602
56035
14
36
4649
46544
Urology
34 [38004474]
34 [38004474]
3.1e-01
1.0e+00
1.3e+00
4.1e+00
1.3e+00
1.0e+00
6.0e-01
cases:8.93%
controls:6.69%
cases:9.20%
controls:3.60%
cases:2.57%
controls:0.70%
cases:1.29%
controls:0.02%
cases:2.37%
controls:0.62%
cases:8.85%
controls:3.43%
cases:13.04%
controls:7.57%
518
3875
5285
54070
534
2085
5269
55860
149
403
5654
57542
75
12
5728
57933
137
361
5652
57448
497
1924
5120
54137
608
3528
4055
43052
Sodium [Moles/volume] in Urine
2955-3 [3003181]
2955-3 [3003181]
5.3e-01
1.9e+00
2.4e+00
—
2.7e+00
1.6e+00
1.1e+00
cases:0.40%
controls:0.23%
cases:0.84%
controls:0.13%
cases:0.14%
controls:0.01%
—
—
cases:0.21%
controls:0.01%
cases:0.62%
controls:0.13%
cases:1.37%
controls:0.46%
23
136
5780
57809
49
74
5754
57871
8
7
5795
57938
—
12
8
5777
57801
35
71
5582
55990
64
215
4599
46365
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
2.1e-01
1.1e+00
2.0e+00
3.0e+00
1.8e+00
9.9e-01
6.8e-01
cases:12.56%
controls:10.42%
cases:14.98%
controls:5.80%
cases:5.95%
controls:0.88%
cases:0.74%
controls:0.04%
cases:5.06%
controls:0.90%
cases:14.03%
controls:5.69%
cases:25.65%
controls:14.83%
729
6037
5074
51908
869
3359
4934
54586
345
509
5458
57436
43
21
5760
57924
293
519
5496
57290
788
3191
4829
52870
1196
6910
3467
39670
Tissue Pathology biopsy report
66121-5 [40768804]
66121-5 [40768804]
9.9e-02
5.8e-01
1.4e+00
4.4e+00
1.8e+00
9.6e-01
5.6e-01
cases:11.15%
controls:10.21%
cases:6.43%
controls:3.71%
cases:1.46%
controls:0.36%
cases:0.67%
controls:0.01%
cases:2.19%
controls:0.36%
cases:7.92%
controls:3.19%
cases:16.71%
controls:10.26%
647
5915
5156
52030
373
2150
5430
55795
85
210
5718
57735
39
5
5764
57940
127
209
5662
57600
445
1789
5172
54272
779
4779
3884
41801
Cathetrisation of artery
TPH07 [2001309747]
TPH07 [2001309747]
3.4e-01
1.5e+00
2.9e+00
—
2.6e+00
1.7e+00
6.6e-01
cases:1.90%
controls:1.35%
cases:2.05%
controls:0.45%
cases:0.52%
controls:0.03%
—
—
cases:0.60%
controls:0.04%
cases:2.19%
controls:0.42%
cases:2.87%
controls:1.50%
110
783
5693
57162
119
262
5684
57683
30
17
5773
57928
—
35
26
5754
57783
123
236
5494
55825
134
701
4529
45879
Other and unspecified adrenocortical insufficiency
E27.4 [45576452]
E27.4 [45576452]
—
2.5e+00
—
1.0e+50
2.6e+00
2.2e+00
2.3e+00
—
—
cases:0.17%
controls:0.01%
—
—
cases:0.10%
controls:0.00%
cases:0.12%
controls:0.01%
cases:0.18%
controls:0.02%
cases:0.30%
controls:0.03%
—
10
8
5793
57937
—
6
0
5797
57945
7
5
5782
57804
10
11
5607
56050
14
14
4649
46566
Renin [Units/volume] in Plasma --upright
92825-9 [37021550]
92825-9 [37021550]
1.8e+00
4.3e+00
—
—
1.0e+50
3.6e+00
—
cases:0.34%
controls:0.06%
cases:0.62%
controls:0.01%
—
—
—
—
cases:0.35%
controls:0.00%
cases:0.32%
controls:0.01%
—
—
20
33
5783
57912
36
5
5767
57940
—
—
20
0
5769
57809
18
5
5599
56056
—
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
2.7e-01
1.2e+00
1.2e+00
4.3e+00
1.1e+00
8.8e-01
6.8e-01
cases:12.18%
controls:9.55%
cases:10.94%
controls:3.59%
cases:1.53%
controls:0.47%
cases:1.14%
controls:0.02%
cases:1.47%
controls:0.48%
cases:7.90%
controls:3.45%
cases:18.42%
controls:10.23%
707
5534
5096
52411
635
2082
5168
55863
89
273
5714
57672
66
9
5737
57936
85
275
5704
57534
444
1935
5173
54126
859
4766
3804
41814
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
2.4e-01
1.5e+00
1.7e+00
—
3.2e+00
2.0e+00
1.0e+00
cases:5.74%
controls:4.55%
cases:4.08%
controls:0.99%
cases:0.43%
controls:0.08%
—
—
cases:1.87%
controls:0.07%
cases:5.15%
controls:0.73%
cases:5.43%
controls:2.05%
333
2638
5470
55307
237
573
5566
57372
25
45
5778
57900
—
108
43
5681
57766
289
412
5328
55649
253
953
4410
45627
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
E11.9 [45561952]
3.5e-01
8.9e-01
9.3e-01
4.7e+00
1.3e+00
8.7e-01
5.9e-01
cases:8.46%
controls:6.09%
cases:7.53%
controls:3.23%
cases:1.55%
controls:0.62%
cases:3.65%
controls:0.03%
cases:2.21%
controls:0.62%
cases:8.03%
controls:3.52%
cases:13.32%
controls:7.88%
491
3530
5312
54415
437
1869
5366
56076
90
358
5713
57587
212
20
5591
57925
128
356
5661
57453
451
1972
5166
54089
621
3669
4042
42911
Hypothyroidism, unspecified
E03.9 [45537945]
E03.9 [45537945]
1.3e-01
8.3e-01
1.3e+00
4.8e+00
1.3e+00
8.0e-01
5.3e-01
cases:2.65%
controls:2.33%
cases:2.50%
controls:1.10%
cases:0.76%
controls:0.21%
cases:1.50%
controls:0.01%
cases:0.78%
controls:0.22%
cases:2.58%
controls:1.18%
cases:5.17%
controls:3.11%
154
1353
5649
56592
145
640
5658
57305
44
120
5759
57825
87
7
5716
57938
45
125
5744
57684
145
662
5472
55399
241
1450
4422
45130
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 [3020044]
14744-7 [3020044]
2.3e-01
1.5e+00
2.9e+00
—
3.0e+00
1.5e+00
7.1e-01
cases:0.48%
controls:0.38%
cases:0.62%
controls:0.14%
cases:0.24%
controls:0.01%
—
—
cases:0.17%
controls:0.01%
cases:0.59%
controls:0.14%
cases:1.07%
controls:0.53%
28
223
5775
57722
36
83
5767
57862
14
8
5789
57937
—
10
5
5779
57804
33
76
5584
55985
50
248
4613
46332
Pure hypercholesterolaemia
E78.01 [2000501514]
E78.01 [2000501514]
2.6e-01
8.7e-01
7.9e-01
5.1e+00
1.4e+00
6.6e-01
4.1e-01
cases:4.65%
controls:3.64%
cases:4.43%
controls:1.91%
cases:0.78%
controls:0.35%
cases:2.38%
controls:0.02%
cases:1.30%
controls:0.33%
cases:4.08%
controls:2.15%
cases:9.59%
controls:6.55%
270
2111
5533
55834
257
1104
5546
56841
45
205
5758
57740
138
9
5665
57936
75
192
5714
57617
229
1204
5388
54857
447
3049
4216
43531
CT examination of upper part of abdomen
JN1AD [2001305516]
JN1AD [2001305516]
2.1e+00
2.6e+00
—
1.0e+50
—
2.5e+00
2.2e+00
cases:0.12%
controls:0.02%
cases:0.21%
controls:0.02%
—
—
cases:0.16%
controls:0.00%
—
—
cases:0.18%
controls:0.01%
cases:0.21%
controls:0.02%
7
9
5796
57936
12
9
5791
57936
—
9
0
5794
57945
—
10
8
5607
56053
10
11
4653
46569
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
19230-2 [3014218]
9.3e-02
1.4e+00
2.0e+00
1.0e+50
3.3e+00
1.9e+00
7.8e-01
cases:0.84%
controls:0.77%
cases:1.52%
controls:0.38%
cases:0.34%
controls:0.05%
cases:0.24%
controls:0.00%
cases:1.26%
controls:0.05%
cases:2.69%
controls:0.43%
cases:3.24%
controls:1.51%
49
446
5754
57499
88
220
5715
57725
20
28
5783
57917
14
0
5789
57945
73
27
5716
57782
151
241
5466
55820
151
705
4512
45875
Other visual field testing
CS494 [2001301478]
CS494 [2001301478]
-1.1e+00
1.0e+00
2.5e+00
—
3.0e+00
1.6e+00
1.1e+00
cases:0.10%
controls:0.30%
cases:0.36%
controls:0.13%
cases:0.22%
controls:0.02%
—
—
cases:0.28%
controls:0.01%
cases:0.80%
controls:0.16%
cases:1.37%
controls:0.45%
6
172
5797
57773
21
74
5782
57871
13
11
5790
57934
—
16
8
5773
57801
45
87
5572
55974
64
209
4599
46371
Emergency Room Visit
ER [9203]
ER [9203]
3.3e-01
1.3e+00
1.4e+00
4.0e+00
1.1e+00
7.0e-01
5.5e-01
cases:41.51%
controls:33.85%
cases:29.69%
controls:10.78%
cases:5.08%
controls:1.34%
cases:2.81%
controls:0.06%
cases:3.83%
controls:1.29%
cases:18.35%
controls:10.01%
cases:38.86%
controls:26.74%
2409
19613
3394
38332
1723
6245
4080
51700
295
774
5508
57171
163
32
5640
57913
222
748
5567
57061
1031
5609
4586
50452
1812
12456
2851
34124
Psychologist
Z2445 [2001311558]
Z2445 [2001311558]
5.0e-01
1.6e+00
2.2e+00
—
2.4e+00
2.0e+00
1.0e+00
cases:0.72%
controls:0.44%
cases:0.41%
controls:0.09%
cases:0.14%
controls:0.02%
—
—
cases:0.17%
controls:0.02%
cases:0.45%
controls:0.06%
cases:0.54%
controls:0.19%
42
256
5761
57689
24
51
5779
57894
8
9
5795
57936
—
10
9
5779
57800
25
33
5592
56028
25
89
4638
46491
Gas panel - Venous blood
24339-4 [3000991]
24339-4 [3000991]
2.1e-01
1.3e+00
1.5e+00
2.3e+00
2.2e+00
1.2e+00
6.6e-01
cases:1.57%
controls:1.27%
cases:2.45%
controls:0.71%
cases:0.47%
controls:0.10%
cases:0.12%
controls:0.01%
cases:0.92%
controls:0.11%
cases:2.55%
controls:0.75%
cases:4.63%
controls:2.45%
91
737
5712
57208
142
411
5661
57534
27
59
5776
57886
7
7
5796
57938
53
62
5736
57747
143
421
5474
55640
216
1139
4447
45441
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]
2880-3 [3019473]
2.3e-01
1.4e+00
2.7e+00
—
2.8e+00
1.4e+00
7.4e-01
cases:0.59%
controls:0.46%
cases:0.69%
controls:0.17%
cases:0.28%
controls:0.02%
—
—
cases:0.17%
controls:0.01%
cases:0.64%
controls:0.15%
cases:1.24%
controls:0.60%
34
269
5769
57676
40
96
5763
57849
16
11
5787
57934
—
10
6
5779
57803
36
85
5581
55976
58
278
4605
46302
Very extensive CT examination of upper part of abdomen
JN1CD [2001305525]
JN1CD [2001305525]
1.1e+00
3.8e+00
—
1.0e+50
—
2.7e+00
2.6e+00
cases:0.17%
controls:0.06%
cases:0.48%
controls:0.01%
—
—
cases:0.48%
controls:0.00%
—
—
cases:0.18%
controls:0.01%
cases:0.17%
controls:0.01%
10
32
5793
57913
28
6
5775
57939
—
28
0
5775
57945
—
10
7
5607
56054
8
6
4655
46574
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
1.7e-01
1.0e+00
1.6e+00
3.2e+00
1.6e+00
9.2e-01
5.2e-01
cases:16.80%
controls:14.50%
cases:17.35%
controls:7.16%
cases:4.43%
controls:0.93%
cases:1.10%
controls:0.05%
cases:4.65%
controls:0.94%
cases:16.33%
controls:7.20%
cases:30.07%
controls:20.38%
975
8403
4828
49542
1007
4149
4796
53796
257
541
5546
57404
64
27
5739
57918
269
543
5520
57266
917
4039
4700
52022
1402
9493
3261
37087
Ophthalmology
18 [38004463]
18 [38004463]
2.1e-01
6.0e-01
1.2e+00
4.0e+00
1.4e+00
9.7e-01
5.9e-01
cases:18.94%
controls:15.93%
cases:12.10%
controls:7.02%
cases:4.50%
controls:1.36%
cases:1.95%
controls:0.04%
cases:5.44%
controls:1.41%
cases:17.48%
controls:7.41%
cases:29.27%
controls:18.67%
1099
9232
4704
48713
702
4069
5101
53876
261
787
5542
57158
113
22
5690
57923
315
817
5474
56992
982
4154
4635
51907
1365
8696
3298
37884
Sleep apnoea
G47.3 [45562094]
G47.3 [45562094]
5.5e-01
8.2e-01
9.4e-01
4.0e+00
1.0e+00
8.0e-01
7.7e-01
cases:9.00%
controls:5.39%
cases:7.41%
controls:3.40%
cases:1.71%
controls:0.67%
cases:2.19%
controls:0.04%
cases:1.92%
controls:0.69%
cases:7.66%
controls:3.58%
cases:13.64%
controls:6.81%
522
3124
5281
54821
430
1973
5373
55972
99
391
5704
57554
127
23
5676
57922
111
399
5678
57410
430
2007
5187
54054
636
3172
4027
43408
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-7.3e-01
-1.1e-01
9.0e-01
—
3.2e+00
2.8e+00
2.8e+00
cases:15.92%
controls:28.21%
cases:8.36%
controls:9.21%
cases:2.21%
controls:0.91%
—
—
cases:1.85%
controls:0.08%
cases:9.35%
controls:0.65%
cases:19.67%
controls:1.49%
924
16349
4879
41596
485
5336
5318
52609
128
525
5675
57420
—
107
45
5682
57764
525
362
5092
55699
917
692
3746
45888
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1963-8 [3016293]
2.5e-01
1.3e+00
1.8e+00
1.0e+50
3.2e+00
1.7e+00
8.0e-01
cases:1.14%
controls:0.89%
cases:1.57%
controls:0.45%
cases:0.33%
controls:0.05%
cases:0.22%
controls:0.00%
cases:1.14%
controls:0.05%
cases:2.47%
controls:0.46%
cases:3.37%
controls:1.54%
66
514
5737
57431
91
259
5712
57686
19
31
5784
57914
13
0
5790
57945
66
27
5723
57782
139
257
5478
55804
157
719
4506
45861
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
3.2e-01
7.6e-01
9.8e-01
4.2e+00
1.2e+00
7.6e-01
5.4e-01
cases:4.79%
controls:3.53%
cases:3.77%
controls:1.81%
cases:0.84%
controls:0.32%
cases:1.38%
controls:0.02%
cases:1.12%
controls:0.34%
cases:3.74%
controls:1.78%
cases:7.44%
controls:4.47%
278
2044
5525
55901
219
1048
5584
56897
49
185
5754
57760
80
12
5723
57933
65
195
5724
57614
210
999
5407
55062
347
2082
4316
44498
Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]
ZY020 [2001311600]
6.8e-01
1.2e+00
1.9e+00
1.0e+50
1.8e+00
1.9e+00
1.3e+00
cases:1.77%
controls:0.91%
cases:0.74%
controls:0.22%
cases:0.19%
controls:0.03%
cases:0.65%
controls:0.00%
cases:0.19%
controls:0.03%
cases:1.18%
controls:0.18%
cases:1.99%
controls:0.55%
103
527
5700
57418
43
128
5760
57817
11
17
5792
57928
38
0
5765
57945
11
19
5778
57790
66
99
5551
55962
93
256
4570
46324
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
2.8e-01
1.3e+00
1.1e+00
3.8e+00
1.3e+00
5.6e-01
4.1e-01
cases:6.46%
controls:4.97%
cases:9.63%
controls:2.91%
cases:1.19%
controls:0.41%
cases:0.95%
controls:0.02%
cases:1.40%
controls:0.39%
cases:6.04%
controls:3.54%
cases:16.30%
controls:11.42%
375
2882
5428
55063
559
1684
5244
56261
69
236
5734
57709
55
12
5748
57933
81
226
5708
57583
339
1986
5278
54075
760
5318
3903
41262
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
2.5e-01
1.1e+00
2.0e+00
2.4e+00
1.5e+00
9.1e-01
6.7e-01
cases:8.17%
controls:6.51%
cases:9.82%
controls:3.67%
cases:4.07%
controls:0.60%
cases:0.24%
controls:0.02%
cases:2.59%
controls:0.61%
cases:8.58%
controls:3.65%
cases:17.76%
controls:9.95%
474
3771
5329
54174
570
2127
5233
55818
236
347
5567
57598
14
13
5789
57932
150
352
5639
57457
482
2044
5135
54017
828
4634
3835
41946
Thorax extensive CT-examination
GD1BD [2001303621]
GD1BD [2001303621]
2.3e-02
2.0e+00
1.9e+00
—
2.4e+00
1.2e+00
1.1e+00
cases:0.64%
controls:0.62%
cases:1.14%
controls:0.16%
cases:0.12%
controls:0.02%
—
—
cases:0.16%
controls:0.01%
cases:0.43%
controls:0.12%
cases:0.88%
controls:0.30%
37
361
5766
57584
66
94
5737
57851
7
10
5796
57935
—
9
8
5780
57801
24
70
5593
55991
41
138
4622
46442
Lack of TSH
E23.05 [2000501473]
E23.05 [2000501473]
—
—
—
1.0e+50
—
4.0e+00
4.6e+00
—
—
—
—
—
—
cases:0.43%
controls:0.00%
—
—
cases:0.69%
controls:0.01%
cases:1.29%
controls:0.01%
—
—
—
25
0
5778
57945
—
39
7
5578
56054
60
6
4603
46574
Hypo-osmolality and hyponatraemia
E87.1 [45542779]
E87.1 [45542779]
5.9e-01
1.8e+00
2.6e+00
—
1.9e+00
1.5e+00
7.1e-01
cases:0.64%
controls:0.35%
cases:0.81%
controls:0.13%
cases:0.26%
controls:0.02%
—
—
cases:0.19%
controls:0.03%
cases:0.66%
controls:0.15%
cases:1.18%
controls:0.59%
37
205
5766
57740
47
77
5756
57868
15
11
5788
57934
—
11
16
5778
57793
37
83
5580
55978
55
273
4608
46307
Abdominal aortic aneurysm, without mention of rupture
I71.4 [45572130]
I71.4 [45572130]
6.5e-01
1.4e+00
2.6e+00
1.0e+50
2.2e+00
1.5e+00
8.6e-01
cases:0.38%
controls:0.20%
cases:0.53%
controls:0.13%
cases:0.26%
controls:0.02%
cases:0.17%
controls:0.00%
cases:0.14%
controls:0.02%
cases:0.64%
controls:0.14%
cases:0.79%
controls:0.34%
22
115
5781
57830
31
78
5772
57867
15
11
5788
57934
10
0
5793
57945
8
9
5781
57800
36
80
5581
55981
37
157
4626
46423
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
2.4e-01
1.1e+00
1.8e+00
—
2.7e+00
1.8e+00
9.2e-01
cases:7.94%
controls:6.35%
cases:4.31%
controls:1.53%
cases:0.59%
controls:0.10%
—
—
cases:1.71%
controls:0.12%
cases:6.27%
controls:1.05%
cases:7.27%
controls:3.03%
461
3679
5342
54266
250
885
5553
57060
34
58
5769
57887
—
99
68
5690
57741
352
590
5265
55471
339
1413
4324
45167
Calculus of kidney
N20.0 [45567830]
N20.0 [45567830]
6.9e-01
2.0e+00
1.9e+00
—
2.1e+00
1.5e+00
1.1e+00
cases:0.47%
controls:0.23%
cases:0.64%
controls:0.09%
cases:0.12%
controls:0.02%
—
—
cases:0.12%
controls:0.02%
cases:0.50%
controls:0.11%
cases:0.73%
controls:0.24%
27
136
5776
57809
37
52
5766
57893
7
11
5796
57934
—
7
9
5782
57800
28
60
5589
56001
34
113
4629
46467
prazosin; oral
C02CA01 [21600411]
C02CA01 [21600411]
1.1e+00
1.7e+00
1.7e+00
—
1.7e+00
1.4e+00
8.5e-01
cases:0.81%
controls:0.28%
cases:1.19%
controls:0.22%
cases:0.47%
controls:0.09%
—
—
cases:0.52%
controls:0.09%
cases:0.98%
controls:0.23%
cases:1.01%
controls:0.43%
47
160
5756
57785
69
125
5734
57820
27
51
5776
57894
—
30
53
5759
57756
55
130
5562
55931
47
202
4616
46378
Gastroenterology
10 [38004455]
10 [38004455]
3.3e-01
1.1e+00
1.1e+00
3.4e+00
1.1e+00
8.1e-01
6.7e-01
cases:8.32%
controls:6.15%
cases:8.32%
controls:2.82%
cases:1.57%
controls:0.53%
cases:0.45%
controls:0.02%
cases:1.52%
controls:0.53%
cases:6.11%
controls:2.80%
cases:12.87%
controls:7.00%
483
3565
5320
54380
483
1633
5320
56312
91
310
5712
57635
26
9
5777
57936
88
307
5701
57502
343
1569
5274
54492
600
3262
4063
43318
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
3.3e-01
7.8e-01
1.5e+00
1.0e+50
2.9e+00
1.9e+00
1.0e+00
cases:8.67%
controls:6.40%
cases:3.34%
controls:1.56%
cases:0.57%
controls:0.13%
cases:2.10%
controls:0.00%
cases:2.02%
controls:0.11%
cases:6.34%
controls:1.03%
cases:7.57%
controls:2.88%
503
3706
5300
54239
194
905
5609
57040
33
74
5770
57871
122
0
5681
57945
117
63
5672
57746
356
577
5261
55484
353
1342
4310
45238
Secondary hypertension, unspecified
I15.9 [45567163]
I15.9 [45567163]
1.4e+00
3.2e+00
—
—
—
2.3e+00
1.5e+00
cases:0.21%
controls:0.05%
cases:0.33%
controls:0.01%
—
—
—
—
—
—
cases:0.14%
controls:0.01%
cases:0.30%
controls:0.06%
12
29
5791
57916
19
8
5784
57937
—
—
—
8
8
5609
56053
14
30
4649
46550
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
2.1e-01
9.8e-01
9.7e-01
3.0e+00
1.5e+00
1.0e+00
6.8e-01
cases:6.72%
controls:5.51%
cases:4.74%
controls:1.83%
cases:0.71%
controls:0.27%
cases:0.36%
controls:0.02%
cases:0.95%
controls:0.21%
cases:4.06%
controls:1.51%
cases:8.71%
controls:4.60%
390
3195
5413
54750
275
1063
5528
56882
41
156
5762
57789
21
10
5782
57935
55
124
5734
57685
228
849
5389
55212
406
2145
4257
44435
Nontoxic multinodular goitre
E04.2 [45576425]
E04.2 [45576425]
6.4e-01
1.5e+00
1.9e+00
1.0e+50
2.2e+00
1.3e+00
8.5e-01
cases:0.71%
controls:0.37%
cases:0.59%
controls:0.13%
cases:0.17%
controls:0.03%
cases:0.40%
controls:0.00%
cases:0.21%
controls:0.02%
cases:0.59%
controls:0.16%
cases:0.90%
controls:0.39%
41
217
5762
57728
34
77
5769
57868
10
15
5793
57930
23
0
5780
57945
12
13
5777
57796
33
90
5584
55971
42
181
4621
46399
Tumor of uncertain or unknown nature in the ovary without histology
D39.10 [2000501354]
D39.10 [2000501354]
1.8e-01
2.0e+00
2.5e+00
—
2.5e+00
1.4e+00
3.9e-01
cases:0.21%
controls:0.17%
cases:0.38%
controls:0.05%
cases:0.10%
controls:0.01%
—
—
cases:0.10%
controls:0.01%
cases:0.18%
controls:0.04%
cases:0.21%
controls:0.15%
12
100
5791
57845
22
29
5781
57916
6
5
5797
57940
—
6
5
5783
57804
10
25
5607
56036
10
68
4653
46512
Calculus of ureter
N20.1 [45582395]
N20.1 [45582395]
8.1e-01
2.1e+00
3.3e+00
—
1.7e+00
1.4e+00
7.6e-01
cases:0.65%
controls:0.29%
cases:0.74%
controls:0.09%
cases:0.22%
controls:0.01%
—
—
cases:0.09%
controls:0.02%
cases:0.41%
controls:0.10%
cases:0.66%
controls:0.31%
38
170
5765
57775
43
52
5760
57893
13
5
5790
57940
—
5
9
5784
57800
23
56
5594
56005
31
146
4632
46434
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
2.7e-01
9.1e-01
1.8e+00
2.6e+00
1.2e+00
1.0e+00
4.6e-01
cases:4.17%
controls:3.22%
cases:2.57%
controls:1.05%
cases:0.67%
controls:0.11%
cases:0.12%
controls:0.01%
cases:0.33%
controls:0.10%
cases:2.67%
controls:0.98%
cases:5.55%
controls:3.57%
242
1868
5561
56077
149
609
5654
57336
39
64
5764
57881
7
5
5796
57940
19
60
5770
57749
150
551
5467
55510
259
1662
4404
44918
IgG subclass 4 [Mass/volume] in Serum
2469-5 [3024980]
2469-5 [3024980]
-2.5e-02
1.3e+00
2.8e+00
—
2.0e+00
1.5e+00
7.0e-01
cases:0.29%
controls:0.30%
cases:0.48%
controls:0.14%
cases:0.17%
controls:0.01%
—
—
cases:0.10%
controls:0.01%
cases:0.50%
controls:0.12%
cases:0.84%
controls:0.42%
17
174
5786
57771
28
80
5775
57865
10
6
5793
57939
—
6
8
5783
57801
28
65
5589
55996
39
194
4624
46386
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
AA1BG [2001300112]
2.1e-01
1.4e+00
2.4e+00
1.0e+50
2.1e+00
1.4e+00
8.9e-01
cases:1.34%
controls:1.10%
cases:1.38%
controls:0.35%
cases:0.33%
controls:0.03%
cases:0.41%
controls:0.00%
cases:0.24%
controls:0.03%
cases:1.32%
controls:0.33%
cases:2.92%
controls:1.22%
78
636
5725
57309
80
200
5723
57745
19
18
5784
57927
24
0
5779
57945
14
17
5775
57792
74
183
5543
55878
136
568
4527
46012
Respiratory and circulatory monitoring
WX700 [2001310817]
WX700 [2001310817]
2.9e-01
9.6e-01
1.2e+00
—
3.1e+00
1.9e+00
7.8e-01
cases:3.22%
controls:2.44%
cases:1.95%
controls:0.75%
cases:0.22%
controls:0.07%
—
—
cases:1.50%
controls:0.07%
cases:3.74%
controls:0.59%
cases:4.46%
controls:2.10%
187
1414
5616
56531
113
437
5690
57508
13
41
5790
57904
—
87
41
5702
57768
210
333
5407
55728
208
976
4455
45604
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
2615-3 [3006217]
-5.6e-02
1.3e+00
2.2e+00
—
2.7e+00
1.5e+00
4.8e-01
cases:0.90%
controls:0.95%
cases:1.52%
controls:0.43%
cases:0.36%
controls:0.04%
—
—
cases:0.88%
controls:0.06%
cases:2.07%
controls:0.45%
cases:2.70%
controls:1.69%
52
549
5751
57396
88
249
5715
57696
21
24
5782
57921
—
51
36
5738
57773
116
254
5501
55807
126
787
4537
45793
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
AA1CG [2001300116]
5.4e-01
1.6e+00
2.8e+00
1.0e+50
1.2e+00
1.7e+00
1.4e+00
cases:1.65%
controls:0.97%
cases:1.72%
controls:0.35%
cases:0.47%
controls:0.03%
cases:0.62%
controls:0.00%
cases:0.12%
controls:0.04%
cases:1.51%
controls:0.27%
cases:3.62%
controls:0.93%
96
564
5707
57381
100
205
5703
57740
27
16
5776
57929
36
0
5767
57945
7
22
5782
57787
85
150
5532
55911
169
431
4494
46149
Intravenous general anesthesia
WX404 [2001310807]
WX404 [2001310807]
2.5e-01
7.8e-01
1.8e+00
—
2.2e+00
2.0e+00
1.1e+00
cases:4.48%
controls:3.54%
cases:1.91%
controls:0.88%
cases:0.41%
controls:0.07%
—
—
cases:0.57%
controls:0.06%
cases:3.49%
controls:0.51%
cases:4.20%
controls:1.43%
260
2051
5543
55894
111
511
5692
57434
24
39
5779
57906
—
33
37
5756
57772
196
286
5421
55775
196
667
4467
45913
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
59275-8 [40762366]
1.6e-01
1.4e+00
2.1e+00
—
2.7e+00
1.3e+00
5.6e-01
cases:1.00%
controls:0.86%
cases:1.64%
controls:0.40%
cases:0.33%
controls:0.04%
—
—
cases:0.67%
controls:0.05%
cases:1.74%
controls:0.46%
cases:2.75%
controls:1.58%
58
496
5745
57449
95
229
5708
57716
19
24
5784
57921
—
39
27
5750
57782
98
257
5519
55804
128
738
4535
45842
Secondary amenorrhoea
N91.1 [45601758]
N91.1 [45601758]
1.3e+00
2.2e+00
—
—
—
2.5e+00
2.1e+00
cases:0.34%
controls:0.10%
cases:0.31%
controls:0.03%
—
—
—
—
—
—
cases:0.25%
controls:0.02%
cases:0.56%
controls:0.07%
20
56
5783
57889
18
20
5785
57925
—
—
—
14
11
5603
56050
26
33
4637
46547
Examination of eyes and vision
Z01.0 [45566391]
Z01.0 [45566391]
4.1e-01
9.0e-01
2.2e+00
—
2.4e+00
1.4e+00
7.3e-01
cases:3.77%
controls:2.53%
cases:2.43%
controls:1.01%
cases:1.19%
controls:0.14%
—
—
cases:1.52%
controls:0.13%
cases:4.20%
controls:1.03%
cases:6.76%
controls:3.37%
219
1464
5584
56481
141
583
5662
57362
69
81
5734
57864
—
88
77
5701
57732
236
575
5381
55486
315
1570
4348
45010
General anaesthesia
WX402 [2001310806]
WX402 [2001310806]
3.0e-01
1.3e+00
2.0e+00
—
2.3e+00
1.5e+00
6.8e-01
cases:3.33%
controls:2.49%
cases:4.33%
controls:1.19%
cases:0.88%
controls:0.13%
—
—
cases:1.14%
controls:0.12%
cases:5.02%
controls:1.15%
cases:7.98%
controls:4.20%
193
1444
5610
56501
251
691
5552
57254
51
73
5752
57872
—
66
68
5723
57741
282
643
5335
55418
372
1955
4291
44625
Neuro-ophthalmology Physician
207WX0109X [903241]
207WX0109X [903241]
1.4e+00
1.8e+00
—
1.0e+50
—
3.2e+00
3.0e+00
cases:0.16%
controls:0.04%
cases:0.17%
controls:0.03%
—
—
cases:0.17%
controls:0.00%
—
—
cases:0.80%
controls:0.03%
cases:1.07%
controls:0.06%
9
22
5794
57923
10
16
5793
57929
—
10
0
5793
57945
—
45
18
5572
56043
50
26
4613
46554
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
2714-4 [3014007]
-1.1e-02
1.3e+00
2.1e+00
—
2.7e+00
1.5e+00
4.6e-01
cases:0.93%
controls:0.94%
cases:1.55%
controls:0.44%
cases:0.36%
controls:0.04%
—
—
cases:0.90%
controls:0.06%
cases:2.10%
controls:0.48%
cases:2.77%
controls:1.76%
54
545
5749
57400
90
253
5713
57692
21
26
5782
57919
—
52
36
5737
57773
118
267
5499
55794
129
821
4534
45759
Pulmonary Disease
29 [38004472]
29 [38004472]
4.4e-01
9.7e-01
1.1e+00
2.6e+00
1.2e+00
9.4e-01
7.7e-01
cases:14.23%
controls:9.69%
cases:12.42%
controls:5.10%
cases:2.90%
controls:0.95%
cases:0.53%
controls:0.04%
cases:3.11%
controls:0.97%
cases:11.80%
controls:4.98%
cases:19.79%
controls:10.23%
826
5612
4977
52333
721
2958
5082
54987
168
553
5635
57392
31
24
5772
57921
180
558
5609
57251
663
2792
4954
53269
923
4764
3740
41816
Osmolality of Urine
2695-5 [3026782]
2695-5 [3026782]
2.8e-01
1.3e+00
1.2e+00
1.9e+00
1.6e+00
9.6e-01
7.3e-01
cases:6.34%
controls:4.87%
cases:6.72%
controls:1.95%
cases:1.02%
controls:0.31%
cases:0.12%
controls:0.02%
cases:1.30%
controls:0.26%
cases:4.66%
controls:1.85%
cases:9.80%
controls:4.99%
368
2822
5435
55123
390
1129
5413
56816
59
179
5744
57766
7
10
5796
57935
75
152
5714
57657
262
1035
5355
55026
457
2325
4206
44255
Follitropin [Units/volume] in Serum or Plasma by Immunoassay
83098-4 [42529215]
83098-4 [42529215]
3.5e-01
1.6e+00
—
—
3.2e+00
1.9e+00
1.4e+00
cases:0.45%
controls:0.32%
cases:0.57%
controls:0.12%
—
—
—
—
cases:0.21%
controls:0.01%
cases:0.53%
controls:0.08%
cases:1.31%
controls:0.34%
26
184
5777
57761
33
67
5770
57878
—
—
12
5
5777
57804
30
47
5587
56014
61
158
4602
46422
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
2019-8 [3027946]
4.3e-02
1.3e+00
1.8e+00
—
2.8e+00
1.6e+00
5.6e-01
cases:2.09%
controls:2.00%
cases:3.22%
controls:0.91%
cases:0.53%
controls:0.09%
—
—
cases:1.88%
controls:0.12%
cases:4.47%
controls:0.94%
cases:5.51%
controls:3.23%
121
1158
5682
56787
187
526
5616
57419
31
53
5772
57892
—
109
69
5680
57740
251
527
5366
55534
257
1504
4406
45076
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
2703-7 [3027801]
4.5e-02
1.3e+00
1.8e+00
—
2.8e+00
1.6e+00
5.6e-01
cases:2.09%
controls:1.99%
cases:3.22%
controls:0.91%
cases:0.53%
controls:0.09%
—
—
cases:1.88%
controls:0.12%
cases:4.45%
controls:0.94%
cases:5.51%
controls:3.23%
121
1156
5682
56789
187
526
5616
57419
31
53
5772
57892
—
109
69
5680
57740
250
527
5367
55534
257
1504
4406
45076
Base excess in Arterial blood by calculation
1925-7 [3003396]
1925-7 [3003396]
5.7e-02
1.2e+00
1.8e+00
—
2.8e+00
1.6e+00
5.4e-01
cases:2.10%
controls:1.99%
cases:3.10%
controls:0.91%
cases:0.53%
controls:0.08%
—
—
cases:1.85%
controls:0.12%
cases:4.38%
controls:0.93%
cases:5.45%
controls:3.23%
122
1152
5681
56793
180
527
5623
57418
31
49
5772
57896
—
107
69
5682
57740
246
521
5371
55540
254
1506
4409
45074
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
2030-5 [3028653]
-9.2e-02
1.3e+00
2.1e+00
—
2.7e+00
1.5e+00
4.6e-01
cases:0.86%
controls:0.94%
cases:1.55%
controls:0.44%
cases:0.36%
controls:0.04%
—
—
cases:0.88%
controls:0.06%
cases:2.10%
controls:0.48%
cases:2.81%
controls:1.79%
50
547
5753
57398
90
254
5713
57691
21
26
5782
57919
—
51
36
5738
57773
118
268
5499
55793
131
833
4532
45747
Optic atrophy
H47.2 [45543066]
H47.2 [45543066]
—
2.0e+00
—
—
—
2.9e+00
3.0e+00
—
—
cases:0.14%
controls:0.02%
—
—
—
—
—
—
cases:0.27%
controls:0.01%
cases:0.45%
controls:0.02%
—
8
11
5795
57934
—
—
—
15
8
5602
56053
21
10
4642
46570
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
R91 [45548995]
3.2e-01
1.7e+00
2.1e+00
—
1.9e+00
1.5e+00
8.5e-01
cases:1.46%
controls:1.06%
cases:2.43%
controls:0.45%
cases:0.60%
controls:0.08%
—
—
cases:0.52%
controls:0.08%
cases:1.87%
controls:0.42%
cases:2.79%
controls:1.21%
85
616
5718
57329
141
262
5662
57683
35
45
5768
57900
—
30
47
5759
57762
105
238
5512
55823
130
563
4533
46017
Other obesity
E66.8 [45533036]
E66.8 [45533036]
1.0e+00
1.2e+00
1.4e+00
—
1.6e+00
1.5e+00
1.2e+00
cases:2.12%
controls:0.79%
cases:1.31%
controls:0.39%
cases:0.29%
controls:0.07%
—
—
cases:0.43%
controls:0.09%
cases:1.62%
controls:0.37%
cases:2.57%
controls:0.82%
123
457
5680
57488
76
227
5727
57718
17
42
5786
57903
—
25
50
5764
57759
91
206
5526
55855
120
383
4543
46197
pH of Arterial blood
2744-1 [3019977]
2744-1 [3019977]
3.4e-02
1.3e+00
1.7e+00
—
2.8e+00
1.6e+00
5.5e-01
cases:2.07%
controls:2.00%
cases:3.14%
controls:0.91%
cases:0.50%
controls:0.09%
—
—
cases:1.87%
controls:0.12%
cases:4.49%
controls:0.94%
cases:5.49%
controls:3.25%
120
1159
5683
56786
182
527
5621
57418
29
52
5774
57893
—
108
70
5681
57739
252
529
5365
55532
256
1514
4407
45066
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
1.1e-01
1.5e+00
2.0e+00
—
2.5e+00
1.4e+00
5.2e-01
cases:2.34%
controls:2.10%
cases:4.67%
controls:1.09%
cases:0.86%
controls:0.12%
—
—
cases:1.78%
controls:0.15%
cases:4.36%
controls:1.12%
cases:6.63%
controls:4.06%
136
1218
5667
56727
271
633
5532
57312
50
69
5753
57876
—
103
87
5686
57722
245
629
5372
55432
309
1892
4354
44688
Gastrin [Moles/volume] in Serum or Plasma
15072-2 [3010370]
15072-2 [3010370]
1.5e+00
3.1e+00
—
—
—
2.8e+00
2.0e+00
cases:0.14%
controls:0.03%
cases:0.26%
controls:0.01%
—
—
—
—
—
—
cases:0.18%
controls:0.01%
cases:0.39%
controls:0.05%
8
17
5795
57928
15
7
5788
57938
—
—
—
10
6
5607
56055
18
25
4645
46555
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
R29.8 [45587505]
4.2e-01
1.6e+00
2.1e+00
—
2.0e+00
1.1e+00
6.5e-01
cases:1.29%
controls:0.86%
cases:1.38%
controls:0.29%
cases:0.24%
controls:0.03%
—
—
cases:0.26%
controls:0.03%
cases:0.87%
controls:0.28%
cases:1.74%
controls:0.91%
75
496
5728
57449
80
169
5723
57776
14
18
5789
57927
—
15
20
5774
57789
49
158
5568
55903
81
425
4582
46155
Hyperlipidaemia, unspecified
E78.5 [45537986]
E78.5 [45537986]
1.1e-02
7.0e-01
9.9e-01
4.3e+00
1.3e+00
6.0e-01
2.1e-01
cases:1.57%
controls:1.55%
cases:1.24%
controls:0.62%
cases:0.26%
controls:0.10%
cases:0.62%
controls:0.01%
cases:0.29%
controls:0.08%
cases:1.21%
controls:0.67%
cases:2.32%
controls:1.89%
91
899
5712
57046
72
358
5731
57587
15
56
5788
57889
36
5
5767
57940
17
48
5772
57761
68
375
5549
55686
108
881
4555
45699
Third [oculomotor] nerve palsy
H49.0 [45586494]
H49.0 [45586494]
—
2.5e+00
—
—
—
2.9e+00
2.4e+00
—
—
cases:0.12%
controls:0.01%
—
—
—
—
—
—
cases:0.16%
controls:0.01%
cases:0.32%
controls:0.03%
—
7
6
5796
57939
—
—
—
9
5
5608
56056
15
13
4648
46567
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
1.5e-01
7.9e-01
2.2e+00
2.4e+00
1.1e+00
6.4e-01
4.5e-01
cases:42.65%
controls:38.95%
cases:48.39%
controls:29.87%
cases:34.15%
controls:5.57%
cases:3.07%
controls:0.28%
cases:14.96%
controls:5.44%
cases:46.11%
controls:31.12%
cases:65.52%
controls:54.85%
2475
22572
3328
35373
2808
17310
2995
40635
1982
3230
3821
54715
178
162
5625
57783
866
3142
4923
54667
2590
17445
3027
38616
3055
25550
1608
21030
Metanephrine [Moles/time] in 24 hour Urine
11140-1 [3033923]
11140-1 [3033923]
1.7e+00
—
—
—
1.0e+50
3.2e+00
2.8e+00
cases:0.31%
controls:0.06%
—
—
—
—
—
—
cases:0.22%
controls:0.00%
cases:0.27%
controls:0.01%
cases:0.32%
controls:0.02%
18
33
5785
57912
—
—
—
13
0
5776
57809
15
6
5602
56055
15
9
4648
46571
Abdominal CT examination
JN3AD [2001305554]
JN3AD [2001305554]
1.9e-01
2.3e+00
1.9e+00
—
1.8e+00
1.0e+00
7.6e-01
cases:1.12%
controls:0.93%
cases:4.89%
controls:0.51%
cases:0.47%
controls:0.07%
—
—
cases:0.29%
controls:0.05%
cases:1.62%
controls:0.60%
cases:4.98%
controls:2.39%
65
539
5738
57406
284
294
5519
57651
27
41
5776
57904
—
17
29
5772
57780
91
338
5526
55723
232
1115
4431
45465
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
14928-6 [3026989]
14928-6 [3026989]
3.8e-01
1.1e+00
2.4e+00
—
1.4e+00
1.3e+00
1.1e+00
cases:2.22%
controls:1.52%
cases:2.29%
controls:0.75%
cases:1.26%
controls:0.11%
—
—
cases:0.50%
controls:0.13%
cases:2.58%
controls:0.70%
cases:5.06%
controls:1.77%
129
883
5674
57062
133
434
5670
57511
73
66
5730
57879
—
29
74
5760
57735
145
394
5472
55667
236
825
4427
45755
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
2.7e-01
1.3e+00
1.5e+00
2.2e+00
1.3e+00
6.4e-01
4.4e-01
cases:8.96%
controls:7.01%
cases:10.55%
controls:2.99%
cases:1.45%
controls:0.33%
cases:0.17%
controls:0.02%
cases:1.19%
controls:0.32%
cases:5.71%
controls:3.08%
cases:14.56%
controls:9.85%
520
4060
5283
53885
612
1734
5191
56211
84
192
5719
57753
10
11
5793
57934
69
187
5720
57622
321
1728
5296
54333
679
4590
3984
41990
Calculus of gallbladder without cholecystitis
K80.2 [45552951]
K80.2 [45552951]
4.8e-01
1.5e+00
1.7e+00
1.0e+50
2.1e+00
1.4e+00
5.4e-01
cases:1.72%
controls:1.08%
cases:1.40%
controls:0.32%
cases:0.29%
controls:0.05%
cases:0.10%
controls:0.00%
cases:0.31%
controls:0.04%
cases:1.16%
controls:0.30%
cases:1.69%
controls:0.99%
100
625
5703
57320
81
188
5722
57757
17
30
5786
57915
6
0
5797
57945
18
22
5771
57787
65
168
5552
55893
79
461
4584
46119
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
2731-8 [3000067]
5.1e-01
1.3e+00
1.8e+00
—
2.0e+00
1.1e+00
8.9e-01
cases:2.71%
controls:1.64%
cases:3.55%
controls:0.97%
cases:1.09%
controls:0.18%
—
—
cases:1.17%
controls:0.16%
cases:3.22%
controls:1.05%
cases:5.62%
controls:2.39%
157
951
5646
56994
206
561
5597
57384
63
102
5740
57843
—
68
94
5721
57715
181
590
5436
55471
262
1113
4401
45467
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
1.5e-01
7.8e-01
2.2e+00
2.4e+00
1.1e+00
6.3e-01
4.4e-01
cases:42.96%
controls:39.29%
cases:48.58%
controls:30.28%
cases:34.59%
controls:5.71%
cases:3.08%
controls:0.29%
cases:15.06%
controls:5.55%
cases:46.45%
controls:31.51%
cases:65.71%
controls:55.22%
2493
22768
3310
35177
2819
17548
2984
40397
2007
3311
3796
54634
179
167
5624
57778
872
3210
4917
54599
2609
17666
3008
38395
3064
25720
1599
20860
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
4.0e-01
1.4e+00
1.5e+00
—
1.9e+00
1.5e+00
9.7e-01
cases:3.58%
controls:2.43%
cases:2.15%
controls:0.56%
cases:0.28%
controls:0.06%
—
—
cases:0.40%
controls:0.06%
cases:1.99%
controls:0.43%
cases:3.15%
controls:1.22%
208
1407
5595
56538
125
323
5678
57622
16
35
5787
57910
—
23
36
5766
57773
112
242
5505
55819
147
568
4516
46012
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
30313-1 [3002173]
3.8e-02
1.3e+00
1.9e+00
—
2.5e+00
1.4e+00
4.3e-01
cases:1.59%
controls:1.53%
cases:2.53%
controls:0.70%
cases:0.45%
controls:0.07%
—
—
cases:1.23%
controls:0.10%
cases:3.06%
controls:0.74%
cases:4.14%
controls:2.73%
92
885
5711
57060
147
407
5656
57538
26
39
5777
57906
—
71
56
5718
57753
172
416
5445
55645
193
1270
4470
45310
Oxygen saturation in Arterial blood
2708-6 [3016502]
2708-6 [3016502]
4.0e-02
1.3e+00
2.0e+00
—
2.4e+00
1.4e+00
4.9e-01
cases:1.74%
controls:1.67%
cases:2.71%
controls:0.76%
cases:0.52%
controls:0.07%
—
—
cases:1.17%
controls:0.10%
cases:3.22%
controls:0.82%
cases:4.68%
controls:2.93%
101
970
5702
56975
157
440
5646
57505
30
40
5773
57905
—
68
60
5721
57749
181
462
5436
55599
218
1364
4445
45216
Iron deficiency anaemia secondary to blood loss (chronic)
D50.0 [45566697]
D50.0 [45566697]
7.2e-02
1.4e+00
2.3e+00
1.0e+50
2.5e+00
1.4e+00
4.1e-01
cases:0.29%
controls:0.27%
cases:0.36%
controls:0.09%
cases:0.10%
controls:0.01%
cases:0.09%
controls:0.00%
cases:0.10%
controls:0.01%
cases:0.37%
controls:0.09%
cases:0.47%
controls:0.31%
17
158
5786
57787
21
53
5782
57892
6
6
5797
57939
5
0
5798
57945
6
5
5783
57804
21
50
5596
56011
22
146
4641
46434
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
F60.30 [2000502022]
9.9e-01
1.4e+00
1.9e+00
—
2.0e+00
1.2e+00
6.4e-01
cases:0.34%
controls:0.13%
cases:0.26%
controls:0.06%
cases:0.16%
controls:0.02%
—
—
cases:0.17%
controls:0.02%
cases:0.25%
controls:0.07%
cases:0.32%
controls:0.17%
20
74
5783
57871
15
37
5788
57908
9
13
5794
57932
—
10
13
5779
57796
14
42
5603
56019
15
79
4648
46501
Osmolality of Serum or Plasma
2692-2 [3008295]
2692-2 [3008295]
9.5e-01
2.1e+00
—
—
—
2.5e+00
2.0e+00
cases:0.36%
controls:0.14%
cases:0.50%
controls:0.06%
—
—
—
—
—
—
cases:0.98%
controls:0.08%
cases:1.42%
controls:0.20%
21
81
5782
57864
29
35
5774
57910
—
—
—
55
45
5562
56016
66
93
4597
46487
Metabolic syndrome
E66.00 [2000501500]
E66.00 [2000501500]
7.2e-01
1.2e+00
1.6e+00
—
2.0e+00
1.1e+00
8.3e-01
cases:1.52%
controls:0.74%
cases:1.07%
controls:0.31%
cases:0.29%
controls:0.06%
—
—
cases:0.45%
controls:0.06%
cases:0.96%
controls:0.32%
cases:2.04%
controls:0.90%
88
430
5715
57515
62
181
5741
57764
17
34
5786
57911
—
26
34
5763
57775
54
181
5563
55880
95
419
4568
46161
Differential panel - Cerebral spinal fluid
29584-0 [3016018]
29584-0 [3016018]
3.9e-01
1.7e+00
2.9e+00
—
—
2.0e+00
9.3e-01
cases:0.22%
controls:0.15%
cases:0.36%
controls:0.07%
cases:0.16%
controls:0.01%
—
—
—
—
cases:0.46%
controls:0.06%
cases:0.71%
controls:0.28%
13
88
5790
57857
21
38
5782
57907
9
5
5794
57940
—
—
26
36
5591
56025
33
130
4630
46450
Extensive MRI examination of brain with 3 Tesla magnet
AA1CM [2001300117]
AA1CM [2001300117]
3.3e-01
2.7e+00
1.0e+50
1.0e+50
—
2.7e+00
2.1e+00
cases:0.19%
controls:0.14%
cases:0.33%
controls:0.02%
cases:0.09%
controls:0.00%
cases:0.17%
controls:0.00%
—
—
cases:0.34%
controls:0.02%
cases:0.56%
controls:0.07%
11
79
5792
57866
19
13
5784
57932
5
0
5798
57945
10
0
5793
57945
—
19
13
5598
56048
26
32
4637
46548
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
9.8e-02
1.2e+00
1.0e+00
2.8e+00
1.2e+00
6.8e-01
5.3e-01
cases:5.55%
controls:5.05%
cases:7.36%
controls:2.29%
cases:0.86%
controls:0.32%
cases:0.22%
controls:0.01%
cases:1.12%
controls:0.34%
cases:4.77%
controls:2.47%
cases:12.18%
controls:7.53%
322
2929
5481
55016
427
1327
5376
56618
50
183
5753
57762
13
8
5790
57937
65
194
5724
57615
268
1384
5349
54677
568
3507
4095
43073
Multidisciplinary treatment meeting
WZC20 [2001310890]
WZC20 [2001310890]
2.6e-02
1.4e+00
1.9e+00
—
2.1e+00
1.1e+00
9.0e-01
cases:0.64%
controls:0.62%
cases:0.97%
controls:0.25%
cases:0.24%
controls:0.04%
—
—
cases:0.21%
controls:0.03%
cases:0.61%
controls:0.19%
cases:1.37%
controls:0.56%
37
360
5766
57585
56
143
5747
57802
14
21
5789
57924
—
12
15
5777
57794
34
108
5583
55953
64
263
4599
46317
Headache
R51.80 [2000503603]
R51.80 [2000503603]
6.0e-01
1.5e+00
2.1e+00
—
1.4e+00
1.1e+00
7.6e-01
cases:3.36%
controls:1.87%
cases:2.53%
controls:0.57%
cases:0.60%
controls:0.08%
—
—
cases:0.28%
controls:0.07%
cases:1.69%
controls:0.59%
cases:4.29%
controls:2.05%
195
1082
5608
56863
147
333
5656
57612
35
45
5768
57900
—
16
39
5773
57770
95
333
5522
55728
200
956
4463
45624
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
1.5e-01
7.1e-01
2.1e+00
2.3e+00
1.0e+00
6.1e-01
4.9e-01
cases:32.24%
controls:29.01%
cases:39.46%
controls:24.36%
cases:29.98%
controls:5.00%
cases:2.12%
controls:0.22%
cases:12.59%
controls:4.81%
cases:38.85%
controls:25.68%
cases:57.30%
controls:45.24%
1871
16812
3932
41133
2290
14115
3513
43830
1740
2900
4063
55045
123
128
5680
57817
729
2778
5060
55031
2182
14399
3435
41662
2672
21071
1991
25509
Atherosclerosis of arteries of extremities
I70.2 [45538421]
I70.2 [45538421]
4.7e-01
7.7e-01
7.0e-01
3.5e+00
1.1e+00
8.0e-01
6.6e-01
cases:2.00%
controls:1.25%
cases:1.67%
controls:0.78%
cases:0.45%
controls:0.22%
cases:0.41%
controls:0.01%
cases:0.62%
controls:0.20%
cases:1.78%
controls:0.81%
cases:3.28%
controls:1.72%
116
726
5687
57219
97
451
5706
57494
26
129
5777
57816
24
7
5779
57938
36
118
5753
57691
100
453
5517
55608
153
802
4510
45778
Hypokalaemia
E87.6 [45537991]
E87.6 [45537991]
7.7e-01
2.7e+00
2.9e+00
1.0e+50
—
1.0e+00
4.8e-01
cases:0.64%
controls:0.30%
cases:1.31%
controls:0.09%
cases:0.16%
controls:0.01%
cases:0.17%
controls:0.00%
—
—
cases:0.32%
controls:0.11%
cases:0.66%
controls:0.41%
37
171
5766
57774
76
54
5727
57891
9
5
5794
57940
10
0
5793
57945
—
18
64
5599
55997
31
192
4632
46388
Cyst of kidney
N28.1 [45558144]
N28.1 [45558144]
9.0e-01
1.9e+00
2.3e+00
1.0e+50
—
1.9e+00
1.2e+00
cases:0.24%
controls:0.10%
cases:0.29%
controls:0.04%
cases:0.10%
controls:0.01%
cases:0.14%
controls:0.00%
—
—
cases:0.46%
controls:0.07%
cases:0.54%
controls:0.17%
14
57
5789
57888
17
26
5786
57919
6
6
5797
57939
8
0
5795
57945
—
26
38
5591
56023
25
77
4638
46503
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
20563-3 [3023081]
1.7e-01
1.7e+00
1.7e+00
—
2.2e+00
1.3e+00
4.4e-01
cases:0.78%
controls:0.65%
cases:1.65%
controls:0.32%
cases:0.19%
controls:0.04%
—
—
cases:0.38%
controls:0.04%
cases:1.30%
controls:0.37%
cases:2.29%
controls:1.49%
45
379
5758
57566
96
184
5707
57761
11
21
5792
57924
—
22
24
5767
57785
73
207
5544
55854
107
696
4556
45884
Obstetrics / Gynecology
16 [38004461]
16 [38004461]
1.4e-01
6.2e-01
9.0e-01
3.8e+00
9.0e-01
5.0e-01
3.7e-01
cases:14.87%
controls:13.20%
cases:9.25%
controls:5.21%
cases:2.17%
controls:0.89%
cases:1.43%
controls:0.03%
cases:2.16%
controls:0.89%
cases:7.96%
controls:4.96%
cases:17.24%
controls:12.55%
863
7648
4940
50297
537
3017
5266
54928
126
518
5677
57427
83
19
5720
57926
125
515
5664
57294
447
2783
5170
53278
804
5844
3859
40736
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
2524-7 [3014111]
-4.1e-02
1.2e+00
2.0e+00
—
2.4e+00
1.2e+00
4.3e-01
cases:1.21%
controls:1.26%
cases:2.19%
controls:0.65%
cases:0.47%
controls:0.06%
—
—
cases:0.74%
controls:0.07%
cases:2.30%
controls:0.69%
cases:3.86%
controls:2.55%
70
728
5733
57217
127
379
5676
57566
27
37
5776
57908
—
43
41
5746
57768
129
389
5488
55672
180
1188
4483
45392
Oncology Clinic/Center
261QX0200X [38004268]
261QX0200X [38004268]
1.7e-01
1.4e+00
2.3e+00
—
2.2e+00
9.0e-01
4.3e-01
cases:6.96%
controls:5.96%
cases:6.65%
controls:1.71%
cases:1.15%
controls:0.12%
—
—
cases:1.14%
controls:0.13%
cases:3.38%
controls:1.40%
cases:7.42%
controls:4.95%
404
3452
5399
54493
386
990
5417
56955
67
68
5736
57877
—
66
77
5723
57732
190
784
5427
55277
346
2306
4317
44274
Endocrine disorder, unspecified
E34.9 [45595814]
E34.9 [45595814]
3.1e+00
—
1.0e+50
—
1.0e+50
1.0e+50
4.1e+00
cases:0.26%
controls:0.01%
—
—
cases:0.19%
controls:0.00%
—
—
cases:0.10%
controls:0.00%
cases:0.46%
controls:0.00%
cases:0.66%
controls:0.01%
15
7
5788
57938
—
11
0
5792
57945
—
6
0
5783
57809
26
0
5591
56061
31
5
4632
46575
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
1.4e-02
1.2e+00
1.1e+00
2.1e+00
1.4e+00
9.7e-01
3.6e-01
cases:1.28%
controls:1.26%
cases:2.27%
controls:0.69%
cases:0.26%
controls:0.08%
cases:0.10%
controls:0.01%
cases:0.33%
controls:0.08%
cases:1.89%
controls:0.72%
cases:4.01%
controls:2.82%
74
729
5729
57216
132
397
5671
57548
15
49
5788
57896
6
7
5797
57938
19
48
5770
57761
106
405
5511
55656
187
1315
4476
45265
Emergency Medicine
93 [38004510]
93 [38004510]
2.5e-01
1.1e+00
1.1e+00
3.1e+00
7.8e-01
5.5e-01
3.9e-01
cases:19.56%
controls:15.87%
cases:21.51%
controls:8.38%
cases:3.38%
controls:1.20%
cases:1.19%
controls:0.06%
cases:2.50%
controls:1.16%
cases:14.99%
controls:9.21%
cases:33.35%
controls:25.27%
1135
9198
4668
48747
1248
4857
4555
53088
196
696
5607
57249
69
33
5734
57912
145
672
5644
57137
842
5163
4775
50898
1555
11773
3108
34807
Extensive abdominal CT
JN3BD [2001305556]
JN3BD [2001305556]
1.4e-01
2.7e+00
2.2e+00
—
1.5e+00
1.4e+00
8.6e-01
cases:1.84%
controls:1.60%
cases:4.76%
controls:0.34%
cases:0.22%
controls:0.03%
—
—
cases:0.14%
controls:0.03%
cases:0.98%
controls:0.23%
cases:1.87%
controls:0.79%
107
930
5696
57015
276
197
5527
57748
13
15
5790
57930
—
8
18
5781
57791
55
130
5562
55931
87
370
4576
46210
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
14920-3 [3008486]
1.8e-01
7.3e-01
2.1e+00
1.7e+00
1.1e+00
7.6e-01
6.3e-01
cases:27.02%
controls:23.54%
cases:23.42%
controls:12.83%
cases:12.08%
controls:1.70%
cases:0.22%
controls:0.04%
cases:4.78%
controls:1.67%
cases:24.75%
controls:13.33%
cases:47.93%
controls:32.91%
1568
13638
4235
44307
1359
7437
4444
50508
701
984
5102
56961
13
24
5790
57921
277
964
5512
56845
1390
7475
4227
48586
2235
15330
2428
31250
Other and unspecified ovarian cysts
N83.2 [45539066]
N83.2 [45539066]
1.8e-01
1.2e+00
2.2e+00
—
2.0e+00
1.1e+00
6.6e-01
cases:1.03%
controls:0.86%
cases:1.00%
controls:0.32%
cases:0.28%
controls:0.03%
—
—
cases:0.26%
controls:0.03%
cases:0.85%
controls:0.29%
cases:1.72%
controls:0.89%
60
501
5743
57444
58
183
5745
57762
16
18
5787
57927
—
15
20
5774
57789
48
162
5569
55899
80
416
4583
46164
Hemolysis interference index of Serum or Plasma
46424-8 [3052851]
46424-8 [3052851]
-1.6e-01
1.2e+00
2.1e+00
—
1.7e+00
1.1e+00
1.0e+00
cases:0.64%
controls:0.75%
cases:0.64%
controls:0.20%
cases:0.21%
controls:0.03%
—
—
cases:0.14%
controls:0.02%
cases:0.43%
controls:0.15%
cases:1.07%
controls:0.39%
37
435
5766
57510
37
113
5766
57832
12
15
5791
57930
—
8
14
5781
57795
24
82
5593
55979
50
181
4613
46399
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
1.2e-01
7.3e-01
2.1e+00
2.2e+00
9.9e-01
5.9e-01
3.4e-01
cases:45.46%
controls:42.51%
cases:52.42%
controls:34.71%
cases:39.27%
controls:7.31%
cases:2.93%
controls:0.32%
cases:16.95%
controls:7.07%
cases:50.70%
controls:36.26%
cases:67.53%
controls:59.64%
2638
24635
3165
33310
3042
20111
2761
37834
2279
4236
3524
53709
170
187
5633
57758
981
4085
4808
53724
2848
20327
2769
35734
3149
27781
1514
18799
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2157-6 [3007220]
1.0e-01
8.0e-01
1.1e+00
3.2e+00
1.0e+00
4.9e-01
4.4e-01
cases:7.29%
controls:6.62%
cases:5.88%
controls:2.72%
cases:0.97%
controls:0.33%
cases:0.26%
controls:0.01%
cases:0.85%
controls:0.31%
cases:4.47%
controls:2.78%
cases:13.68%
controls:9.28%
423
3835
5380
54110
341
1578
5462
56367
56
189
5747
57756
15
6
5788
57939
49
178
5740
57631
251
1558
5366
54503
638
4322
4025
42258
Neck ultrasound examination
EP1AE [2001302284]
EP1AE [2001302284]
5.7e-01
1.6e+00
1.6e+00
1.0e+50
2.1e+00
1.5e+00
1.3e+00
cases:1.21%
controls:0.69%
cases:1.10%
controls:0.21%
cases:0.10%
controls:0.02%
cases:0.24%
controls:0.00%
cases:0.19%
controls:0.02%
cases:0.89%
controls:0.21%
cases:1.89%
controls:0.52%
70
397
5733
57548
64
124
5739
57821
6
12
5797
57933
14
0
5789
57945
11
14
5778
57795
50
116
5567
55945
88
242
4575
46338
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
1.4e-01
1.0e+00
1.4e+00
2.0e+00
1.2e+00
8.1e-01
5.7e-01
cases:11.91%
controls:10.50%
cases:14.82%
controls:5.75%
cases:3.77%
controls:0.96%
cases:0.26%
controls:0.03%
cases:3.01%
controls:0.96%
cases:12.37%
controls:5.93%
cases:23.40%
controls:14.72%
691
6087
5112
51858
860
3331
4943
54614
219
557
5584
57388
15
20
5788
57925
174
554
5615
57255
695
3327
4922
52734
1091
6855
3572
39725
Atrial fibrillation and flutter
I48 [45596206]
I48 [45596206]
1.9e-01
5.9e-01
7.0e-01
3.6e+00
8.7e-01
5.9e-01
4.3e-01
cases:6.62%
controls:5.52%
cases:5.41%
controls:3.07%
cases:1.24%
controls:0.62%
cases:1.33%
controls:0.04%
cases:1.45%
controls:0.61%
cases:5.25%
controls:2.99%
cases:9.14%
controls:6.17%
384
3197
5419
54748
314
1778
5489
56167
72
358
5731
57587
77
21
5726
57924
84
353
5705
57456
295
1675
5322
54386
426
2872
4237
43708
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
2614-6 [3007930]
2.1e-01
1.6e+00
1.7e+00
—
2.4e+00
1.3e+00
3.7e-01
cases:0.78%
controls:0.63%
cases:1.55%
controls:0.30%
cases:0.17%
controls:0.03%
—
—
cases:0.36%
controls:0.03%
cases:1.23%
controls:0.35%
cases:2.04%
controls:1.42%
45
363
5758
57582
90
176
5713
57769
10
19
5793
57926
—
21
20
5768
57789
69
195
5548
55866
95
662
4568
45918
Vascular Surgery
77 [38004496]
77 [38004496]
1.6e-01
6.9e-01
1.2e+00
2.6e+00
9.5e-01
8.4e-01
6.7e-01
cases:3.53%
controls:3.02%
cases:2.55%
controls:1.30%
cases:0.78%
controls:0.23%
cases:0.16%
controls:0.01%
cases:0.64%
controls:0.25%
cases:2.81%
controls:1.23%
cases:6.46%
controls:3.41%
205
1750
5598
56195
148
754
5655
57191
45
135
5758
57810
9
7
5794
57938
37
143
5752
57666
158
691
5459
55370
301
1590
4362
44990
Malignant neoplasm of prostate
C61 [45547509]
C61 [45547509]
5.3e-02
5.2e-01
9.5e-01
3.4e+00
1.1e+00
5.4e-01
3.9e-01
cases:1.95%
controls:1.85%
cases:2.45%
controls:1.48%
cases:1.05%
controls:0.41%
cases:1.07%
controls:0.04%
cases:1.26%
controls:0.42%
cases:2.56%
controls:1.52%
cases:3.11%
controls:2.13%
113
1071
5690
56874
142
855
5661
57090
61
237
5742
57708
62
21
5741
57924
73
244
5716
57565
144
850
5473
55211
145
994
4518
45586
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
1.6e-01
1.2e+00
1.1e+00
2.0e+00
1.3e+00
7.3e-01
5.1e-01
cases:6.84%
controls:5.86%
cases:9.18%
controls:3.03%
cases:1.53%
controls:0.50%
cases:0.16%
controls:0.02%
cases:1.42%
controls:0.39%
cases:6.07%
controls:3.02%
cases:13.90%
controls:8.84%
397
3397
5406
54548
533
1757
5270
56188
89
292
5714
57653
9
12
5794
57933
82
227
5707
57582
341
1693
5276
54368
648
4120
4015
42460
Parathyrin.intact [Moles/volume] in Serum or Plasma
14866-8 [3010566]
14866-8 [3010566]
8.5e-01
1.4e+00
2.4e+00
—
—
1.3e+00
8.7e-01
cases:0.78%
controls:0.33%
cases:0.95%
controls:0.22%
cases:0.33%
controls:0.03%
—
—
—
—
cases:0.78%
controls:0.21%
cases:1.31%
controls:0.55%
45
192
5758
57753
55
130
5748
57815
19
18
5784
57927
—
—
44
120
5573
55941
61
256
4602
46324
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
2.1e-01
1.1e+00
1.0e+00
2.0e+00
1.3e+00
6.8e-01
4.8e-01
cases:8.34%
controls:6.85%
cases:10.43%
controls:3.57%
cases:1.65%
controls:0.59%
cases:0.19%
controls:0.03%
cases:1.62%
controls:0.47%
cases:6.91%
controls:3.64%
cases:16.17%
controls:10.64%
484
3967
5319
53978
605
2069
5198
55876
96
341
5707
57604
11
15
5792
57930
94
269
5695
57540
388
2040
5229
54021
754
4958
3909
41622
Diplopia
H53.2 [45576792]
H53.2 [45576792]
2.9e-01
1.9e+00
—
1.0e+50
2.4e+00
1.6e+00
9.2e-01
cases:0.36%
controls:0.27%
cases:0.48%
controls:0.07%
—
—
cases:0.09%
controls:0.00%
cases:0.17%
controls:0.02%
cases:0.32%
controls:0.07%
cases:0.73%
controls:0.29%
21
157
5782
57788
28
41
5775
57904
—
5
0
5798
57945
10
9
5779
57800
18
38
5599
56023
34
136
4629
46444
Chronic kidney disease, unspecified
N18.9 [45553438]
N18.9 [45553438]
1.8e-01
6.4e-01
1.2e+00
3.6e+00
7.6e-01
6.0e-01
7.6e-01
cases:0.72%
controls:0.61%
cases:0.84%
controls:0.45%
cases:0.43%
controls:0.13%
cases:0.33%
controls:0.01%
cases:0.28%
controls:0.13%
cases:0.93%
controls:0.51%
cases:2.29%
controls:1.09%
42
352
5761
57593
49
260
5754
57685
25
78
5778
57867
19
5
5784
57940
16
75
5773
57734
52
285
5565
55776
107
507
4556
46073
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
47598-8 [3048816]
3.2e-01
1.1e+00
2.3e+00
—
1.4e+00
9.7e-01
6.9e-01
cases:2.24%
controls:1.64%
cases:2.53%
controls:0.86%
cases:1.14%
controls:0.11%
—
—
cases:0.50%
controls:0.12%
cases:2.19%
controls:0.84%
cases:4.65%
controls:2.40%
130
952
5673
56993
147
498
5656
57447
66
66
5737
57879
—
29
72
5760
57737
123
470
5494
55591
217
1118
4446
45462
Gas panel - Arterial blood
24336-0 [3019060]
24336-0 [3019060]
9.5e-03
1.1e+00
1.7e+00
—
2.1e+00
1.3e+00
5.0e-01
cases:1.28%
controls:1.26%
cases:1.57%
controls:0.52%
cases:0.21%
controls:0.04%
—
—
cases:0.62%
controls:0.08%
cases:1.76%
controls:0.49%
cases:2.59%
controls:1.58%
74
732
5729
57213
91
300
5712
57645
12
21
5791
57924
—
36
46
5753
57763
99
277
5518
55784
121
738
4542
45842
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 [3027475]
26454-9 [3027475]
2.5e-01
1.6e+00
2.7e+00
—
—
1.5e+00
8.4e-01
cases:0.53%
controls:0.42%
cases:0.67%
controls:0.14%
cases:0.24%
controls:0.02%
—
—
—
—
cases:0.64%
controls:0.14%
cases:1.24%
controls:0.54%
31
241
5772
57704
39
80
5764
57865
14
9
5789
57936
—
—
36
78
5581
55983
58
252
4605
46328
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
1.8e-01
1.2e+00
1.1e+00
2.1e+00
9.2e-01
7.1e-01
5.4e-01
cases:14.72%
controls:12.61%
cases:19.39%
controls:6.94%
cases:3.86%
controls:1.36%
cases:0.48%
controls:0.06%
cases:3.39%
controls:1.38%
cases:13.26%
controls:7.00%
cases:26.66%
controls:17.51%
854
7309
4949
50636
1125
4024
4678
53921
224
789
5579
57156
28
34
5775
57911
196
795
5593
57014
745
3923
4872
52138
1243
8156
3420
38424
Anterior pituitary hypofunction
101 [2001600101]
101 [2001600101]
2.2e+00
—
1.0e+50
—
1.0e+50
1.0e+50
4.5e+00
cases:0.21%
controls:0.02%
—
—
cases:0.26%
controls:0.00%
—
—
cases:0.86%
controls:0.00%
cases:2.46%
controls:0.00%
cases:1.48%
controls:0.02%
12
13
5791
57932
—
15
0
5788
57945
—
50
0
5739
57809
138
0
5479
56061
69
8
4594
46572
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
4.3e-01
1.2e+00
1.4e+00
—
1.6e+00
1.1e+00
9.1e-01
cases:7.34%
controls:4.92%
cases:4.14%
controls:1.24%
cases:0.72%
controls:0.18%
—
—
cases:0.73%
controls:0.15%
cases:2.99%
controls:0.98%
cases:5.51%
controls:2.29%
426
2848
5377
55097
240
720
5563
57225
42
103
5761
57842
—
42
88
5747
57721
168
547
5449
55514
257
1066
4406
45514
Postprocedural hypoparathyroidism
E89.2 [45586178]
E89.2 [45586178]
9.8e-01
1.5e+00
—
1.0e+50
2.5e+00
2.5e+00
1.7e+00
cases:0.14%
controls:0.05%
cases:0.14%
controls:0.03%
—
—
cases:0.12%
controls:0.00%
cases:0.12%
controls:0.01%
cases:0.34%
controls:0.03%
cases:0.26%
controls:0.05%
8
30
5795
57915
8
18
5795
57927
—
7
0
5796
57945
7
6
5782
57803
19
16
5598
56045
12
21
4651
46559
pH of Specimen
17433-4 [3019225]
17433-4 [3019225]
1.5e-01
9.4e-01
2.3e+00
—
1.9e+00
8.6e-01
7.6e-01
cases:2.76%
controls:2.37%
cases:3.17%
controls:1.27%
cases:1.59%
controls:0.17%
—
—
cases:1.26%
controls:0.20%
cases:2.83%
controls:1.21%
cases:5.62%
controls:2.71%
160
1376
5643
56569
184
734
5619
57211
92
98
5711
57847
—
73
115
5716
57694
159
681
5458
55380
262
1264
4401
45316
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
1.7e-01
1.2e+00
1.2e+00
1.9e+00
1.2e+00
7.0e-01
4.8e-01
cases:6.65%
controls:5.70%
cases:8.63%
controls:2.89%
cases:1.45%
controls:0.45%
cases:0.16%
controls:0.02%
cases:1.24%
controls:0.37%
cases:5.43%
controls:2.78%
cases:12.80%
controls:8.30%
386
3300
5417
54645
501
1674
5302
56271
84
259
5719
57686
9
13
5794
57932
72
216
5717
57593
305
1559
5312
54502
597
3867
4066
42713
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 [3016543]
26465-5 [3016543]
2.6e-01
1.5e+00
2.7e+00
—
—
1.5e+00
8.6e-01
cases:0.53%
controls:0.41%
cases:0.62%
controls:0.14%
cases:0.24%
controls:0.02%
—
—
—
—
cases:0.64%
controls:0.14%
cases:1.27%
controls:0.54%
31
240
5772
57705
36
80
5767
57865
14
9
5789
57936
—
—
36
77
5581
55984
59
250
4604
46330
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
2.0e-01
9.7e-01
1.1e+00
2.7e+00
8.8e-01
4.9e-01
4.6e-01
cases:4.91%
controls:4.04%
cases:5.12%
controls:2.01%
cases:0.76%
controls:0.26%
cases:0.24%
controls:0.02%
cases:0.62%
controls:0.26%
cases:3.19%
controls:1.97%
cases:9.22%
controls:6.00%
285
2342
5518
55603
297
1164
5506
56781
44
150
5759
57795
14
9
5789
57936
36
150
5753
57659
179
1103
5438
54958
430
2797
4233
43783
Benign neoplasm: Pancreas
D13.6 [45605344]
D13.6 [45605344]
—
2.0e+00
—
—
—
2.6e+00
2.0e+00
—
—
cases:0.17%
controls:0.02%
—
—
—
—
—
—
cases:0.20%
controls:0.01%
cases:0.36%
controls:0.05%
—
10
13
5793
57932
—
—
—
11
8
5606
56053
17
24
4646
46556
Thoracal epidural anesthesia
WX302 [2001310795]
WX302 [2001310795]
1.1e-01
1.7e+00
—
—
2.3e+00
1.7e+00
8.9e-01
cases:0.65%
controls:0.59%
cases:0.90%
controls:0.17%
—
—
—
—
cases:0.10%
controls:0.01%
cases:0.64%
controls:0.12%
cases:0.90%
controls:0.37%
38
340
5765
57605
52
97
5751
57848
—
—
6
6
5783
57803
36
65
5581
55996
42
173
4621
46407
Infiltration anesthesia
WX110 [2001310767]
WX110 [2001310767]
2.3e-01
4.8e-01
5.3e-01
3.1e+00
1.2e+00
6.3e-01
3.9e-01
cases:26.07%
controls:21.89%
cases:12.92%
controls:8.44%
cases:1.72%
controls:1.02%
cases:0.74%
controls:0.03%
cases:3.23%
controls:1.01%
cases:14.78%
controls:8.42%
cases:31.27%
controls:23.46%
1513
12685
4290
45260
750
4890
5053
53055
100
592
5703
57353
43
19
5760
57926
187
585
5602
57224
830
4719
4787
51342
1458
10927
3205
35653
Atherosclerotic heart disease
I25.1 [45596196]
I25.1 [45596196]
-5.8e-02
4.4e-01
6.8e-01
4.1e+00
9.0e-01
4.0e-01
2.0e-01
cases:4.33%
controls:4.57%
cases:3.72%
controls:2.43%
cases:0.91%
controls:0.46%
cases:1.38%
controls:0.02%
cases:1.14%
controls:0.47%
cases:3.85%
controls:2.61%
cases:7.21%
controls:6.00%
251
2650
5552
55295
216
1407
5587
56538
53
269
5750
57676
80
13
5723
57932
66
270
5723
57539
216
1462
5401
54599
336
2793
4327
43787
Normetanephrine [Moles/time] in 24 hour Urine
15083-9 [3000213]
15083-9 [3000213]
1.7e+00
—
1.0e+50
—
—
2.6e+00
2.3e+00
cases:0.17%
controls:0.03%
—
—
cases:0.21%
controls:0.00%
—
—
—
—
cases:0.14%
controls:0.01%
cases:0.13%
controls:0.01%
10
19
5793
57926
—
12
0
5791
57945
—
—
8
6
5609
56055
6
6
4657
46574
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
1.9e-01
9.7e-01
9.6e-01
2.9e+00
8.4e-01
3.5e-01
3.1e-01
cases:10.15%
controls:8.58%
cases:9.94%
controls:4.02%
cases:1.38%
controls:0.53%
cases:0.41%
controls:0.02%
cases:1.17%
controls:0.51%
cases:6.27%
controls:4.49%
cases:16.75%
controls:12.81%
589
4969
5214
52976
577
2332
5226
55613
80
308
5723
57637
24
13
5779
57932
68
295
5721
57514
352
2515
5265
53546
781
5966
3882
40614
Other specified counselling
Z71.8 [45581061]
Z71.8 [45581061]
3.4e-01
7.3e-01
9.1e-01
2.5e+00
9.9e-01
6.8e-01
4.0e-01
cases:6.20%
controls:4.51%
cases:4.69%
controls:2.32%
cases:0.86%
controls:0.35%
cases:0.19%
controls:0.02%
cases:0.88%
controls:0.33%
cases:4.91%
controls:2.55%
cases:12.14%
controls:8.50%
360
2613
5443
55332
272
1347
5531
56598
50
203
5753
57742
11
9
5792
57936
51
190
5738
57619
276
1429
5341
54632
566
3959
4097
42621
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
30383-4 [3000850]
1.5e-01
1.1e+00
8.5e-01
2.0e+00
1.3e+00
7.4e-01
5.4e-01
cases:5.46%
controls:4.72%
cases:6.01%
controls:2.10%
cases:0.78%
controls:0.33%
cases:0.10%
controls:0.01%
cases:0.88%
controls:0.25%
cases:4.13%
controls:2.00%
cases:9.69%
controls:5.88%
317
2734
5486
55211
349
1217
5454
56728
45
192
5758
57753
6
8
5797
57937
51
142
5738
57667
232
1124
5385
54937
452
2739
4211
43841
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
83084-4 [42529201]
83084-4 [42529201]
-2.8e-01
1.2e+00
1.6e+00
—
1.6e+00
1.2e+00
9.4e-01
cases:0.24%
controls:0.32%
cases:0.72%
controls:0.22%
cases:0.21%
controls:0.04%
—
—
cases:0.21%
controls:0.04%
cases:0.73%
controls:0.22%
cases:1.07%
controls:0.42%
14
185
5789
57760
42
127
5761
57818
12
25
5791
57920
—
12
24
5777
57785
41
125
5576
55936
50
196
4613
46384
Cardiology
6 [38004451]
6 [38004451]
1.9e-01
6.9e-01
1.0e+00
2.6e+00
8.6e-01
6.8e-01
4.8e-01
cases:13.51%
controls:11.43%
cases:10.27%
controls:5.44%
cases:2.19%
controls:0.81%
cases:0.40%
controls:0.03%
cases:1.99%
controls:0.85%
cases:9.67%
controls:5.17%
cases:18.81%
controls:12.53%
784
6626
5019
51319
596
3154
5207
54791
127
470
5676
57475
23
17
5780
57928
115
490
5674
57319
543
2896
5074
53165
877
5837
3786
40743
Dietary counselling and surveillance
Z71.3 [45552101]
Z71.3 [45552101]
8.1e-01
1.2e+00
1.5e+00
—
1.8e+00
1.6e+00
1.1e+00
cases:1.14%
controls:0.51%
cases:0.69%
controls:0.20%
cases:0.10%
controls:0.02%
—
—
cases:0.16%
controls:0.03%
cases:0.66%
controls:0.14%
cases:1.20%
controls:0.41%
66
296
5737
57649
40
115
5763
57830
6
13
5797
57932
—
9
15
5780
57794
37
78
5580
55983
56
193
4607
46387
Malignant tumour
130 [2001600128]
130 [2001600128]
-2.0e-01
8.2e-01
2.1e+00
—
2.1e+00
1.4e+00
4.7e-01
cases:0.50%
controls:0.61%
cases:0.64%
controls:0.28%
cases:0.17%
controls:0.02%
—
—
cases:0.22%
controls:0.03%
cases:0.98%
controls:0.24%
cases:1.09%
controls:0.69%
29
355
5774
57590
37
163
5766
57782
10
12
5793
57933
—
13
16
5776
57793
55
132
5562
55929
51
321
4612
46259
moxonidine; oral
C02AC05 [21600401]
C02AC05 [21600401]
9.3e-01
1.2e+00
1.4e+00
—
1.0e+00
1.1e+00
8.6e-01
cases:1.86%
controls:0.74%
cases:1.74%
controls:0.54%
cases:0.59%
controls:0.15%
—
—
cases:0.41%
controls:0.15%
cases:1.66%
controls:0.55%
cases:1.91%
controls:0.82%
108
429
5695
57516
101
311
5702
57634
34
88
5769
57857
—
24
88
5765
57721
93
307
5524
55754
89
381
4574
46199
Hypopituitarism
E23.0 [45561963]
E23.0 [45561963]
2.1e+00
—
1.0e+50
—
1.0e+50
1.0e+50
4.4e+00
cases:0.21%
controls:0.03%
—
—
cases:0.19%
controls:0.00%
—
—
cases:0.69%
controls:0.00%
cases:1.94%
controls:0.00%
cases:1.50%
controls:0.02%
12
15
5791
57930
—
11
0
5792
57945
—
40
0
5749
57809
109
0
5508
56061
70
9
4593
46571
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
2.3e-01
1.1e+00
9.7e-01
2.0e+00
1.1e+00
6.1e-01
4.4e-01
cases:9.41%
controls:7.62%
cases:11.55%
controls:4.21%
cases:1.84%
controls:0.70%
cases:0.21%
controls:0.03%
cases:1.73%
controls:0.56%
cases:7.98%
controls:4.50%
cases:18.29%
controls:12.64%
546
4413
5257
53532
670
2439
5133
55506
107
408
5696
57537
12
17
5791
57928
100
325
5689
57484
448
2520
5169
53541
853
5886
3810
40694
Extensive MRI examination of soft tissue of neck with high intesity magnet
EP1CG [2001302289]
EP1CG [2001302289]
-2.9e-01
2.4e+00
—
—
—
2.0e+00
2.1e+00
cases:0.09%
controls:0.12%
cases:0.26%
controls:0.02%
—
—
—
—
—
—
cases:0.14%
controls:0.02%
cases:0.49%
controls:0.06%
5
67
5798
57878
15
14
5788
57931
—
—
—
8
11
5609
56050
23
29
4640
46551
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
1.6e-01
1.1e+00
9.5e-01
1.9e+00
1.2e+00
6.7e-01
4.6e-01
cases:9.72%
controls:8.40%
cases:11.17%
controls:4.12%
cases:1.69%
controls:0.66%
cases:0.19%
controls:0.03%
cases:1.73%
controls:0.53%
cases:7.57%
controls:4.04%
cases:17.01%
controls:11.41%
564
4868
5239
53077
648
2387
5155
55558
98
384
5705
57561
11
16
5792
57929
100
309
5689
57500
425
2263
5192
53798
793
5315
3870
41265
Hypercalcemia
E83.50 [2000501535]
E83.50 [2000501535]
1.5e+00
3.1e+00
—
1.0e+50
—
1.8e+00
9.3e-01
cases:0.38%
controls:0.09%
cases:0.74%
controls:0.03%
—
—
cases:0.14%
controls:0.00%
—
—
cases:0.25%
controls:0.04%
cases:0.34%
controls:0.14%
22
50
5781
57895
43
19
5760
57926
—
8
0
5795
57945
—
14
23
5603
56038
16
63
4647
46517
Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
22126-7 [3010380]
22126-7 [3010380]
4.2e-01
1.4e+00
2.5e+00
—
—
1.7e+00
8.4e-01
cases:0.28%
controls:0.18%
cases:0.29%
controls:0.07%
cases:0.10%
controls:0.01%
—
—
—
—
cases:0.21%
controls:0.04%
cases:0.45%
controls:0.20%
16
105
5787
57840
17
41
5786
57904
6
5
5797
57940
—
—
12
23
5605
56038
21
91
4642
46489
varenicline; oral
N07BA03 [21604819]
N07BA03 [21604819]
9.2e-01
1.5e+00
1.1e+00
—
1.7e+00
1.4e+00
9.9e-01
cases:2.22%
controls:0.89%
cases:0.97%
controls:0.23%
cases:0.09%
controls:0.03%
—
—
cases:0.16%
controls:0.03%
cases:0.77%
controls:0.20%
cases:1.84%
controls:0.70%
129
518
5674
57427
56
132
5747
57813
5
17
5798
57928
—
9
17
5780
57792
43
111
5574
55950
86
324
4577
46256
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
3.7e-01
9.9e-01
5.9e-01
1.4e+00
8.2e-01
1.2e+00
9.6e-01
cases:95.64%
controls:93.80%
cases:94.50%
controls:86.41%
cases:64.19%
controls:49.96%
cases:9.79%
controls:2.58%
cases:69.32%
controls:49.86%
cases:95.71%
controls:86.99%
cases:98.37%
controls:95.84%
5550
54354
253
3591
5484
50068
319
7877
3725
28947
2078
28998
568
1494
5235
56451
4013
28822
1776
28987
5376
48770
241
7291
4587
44642
76
1938
Pulmonary embolism without mention of acute cor pulmonale
I26.9 [45552785]
I26.9 [45552785]
1.1e-01
1.4e+00
1.5e+00
—
1.6e+00
1.2e+00
6.1e-01
cases:0.55%
controls:0.49%
cases:0.86%
controls:0.21%
cases:0.17%
controls:0.04%
—
—
cases:0.22%
controls:0.04%
cases:0.78%
controls:0.23%
cases:1.14%
controls:0.62%
32
286
5771
57659
50
119
5753
57826
10
23
5793
57922
—
13
26
5776
57783
44
131
5573
55930
53
289
4610
46291
Thyrotropin receptor Ab [Units/volume] in Serum
5385-0 [3017044]
5385-0 [3017044]
5.7e-01
1.0e+00
1.7e+00
—
2.3e+00
6.4e-01
7.3e-01
cases:0.95%
controls:0.54%
cases:0.71%
controls:0.26%
cases:0.21%
controls:0.04%
—
—
cases:0.22%
controls:0.02%
cases:0.48%
controls:0.26%
cases:1.48%
controls:0.72%
55
311
5748
57634
41
152
5762
57793
12
21
5791
57924
—
13
13
5776
57796
27
143
5590
55918
69
336
4594
46244
Lack of ACTH
E23.03 [2000501471]
E23.03 [2000501471]
1.7e+00
2.9e+00
—
1.0e+50
—
—
3.4e+00
cases:0.09%
controls:0.02%
cases:0.16%
controls:0.01%
—
—
cases:0.14%
controls:0.00%
—
—
—
—
cases:0.60%
controls:0.02%
5
9
5798
57936
9
5
5794
57940
—
8
0
5795
57945
—
—
28
9
4635
46571
pH of Blood
11558-4 [3010421]
11558-4 [3010421]
4.6e-01
9.6e-01
1.8e+00
—
2.0e+00
8.8e-01
7.2e-01
cases:0.83%
controls:0.52%
cases:0.71%
controls:0.27%
cases:0.16%
controls:0.03%
—
—
cases:0.17%
controls:0.02%
cases:0.62%
controls:0.26%
cases:1.48%
controls:0.72%
48
303
5755
57642
41
158
5762
57787
9
15
5794
57930
—
10
14
5779
57795
35
145
5582
55916
69
337
4594
46243
Pathology report gross observation
24419-4 [3002256]
24419-4 [3002256]
6.0e-02
1.1e+00
1.8e+00
—
1.5e+00
1.2e+00
6.6e-01
cases:2.91%
controls:2.75%
cases:2.81%
controls:0.93%
cases:0.50%
controls:0.08%
—
—
cases:0.41%
controls:0.09%
cases:2.37%
controls:0.71%
cases:5.21%
controls:2.77%
169
1592
5634
56353
163
539
5640
57406
29
49
5774
57896
—
24
52
5765
57757
133
397
5484
55664
243
1291
4420
45289
Adjuvant radiotherapy
WF003 [2001310702]
WF003 [2001310702]
-1.4e-01
5.6e-01
2.1e+00
—
1.9e+00
1.4e+00
8.3e-01
cases:0.34%
controls:0.40%
cases:0.26%
controls:0.15%
cases:0.14%
controls:0.02%
—
—
cases:0.16%
controls:0.02%
cases:0.30%
controls:0.07%
cases:0.49%
controls:0.21%
20
230
5783
57715
15
86
5788
57859
8
10
5795
57935
—
9
13
5780
57796
17
40
5600
56021
23
100
4640
46480
Cyst of pancreas
K86.2 [45591612]
K86.2 [45591612]
4.7e-01
1.4e+00
2.3e+00
1.0e+50
2.0e+00
1.5e+00
1.1e+00
cases:0.16%
controls:0.10%
cases:0.29%
controls:0.07%
cases:0.12%
controls:0.01%
cases:0.14%
controls:0.00%
cases:0.09%
controls:0.01%
cases:0.28%
controls:0.07%
cases:0.41%
controls:0.14%
9
56
5794
57889
17
41
5786
57904
7
7
5796
57938
8
0
5795
57945
5
7
5784
57802
16
37
5601
56024
19
63
4644
46517
Leiomyoma of uterus, unspecified
D25.9 [45542693]
D25.9 [45542693]
2.2e-01
1.2e+00
1.9e+00
1.0e+50
2.4e+00
7.6e-01
3.8e-01
cases:0.93%
controls:0.75%
cases:0.81%
controls:0.25%
cases:0.17%
controls:0.03%
cases:0.09%
controls:0.00%
cases:0.28%
controls:0.02%
cases:0.46%
controls:0.22%
cases:0.97%
controls:0.66%
54
434
5749
57511
47
142
5756
57803
10
15
5793
57930
5
0
5798
57945
16
14
5773
57795
26
122
5591
55939
45
307
4618
46273
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
1.9e-01
9.9e-01
9.9e-01
2.0e+00
7.7e-01
7.6e-01
5.7e-01
cases:13.87%
controls:11.72%
cases:16.25%
controls:6.75%
cases:5.62%
controls:2.17%
cases:0.95%
controls:0.13%
cases:4.40%
controls:2.10%
cases:13.55%
controls:6.81%
cases:24.34%
controls:15.35%
805
6790
4998
51155
943
3911
4860
54034
326
1256
5477
56689
55
75
5748
57870
255
1212
5534
56597
761
3816
4856
52245
1135
7151
3528
39429
Very extensive body CT
JN4CD [2001310902]
JN4CD [2001310902]
2.4e-01
1.9e+00
2.3e+00
—
-1.0e+50
1.1e+00
8.9e-01
cases:0.52%
controls:0.41%
cases:0.71%
controls:0.10%
cases:0.10%
controls:0.01%
—
—
cases:0.00%
controls:0.01%
cases:0.23%
controls:0.07%
cases:0.41%
controls:0.17%
30
236
5773
57709
41
59
5762
57886
6
6
5797
57939
—
0
7
5789
57802
13
42
5604
56019
19
78
4644
46502
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
1.4e-01
8.8e-01
9.8e-01
2.3e+00
9.2e-01
6.1e-01
3.9e-01
cases:38.24%
controls:34.93%
cases:40.98%
controls:22.40%
cases:10.80%
controls:4.36%
cases:2.57%
controls:0.25%
cases:10.21%
controls:4.34%
cases:35.07%
controls:22.68%
cases:56.66%
controls:46.91%
2219
20242
3584
37703
2378
12980
3425
44965
627
2526
5176
55419
149
146
5654
57799
591
2510
5198
55299
1970
12713
3647
43348
2642
21849
2021
24731
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
8.0e-02
6.1e-01
1.6e+00
2.3e+00
9.4e-01
5.1e-01
3.1e-01
cases:30.42%
controls:28.75%
cases:35.64%
controls:23.17%
cases:22.06%
controls:5.29%
cases:2.45%
controls:0.26%
cases:11.85%
controls:5.00%
cases:34.86%
controls:24.35%
cases:50.16%
controls:42.44%
1765
16659
4038
41286
2068
13427
3735
44518
1280
3063
4523
54882
142
152
5661
57793
686
2891
5103
54918
1958
13651
3659
42410
2339
19770
2324
26810
Other malignant neoplasm of kidney, except renal pelvis
C64.88 [2000501096]
C64.88 [2000501096]
4.3e-01
7.3e-01
7.8e-01
3.3e+00
7.5e-01
1.2e+00
1.0e+00
cases:0.43%
controls:0.28%
cases:0.50%
controls:0.24%
cases:0.17%
controls:0.08%
cases:0.28%
controls:0.01%
cases:0.17%
controls:0.08%
cases:0.82%
controls:0.24%
cases:0.88%
controls:0.33%
25
163
5778
57782
29
140
5774
57805
10
46
5793
57899
16
6
5787
57939
10
47
5779
57762
46
137
5571
55924
41
152
4622
46428
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
T81.4 [45575538]
2.6e-01
9.4e-01
1.7e+00
—
1.5e+00
1.4e+00
6.6e-01
cases:1.67%
controls:1.29%
cases:0.93%
controls:0.36%
cases:0.19%
controls:0.04%
—
—
cases:0.21%
controls:0.04%
cases:1.25%
controls:0.30%
cases:2.08%
controls:1.09%
97
749
5706
57196
54
211
5749
57734
11
21
5792
57924
—
12
26
5777
57783
70
168
5547
55893
97
506
4566
46074
Hyperplasia of prostate
N40 [45563015]
N40 [45563015]
1.7e-01
4.6e-01
8.5e-01
3.8e+00
8.1e-01
2.7e-01
2.3e-01
cases:4.45%
controls:3.76%
cases:2.76%
controls:1.77%
cases:0.65%
controls:0.28%
cases:0.72%
controls:0.02%
cases:0.59%
controls:0.26%
cases:2.49%
controls:1.91%
cases:6.11%
controls:4.90%
258
2180
5545
55765
160
1023
5643
56922
38
162
5765
57783
42
9
5761
57936
34
151
5755
57658
140
1071
5477
54990
285
2284
4378
44296
Obesity due to excess calories
E66.01 [2000501501]
E66.01 [2000501501]
6.9e-01
1.0e+00
1.3e+00
—
1.4e+00
1.0e+00
8.2e-01
cases:2.36%
controls:1.20%
cases:1.62%
controls:0.60%
cases:0.43%
controls:0.12%
—
—
cases:0.43%
controls:0.11%
cases:1.90%
controls:0.68%
cases:3.80%
controls:1.71%
137
697
5666
57248
94
345
5709
57600
25
71
5778
57874
—
25
63
5764
57746
107
381
5510
55680
177
797
4486
45783
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
W01 [45756243]
2.6e-01
5.9e-01
7.3e-01
3.3e+00
7.9e-01
3.3e-01
2.2e-01
cases:5.27%
controls:4.12%
cases:2.57%
controls:1.44%
cases:0.47%
controls:0.22%
cases:0.28%
controls:0.01%
cases:0.43%
controls:0.20%
cases:2.30%
controls:1.66%
cases:7.06%
controls:5.75%
306
2388
5497
55557
149
837
5654
57108
27
130
5776
57815
16
6
5787
57939
25
114
5764
57695
129
932
5488
55129
329
2680
4334
43900
Treatment plan or consultation
WZC00 [2001310885]
WZC00 [2001310885]
9.1e-02
5.6e-01
6.4e-01
2.9e+00
9.3e-01
6.9e-01
4.4e-01
cases:6.91%
controls:6.35%
cases:4.03%
controls:2.35%
cases:0.59%
controls:0.31%
cases:0.19%
controls:0.01%
cases:0.79%
controls:0.31%
cases:4.29%
controls:2.21%
cases:10.74%
controls:7.16%
401
3677
5402
54268
234
1363
5569
56582
34
179
5769
57766
11
6
5792
57939
46
182
5743
57627
241
1237
5376
54824
501
3336
4162
43244
Other abnormal findings on diagnostic imaging of central nervous system
R90.8 [45539369]
R90.8 [45539369]
7.9e-01
2.8e+00
—
1.0e+50
—
2.2e+00
1.2e+00
cases:0.16%
controls:0.07%
cases:0.50%
controls:0.03%
—
—
cases:0.12%
controls:0.00%
—
—
cases:0.27%
controls:0.03%
cases:0.32%
controls:0.10%
9
41
5794
57904
29
18
5774
57927
—
7
0
5796
57945
—
15
17
5602
56044
15
45
4648
46535
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
2.0e-01
7.5e-01
1.5e+00
1.7e+00
8.5e-01
6.1e-01
5.9e-01
cases:12.65%
controls:10.57%
cases:15.99%
controls:8.25%
cases:8.39%
controls:2.03%
cases:0.41%
controls:0.08%
cases:4.25%
controls:1.87%
cases:15.22%
controls:8.90%
cases:26.49%
controls:16.67%
734
6125
5069
51820
928
4780
4875
53165
487
1177
5316
56768
24
45
5779
57900
246
1079
5543
56730
855
4988
4762
51073
1235
7766
3428
38814
alfacalcidol; oral, parenteral
A11CC03 [21600818]
A11CC03 [21600818]
6.6e-01
9.1e-01
6.9e-01
—
1.8e+00
1.4e+00
1.3e+00
cases:0.60%
controls:0.31%
cases:0.64%
controls:0.26%
cases:0.14%
controls:0.07%
—
—
cases:0.38%
controls:0.06%
cases:0.96%
controls:0.24%
cases:1.35%
controls:0.36%
35
181
5768
57764
37
149
5766
57796
8
40
5795
57905
—
22
35
5767
57774
54
134
5563
55927
63
166
4600
46414
Other investigative procedure of eye
XCW99 [2001301491]
XCW99 [2001301491]
3.5e-01
8.3e-01
1.3e+00
1.0e+50
1.7e+00
1.2e+00
7.0e-01
cases:2.46%
controls:1.74%
cases:1.29%
controls:0.57%
cases:0.34%
controls:0.09%
cases:0.14%
controls:0.00%
cases:0.55%
controls:0.10%
cases:1.87%
controls:0.55%
cases:3.22%
controls:1.63%
143
1009
5660
56936
75
329
5728
57616
20
54
5783
57891
8
0
5795
57945
32
57
5757
57752
105
310
5512
55751
150
759
4513
45821
Extirpation of intracranial lesion
AAB00 [2001300256]
AAB00 [2001300256]
1.0e+00
2.2e+00
—
1.0e+50
—
2.2e+00
1.8e+00
cases:0.21%
controls:0.07%
cases:0.24%
controls:0.03%
—
—
cases:0.16%
controls:0.00%
—
—
cases:0.30%
controls:0.03%
cases:0.28%
controls:0.05%
12
43
5791
57902
14
16
5789
57929
—
9
0
5794
57945
—
17
19
5600
56042
13
22
4650
46558
Volume of Urine
28009-9 [3036603]
28009-9 [3036603]
9.0e-01
2.5e+00
—
—
—
2.4e+00
1.3e+00
cases:0.24%
controls:0.10%
cases:0.71%
controls:0.06%
—
—
—
—
—
—
cases:0.71%
controls:0.07%
cases:0.88%
controls:0.25%
14
57
5789
57888
41
34
5762
57911
—
—
—
40
38
5577
56023
41
116
4622
46464
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
UJD10 [2001304788]
3.7e-01
1.3e+00
1.5e+00
—
1.2e+00
1.0e+00
6.4e-01
cases:6.63%
controls:4.68%
cases:5.27%
controls:1.43%
cases:0.60%
controls:0.13%
—
—
cases:0.41%
controls:0.12%
cases:3.38%
controls:1.25%
cases:8.08%
controls:4.45%
385
2710
5418
55235
306
828
5497
57117
35
77
5768
57868
—
24
71
5765
57738
190
703
5427
55358
377
2073
4286
44507
Other and unspecified abdominal pain
R10.4 [45568113]
R10.4 [45568113]
4.4e-01
1.7e+00
1.4e+00
—
1.3e+00
6.9e-01
6.6e-01
cases:8.39%
controls:5.55%
cases:8.39%
controls:1.71%
cases:0.83%
controls:0.21%
—
—
cases:0.66%
controls:0.19%
cases:3.54%
controls:1.81%
cases:10.87%
controls:5.94%
487
3214
5316
54731
487
989
5316
56956
48
120
5755
57825
—
38
109
5751
57700
199
1013
5418
55048
507
2769
4156
43811
Measurement of bone density from two or more locations with X-ray
NK6QA [2001308500]
NK6QA [2001308500]
9.8e-02
1.4e+00
8.7e-01
—
2.2e+00
1.3e+00
1.3e+00
cases:1.07%
controls:0.97%
cases:1.07%
controls:0.27%
cases:0.09%
controls:0.04%
—
—
cases:0.12%
controls:0.01%
cases:0.98%
controls:0.28%
cases:2.59%
controls:0.75%
62
562
5741
57383
62
156
5741
57789
5
21
5798
57924
—
7
8
5782
57801
55
156
5562
55905
121
350
4542
46230
Paralysis of vocal cords and larynx
J38.0 [45543265]
J38.0 [45543265]
-1.2e-01
8.4e-01
1.4e+00
—
2.3e+00
2.5e+00
1.3e+00
cases:0.12%
controls:0.14%
cases:0.16%
controls:0.07%
cases:0.09%
controls:0.02%
—
—
cases:0.12%
controls:0.01%
cases:0.66%
controls:0.06%
cases:0.64%
controls:0.18%
7
79
5796
57866
9
39
5794
57906
5
12
5798
57933
—
7
7
5782
57802
37
31
5580
56030
30
84
4633
46496
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
3.3e-01
7.8e-01
1.3e+00
—
1.6e+00
1.2e+00
8.6e-01
cases:9.12%
controls:6.70%
cases:3.46%
controls:1.61%
cases:0.47%
controls:0.13%
—
—
cases:0.62%
controls:0.12%
cases:3.65%
controls:1.17%
cases:8.02%
controls:3.57%
529
3885
5274
54060
201
935
5602
57010
27
75
5776
57870
—
36
70
5753
57739
205
654
5412
55407
374
1665
4289
44915
Cancer Ag 19-9 [Units/volume] in Serum or Plasma
24108-3 [3022914]
24108-3 [3022914]
-2.9e-01
1.3e+00
1.9e+00
—
1.3e+00
9.7e-01
5.6e-01
cases:0.55%
controls:0.74%
cases:1.57%
controls:0.42%
cases:0.52%
controls:0.07%
—
—
cases:0.22%
controls:0.06%
cases:1.00%
controls:0.38%
cases:1.50%
controls:0.87%
32
426
5771
57519
91
243
5712
57702
30
43
5773
57902
—
13
37
5776
57772
56
213
5561
55848
70
404
4593
46176
General Practice
1 [38004446]
1 [38004446]
2.3e-01
7.0e-01
8.1e-01
2.5e+00
1.0e+00
4.5e-01
3.9e-01
cases:15.78%
controls:12.97%
cases:9.34%
controls:4.89%
cases:1.48%
controls:0.67%
cases:0.34%
controls:0.03%
cases:1.87%
controls:0.68%
cases:8.10%
controls:5.34%
cases:20.42%
controls:14.82%
916
7514
4887
50431
542
2831
5261
55114
86
386
5717
57559
20
17
5783
57928
108
393
5681
57416
455
2995
5162
53066
952
6905
3711
39675
Abdominal CT examination both without and with contrast
JN3CD [2001305561]
JN3CD [2001305561]
6.2e-01
2.8e+00
—
1.0e+50
—
1.4e+00
1.3e+00
cases:0.64%
controls:0.34%
cases:1.15%
controls:0.07%
—
—
cases:0.19%
controls:0.00%
—
—
cases:0.23%
controls:0.06%
cases:0.56%
controls:0.15%
37
199
5766
57746
67
43
5736
57902
—
11
0
5792
57945
—
13
33
5604
56028
26
71
4637
46509
Anaemia, unspecified
D64.9 [45600610]
D64.9 [45600610]
3.9e-01
1.3e+00
1.7e+00
—
1.4e+00
7.9e-01
4.4e-01
cases:1.52%
controls:1.03%
cases:1.76%
controls:0.47%
cases:0.34%
controls:0.06%
—
—
cases:0.31%
controls:0.08%
cases:1.03%
controls:0.47%
cases:2.53%
controls:1.65%
88
598
5715
57347
102
273
5701
57672
20
37
5783
57908
—
18
44
5771
57765
58
265
5559
55796
118
769
4545
45811
12 lead EKG panel
34534-8 [3044889]
34534-8 [3044889]
1.3e-01
6.1e-01
1.0e+00
2.6e+00
8.6e-01
5.2e-01
3.4e-01
cases:24.00%
controls:21.69%
cases:19.01%
controls:11.34%
cases:3.69%
controls:1.38%
cases:0.60%
controls:0.05%
cases:2.95%
controls:1.27%
cases:17.32%
controls:11.04%
cases:35.88%
controls:28.38%
1393
12569
4410
45376
1103
6572
4700
51373
214
800
5589
57145
35
27
5768
57918
171
737
5618
57072
973
6188
4644
49873
1673
13221
2990
33359
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
14627-4 [3027273]
2.4e-01
1.5e+00
1.8e+00
—
1.8e+00
1.0e+00
2.9e-01
cases:1.03%
controls:0.82%
cases:1.91%
controls:0.44%
cases:0.28%
controls:0.05%
—
—
cases:0.33%
controls:0.06%
cases:1.25%
controls:0.46%
cases:2.36%
controls:1.78%
60
473
5743
57472
111
255
5692
57690
16
27
5787
57918
—
19
33
5770
57776
70
260
5547
55801
110
831
4553
45749
Gas and Carbon monoxide and Electrolytes panel - Arterial blood
93685-6 [1001509]
93685-6 [1001509]
3.7e-01
1.2e+00
-1.0e+50
1.0e+50
1.0e+50
3.8e+00
2.2e+00
cases:0.19%
controls:0.13%
cases:0.14%
controls:0.04%
cases:0.00%
controls:0.01%
cases:0.16%
controls:0.00%
cases:0.79%
controls:0.00%
cases:1.39%
controls:0.03%
cases:0.73%
controls:0.08%
11
76
5792
57869
8
25
5795
57920
0
5
5803
57940
9
0
5794
57945
46
0
5743
57809
78
17
5539
56044
34
39
4629
46541
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
1960-4 [3008152]
3.7e-02
1.1e+00
1.4e+00
—
2.2e+00
1.3e+00
2.3e-01
cases:1.26%
controls:1.21%
cases:1.60%
controls:0.53%
cases:0.19%
controls:0.05%
—
—
cases:0.64%
controls:0.07%
cases:1.90%
controls:0.54%
cases:2.44%
controls:1.95%
73
703
5730
57242
93
306
5710
57639
11
27
5792
57918
—
37
41
5752
57768
107
304
5510
55757
114
906
4549
45674
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1805-1 [3016417]
2.7e-01
1.5e+00
1.8e+00
—
1.1e+00
9.3e-01
5.6e-01
cases:2.40%
controls:1.83%
cases:3.72%
controls:0.83%
cases:0.67%
controls:0.11%
—
—
cases:0.35%
controls:0.11%
cases:1.90%
controls:0.76%
cases:4.46%
controls:2.60%
139
1063
5664
56882
216
481
5587
57464
39
63
5764
57882
—
20
64
5769
57745
107
427
5510
55634
208
1211
4455
45369
Cytology report of Tissue fine needle aspirate Cyto stain
33718-8 [3043109]
33718-8 [3043109]
2.6e-02
1.3e+00
2.5e+00
—
—
1.3e+00
9.4e-01
cases:0.52%
controls:0.50%
cases:0.59%
controls:0.16%
cases:0.12%
controls:0.01%
—
—
—
—
cases:0.43%
controls:0.12%
cases:1.09%
controls:0.43%
30
292
5773
57653
34
95
5769
57850
7
6
5796
57939
—
—
24
65
5593
55996
51
200
4612
46380
Recurrent depressive disorder, current episode severe without psychotic symptoms
F33.2 [45547705]
F33.2 [45547705]
5.0e-01
9.4e-01
9.3e-01
2.8e+00
9.7e-01
9.7e-01
8.0e-01
cases:0.93%
controls:0.57%
cases:0.69%
controls:0.27%
cases:0.26%
controls:0.10%
cases:0.14%
controls:0.01%
cases:0.26%
controls:0.10%
cases:0.64%
controls:0.24%
cases:1.24%
controls:0.56%
54
328
5749
57617
40
156
5763
57789
15
59
5788
57886
8
5
5795
57940
15
57
5774
57752
36
137
5581
55924
58
263
4605
46317
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
6.6e-02
5.9e-01
1.6e+00
2.2e+00
8.8e-01
4.9e-01
2.9e-01
cases:40.27%
controls:38.70%
cases:38.57%
controls:25.83%
cases:19.58%
controls:4.82%
cases:1.96%
controls:0.23%
cases:10.21%
controls:4.49%
cases:36.26%
controls:25.84%
cases:56.83%
controls:49.65%
2337
22425
3466
35520
2238
14970
3565
42975
1136
2794
4667
55151
114
134
5689
57811
591
2593
5198
55216
2037
14487
3580
41574
2650
23125
2013
23455
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
2.4e-01
1.1e+00
1.4e+00
—
1.6e+00
1.0e+00
5.6e-01
cases:4.05%
controls:3.20%
cases:3.55%
controls:1.24%
cases:0.57%
controls:0.14%
—
—
cases:0.57%
controls:0.11%
cases:3.01%
controls:1.09%
cases:6.18%
controls:3.62%
235
1855
5568
56090
206
718
5597
57227
33
80
5770
57865
—
33
65
5756
57744
169
610
5448
55451
288
1688
4375
44892
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
4.0e-02
4.3e-01
1.7e+00
2.3e+00
9.5e-01
4.4e-01
1.6e-01
cases:51.49%
controls:50.50%
cases:57.88%
controls:47.20%
cases:49.39%
controls:15.02%
cases:7.07%
controls:0.78%
cases:30.45%
controls:14.54%
cases:60.05%
controls:49.20%
cases:71.69%
controls:68.26%
2988
29262
2815
28683
3359
27348
2444
30597
2866
8701
2937
49244
410
450
5393
57495
1763
8403
4026
49406
3373
27580
2244
28481
3343
31794
1320
14786
Abdominal ultrasound examination
JN3AE [2001305555]
JN3AE [2001305555]
1.7e-01
1.4e+00
1.4e+00
1.0e+50
1.5e+00
8.2e-01
8.4e-01
cases:2.03%
controls:1.72%
cases:2.22%
controls:0.54%
cases:0.21%
controls:0.05%
cases:0.12%
controls:0.00%
cases:0.17%
controls:0.04%
cases:1.07%
controls:0.47%
cases:3.54%
controls:1.56%
118
995
5685
56950
129
315
5674
57630
12
31
5791
57914
7
0
5796
57945
10
22
5779
57787
60
266
5557
55795
165
726
4498
45854
metronidazole; oral, rectal
P01AB01 [21604857]
P01AB01 [21604857]
4.1e-01
1.1e+00
1.0e+00
2.5e+00
4.4e-01
5.0e-01
4.5e-01
cases:10.82%
controls:7.46%
cases:5.74%
controls:2.02%
cases:0.50%
controls:0.18%
cases:0.10%
controls:0.01%
cases:0.38%
controls:0.25%
cases:3.31%
controls:2.04%
cases:9.74%
controls:6.41%
628
4324
5175
53621
333
1173
5470
56772
29
105
5774
57840
6
5
5797
57940
22
142
5767
57667
186
1141
5431
54920
454
2987
4209
43593
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
14338-8 [3013742]
5.6e-02
1.1e+00
1.9e+00
—
1.4e+00
9.3e-01
6.4e-01
cases:1.98%
controls:1.88%
cases:2.64%
controls:0.91%
cases:0.67%
controls:0.10%
—
—
cases:0.43%
controls:0.11%
cases:2.10%
controls:0.84%
cases:4.18%
controls:2.25%
115
1087
5688
56858
153
529
5650
57416
39
57
5764
57888
—
25
64
5764
57745
118
471
5499
55590
195
1050
4468
45530
Bacteria identified in Urine by Culture
630-4 [3026008]
630-4 [3026008]
1.8e-01
8.0e-01
7.6e-01
2.2e+00
1.2e+00
5.5e-01
3.1e-01
cases:7.51%
controls:6.37%
cases:6.77%
controls:3.17%
cases:0.95%
controls:0.44%
cases:0.12%
controls:0.01%
cases:1.35%
controls:0.43%
cases:5.82%
controls:3.45%
cases:13.34%
controls:10.17%
436
3689
5367
54256
393
1839
5410
56106
55
257
5748
57688
7
8
5796
57937
78
246
5711
57563
327
1934
5290
54127
622
4736
4041
41844
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
6.1e-02
6.0e-01
1.5e+00
2.2e+00
8.4e-01
4.8e-01
2.4e-01
cases:47.42%
controls:45.91%
cases:52.94%
controls:38.16%
cases:30.35%
controls:8.58%
cases:3.38%
controls:0.40%
cases:17.05%
controls:8.12%
cases:51.58%
controls:39.66%
cases:68.88%
controls:63.53%
2752
26604
3051
31341
3072
22112
2731
35833
1761
4974
4042
52971
196
230
5607
57715
987
4693
4802
53116
2897
22236
2720
33825
3212
29593
1451
16987
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
6.4e-02
6.0e-01
1.5e+00
2.2e+00
8.5e-01
4.9e-01
2.4e-01
cases:47.41%
controls:45.81%
cases:52.82%
controls:38.09%
cases:30.26%
controls:8.56%
cases:3.34%
controls:0.40%
cases:17.03%
controls:8.08%
cases:51.59%
controls:39.57%
cases:68.88%
controls:63.42%
2751
26545
3052
31400
3065
22072
2738
35873
1756
4960
4047
52985
194
230
5609
57715
986
4673
4803
53136
2898
22185
2719
33876
3212
29540
1451
17040
Intravenous
ZX120 [2001311495]
ZX120 [2001311495]
2.2e-01
8.5e-01
1.5e+00
—
1.2e+00
1.3e+00
9.6e-01
cases:1.57%
controls:1.26%
cases:1.22%
controls:0.53%
cases:0.50%
controls:0.11%
—
—
cases:0.36%
controls:0.11%
cases:1.39%
controls:0.37%
cases:2.27%
controls:0.88%
91
728
5712
57217
71
305
5732
57640
29
64
5774
57881
—
21
62
5768
57747
78
210
5539
55851
106
410
4557
46170
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
J44.8 [45586673]
5.5e-01
1.0e+00
9.9e-01
—
1.4e+00
9.9e-01
8.8e-01
cases:2.91%
controls:1.71%
cases:2.83%
controls:1.02%
cases:0.59%
controls:0.22%
—
—
cases:0.76%
controls:0.19%
cases:2.67%
controls:1.01%
cases:4.76%
controls:2.02%
169
990
5634
56955
164
589
5639
57356
34
127
5769
57818
—
44
107
5745
57702
150
565
5467
55496
222
942
4441
45638
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
6.1e-02
6.0e-01
1.5e+00
2.2e+00
8.4e-01
4.8e-01
2.4e-01
cases:47.39%
controls:45.86%
cases:52.83%
controls:38.10%
cases:30.28%
controls:8.56%
cases:3.34%
controls:0.40%
cases:17.02%
controls:8.10%
cases:51.58%
controls:39.62%
cases:68.86%
controls:63.51%
2750
26576
3053
31369
3066
22078
2737
35867
1757
4962
4046
52983
194
230
5609
57715
985
4680
4804
53129
2897
22210
2720
33851
3211
29583
1452
16997
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
6.1e-02
6.0e-01
1.5e+00
2.2e+00
8.5e-01
4.8e-01
2.4e-01
cases:47.44%
controls:45.92%
cases:52.89%
controls:38.15%
cases:30.28%
controls:8.58%
cases:3.34%
controls:0.40%
cases:17.03%
controls:8.10%
cases:51.58%
controls:39.66%
cases:68.86%
controls:63.52%
2753
26606
3050
31339
3069
22105
2734
35840
1757
4972
4046
52973
194
230
5609
57715
986
4680
4803
53129
2897
22232
2720
33829
3211
29587
1452
16993
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
6.0e-02
6.0e-01
1.5e+00
2.2e+00
8.4e-01
4.8e-01
2.4e-01
cases:47.46%
controls:45.96%
cases:52.97%
controls:38.18%
cases:30.31%
controls:8.59%
cases:3.34%
controls:0.40%
cases:17.05%
controls:8.13%
cases:51.65%
controls:39.69%
cases:68.90%
controls:63.55%
2754
26629
3049
31316
3074
22122
2729
35823
1759
4979
4044
52966
194
231
5609
57714
987
4700
4802
53109
2901
22249
2716
33812
3213
29602
1450
16978
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
6.1e-02
6.0e-01
1.5e+00
2.2e+00
8.4e-01
4.8e-01
2.4e-01
cases:47.48%
controls:45.97%
cases:52.94%
controls:38.21%
cases:30.31%
controls:8.59%
cases:3.36%
controls:0.40%
cases:17.03%
controls:8.13%
cases:51.61%
controls:39.73%
cases:68.90%
controls:63.61%
2755
26635
3048
31310
3072
22143
2731
35802
1759
4980
4044
52965
195
230
5608
57715
986
4699
4803
53110
2899
22275
2718
33786
3213
29629
1450
16951
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
6.1e-02
6.0e-01
1.5e+00
2.2e+00
8.4e-01
4.8e-01
2.4e-01
cases:47.44%
controls:45.91%
cases:52.89%
controls:38.17%
cases:30.28%
controls:8.59%
cases:3.34%
controls:0.40%
cases:17.05%
controls:8.11%
cases:51.59%
controls:39.67%
cases:68.86%
controls:63.55%
2753
26605
3050
31340
3069
22118
2734
35827
1757
4977
4046
52968
194
230
5609
57715
987
4690
4802
53119
2898
22242
2719
33819
3211
29603
1452
16977
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
T81.0 [45599741]
T81.0 [45599741]
3.6e-01
1.2e+00
1.7e+00
—
2.6e+00
1.4e+00
6.9e-01
cases:0.88%
controls:0.61%
cases:0.57%
controls:0.18%
cases:0.09%
controls:0.02%
—
—
cases:0.16%
controls:0.01%
cases:0.53%
controls:0.13%
cases:0.97%
controls:0.49%
51
355
5752
57590
33
102
5770
57843
5
9
5798
57936
—
9
7
5780
57802
30
72
5587
55989
45
227
4618
46353
Aldosterone [Moles/volume] in Serum or Plasma --upright
15012-8 [3003171]
15012-8 [3003171]
2.1e+00
—
1.0e+50
—
1.0e+50
3.7e+00
—
cases:0.45%
controls:0.06%
—
—
cases:1.84%
controls:0.00%
—
—
cases:0.40%
controls:0.00%
cases:0.37%
controls:0.01%
—
—
26
32
5777
57913
—
107
0
5696
57945
—
23
0
5766
57809
21
5
5596
56056
—
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
1.4e-01
3.5e-01
5.5e-01
3.6e+00
6.1e-01
3.9e-01
2.4e-01
cases:73.96%
controls:71.27%
cases:72.32%
controls:64.77%
cases:39.38%
controls:27.33%
cases:39.50%
controls:1.81%
cases:41.16%
controls:27.62%
cases:74.83%
controls:66.86%
cases:85.70%
controls:82.51%
4292
41295
1511
16650
4197
37530
1606
20415
2285
15837
3518
42108
2292
1050
3511
56895
2383
15966
3406
41843
4203
37482
1414
18579
3996
38434
667
8146
Human epididymis protein 4 [Moles/volume] in Serum or Plasma
55180-4 [40758310]
55180-4 [40758310]
2.1e-01
1.6e+00
2.2e+00
—
—
1.0e+00
9.9e-01
cases:0.55%
controls:0.45%
cases:0.76%
controls:0.15%
cases:0.17%
controls:0.02%
—
—
—
—
cases:0.34%
controls:0.12%
cases:0.90%
controls:0.34%
32
260
5771
57685
44
86
5759
57859
10
11
5793
57934
—
—
19
70
5598
55991
42
157
4621
46423
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
215
83
26.85
312.78
1.3
1.3
61.60
77.82
mu/l
0.33
160
63
518
126
44.98
307.65
3.9
1.5
0.99
1.01
ug/l
0.05
506
118
1410
1535
11.76
307.65
4.8
1.4
376.64
294.09
mu/l
3.37
1374
1393
3043
5047
11.41
307.65
4.2
2.2
312.28
382.77
nmol/l
40.54
2900
4682
1365
665
26.42
307.65
1.5
1.5
59.17
70.22
mu/l
0.38
1297
590
1306
550
30.23
307.65
1.5
1.3
0.21
0.21
nmol/l
0.02
1028
436
457
503
9.77
307.65
4.1
1.4
447.85
335.93
mu/l
1.29
431
388
1492
665
29.71
307.65
1.5
1.3
0.23
0.31
nmol/l
0.43
116
33
665
216
34.58
307.65
2.1
1.5
4.33
3.92
nmol/l
0.10
584
166
805
1337
6.82
307.65
2.0
1.3
8.07
11.11
u/l
6.80
661
1082
371
205
19.25
307.65
1.2
1.4
2.67
4.89
umol/l
11.43
343
176
1225
549
27.91
307.65
1.5
1.3
—
—
nmol/l
—
0
0
1200
292
51.36
307.65
3.3
1.6
17.00
19.08
nmol/l
3.29
1183
273
234
89
27.34
307.65
1.3
1.1
267.89
327.57
pmol/l
0.64
171
65
443
142
33.65
307.65
2.0
1.2
129.41
270.69
nmol/24h
0.33
443
142
1279
624
25.91
307.65
1.4
1.3
390.11
309.24
pmol/l
0.52
1193
524
1439
641
29.39
307.65
1.5
1.3
0.66
3.38
nmol/l
0.49
1412
613
1144
4230
3.12
230.32
4.7
2.2
11.63
13.26
nmol/l
9.71
1070
3820
4068
27723
2.51
226.67
9.7
7.4
1.21
1.21
mmol/l
0.67
3624
23996
3626
24837
2.20
179.00
8.1
6.8
1.21
1.21
mmol/l
0.32
3449
22997
754
2512
3.30
178.18
1.9
1.4
22.43
30.48
iu/l
9.10
622
2165
335
641
5.48
166.64
3.8
3.4
4.77
14.24
nmol/l
0.56
325
622
4285
31929
2.26
163.62
6.5
5.2
6.74
6.69
mmol/l
0.80
4167
30309
196
232
8.70
153.05
1.3
1.2
171.18
158.88
mmol/24h
0.94
196
232
137
97
14.44
151.14
1.3
1.1
0.80
0.70
umol/24h
0.32
62
50
3507
24763
2.03
146.18
5.8
5.2
35.57
35.67
g/l
0.55
3362
23256
856
3457
2.73
141.66
3.5
3.5
4.40
4.46
pmol/l
1.05
796
3098
3496
25152
1.96
132.11
14.9
14.9
1.22
1.24
inr
2.40
2983
20930
3866
28841
1.99
130.67
6.9
6.9
10.66
11.42
umol/l
3.41
3733
27569
211
326
6.68
130.46
1.4
1.7
—
—
—
0
0
4982
41135
2.37
124.71
6.7
4.5
14.90
14.78
pmol/l
2.82
4749
37889
318
773
4.29
118.22
1.9
1.4
0.32
0.37
nmol/l
0.68
226
584
4968
41337
2.29
115.86
10.0
8.6
80.12
79.09
u/l
0.73
4820
39322
476
1547
3.26
115.45
2.9
1.8
41.46
42.26
nmol/l
0.23
470
1497
405
1191
3.58
115.04
3.0
1.8
172.58
204.19
pmol/l
7.28
384
1125
1241
6545
2.14
110.29
7.4
7.9
5.20
5.09
kpa
3.69
1208
6295
1239
6541
2.13
109.77
7.4
7.9
12.98
12.43
kpa
2.57
1200
6292
1393
7705
2.06
108.86
6.7
7.4
104.51
104.35
mmol/l
0.58
1393
7700
1224
6492
2.12
106.80
7.4
7.9
1.03
0.92
mmol/l
0.45
1003
5353
3982
31160
1.86
102.63
9.6
10.1
4.41
4.10
e9/l
10.83
3463
27010
3391
25425
1.79
99.05
3.2
2.8
—
—
estimate
—
0
0
346
1014
3.56
98.56
2.1
1.9
5.65
4.91
mmol/24h
2.64
304
904
1321
7397
2.01
98.50
6.3
6.3
1.01
1.04
mmol/l
2.93
1249
6889
259
633
4.23
95.42
2.2
1.4
283.48
276.60
mosm/kgh2o
4.75
232
480
741
3392
2.36
91.77
7.6
9.9
24.25
24.27
mmol/l
0.08
733
3335
3320
25080
1.74
91.08
3.1
2.5
75.96
77.99
nmol/l
4.37
3092
22748
2111
14044
1.78
90.69
4.4
4.2
92.48
90.00
%
4.47
2060
13751
875
4326
2.20
90.03
4.8
3.9
95.55
90.60
ng/l
0.71
779
3724
2499
17483
1.75
89.85
3.2
2.7
67.49
64.90
u/l
0.10
2349
16246
4709
39689
1.93
86.48
5.3
4.5
13.05
12.18
mm/h
3.79
4512
37214
3412
26214
1.72
85.72
7.0
6.7
27.21
27.68
%
1.74
3274
24829
3361
25745
1.71
85.10
6.9
6.6
58.13
57.37
%
3.36
3248
24597
3579
27970
1.71
83.35
6.6
6.5
0.04
0.04
e9/l
1.33
3064
23949
3658
28809
1.71
82.27
6.9
6.7
0.19
0.19
e9/l
0.05
3185
25102
3564
27891
1.70
81.88
6.7
6.5
0.60
0.59
e9/l
3.61
3042
23882
3619
28488
1.70
80.84
6.7
6.6
1.95
1.90
e9/l
1.01
3178
24999
2505
17955
1.69
79.36
3.9
3.5
108.21
76.88
e6/l
0.29
1963
13696
752
3680
2.20
78.71
6.6
8.4
24.61
24.85
mmol/l
1.11
746
3665
1049
5828
1.97
77.97
8.0
8.3
95.80
95.69
%
0.23
1024
5624
2763
20427
1.66
76.94
4.6
4.1
95.35
98.07
e6/l
0.05
2029
14400
74
62
12.07
73.72
3.5
2.7
99.96
85.45
pmol/l
0.15
60
57
5387
48363
2.34
73.30
7.3
5.5
1.72
1.91
mu/l
24.36
5098
44894
976
5441
1.95
71.24
8.3
8.8
123.60
121.18
g/l
3.23
955
5308
4200
34966
1.70
70.66
5.7
4.8
1546.05
1811.11
e6/l
0.12
58
455
3117
24075
1.63
70.54
14.0
11.9
0.01
0.00
e9/l
0.41
2556
19547
2194
15557
1.65
69.89
3.7
3.3
0.40
0.41
e6/l
0.05
1668
11406
1967
13596
1.67
68.99
2.7
2.4
—
—
—
0
0
5689
52642
3.40
68.87
28.7
19.3
139.78
139.70
mmol/l
1.61
5665
51686
2369
17207
1.63
68.05
2.4
2.2
190.28
214.26
u/l
0.71
2266
16284
5690
52746
3.35
66.86
28.9
19.5
3.95
3.97
mmol/l
9.56
5660
51696
1312
8205
1.77
65.81
2.8
2.7
21.07
22.59
%
4.16
1244
7668
1470
9536
1.72
64.58
3.5
3.5
0.81
0.81
mmol/l
0.08
1402
8987
63
51
12.48
64.09
1.2
1.1
2.09
1.63
umol/24h
1.99
63
51
5577
51317
2.65
63.50
22.6
16.6
24.07
24.04
mg/l
0.02
5014
42467
1387
8913
1.73
62.79
2.8
2.6
2.34
2.32
g/l
0.75
1302
8286
1458
9559
1.70
61.07
2.9
2.7
12.35
13.03
umol/l
3.15
1385
8961
2012
14404
1.60
59.10
2.7
2.4
2.95
2.80
mg/l
1.91
1787
12497
5444
49888
2.21
57.04
23.1
16.1
80.76
80.66
ml/min/173m2
0.13
5224
46311
2034
14784
1.57
55.03
3.6
3.3
0.40
309.30
estimate
0.62
11
50
2444
18528
1.55
54.72
3.3
3.4
33.70
35.03
u/l
0.22
2324
17498
1770
12475
1.60
54.54
3.1
2.8
6.07
5.55
e6/l
0.67
1637
11400
2208
16446
1.55
53.09
3.3
3.2
1542.37
1283.24
ng/l
1.08
1944
14210
3036
24416
1.50
49.70
2.4
2.1
94.62
96.40
pmol/l
1.24
1714
12847
610
3250
1.98
49.68
8.8
10.4
16.34
16.00
%
2.13
592
3127
1280
8562
1.63
47.87
2.0
2.1
29.44
29.64
s
0.45
1248
8341
63
77
8.26
47.86
3.4
1.8
40.27
36.27
pmol/l
0.13
58
66
846
5068
1.78
47.61
7.5
7.9
1.25
1.32
mmol/l
1.21
829
4976
646
3583
1.90
46.56
8.8
10.2
0.62
0.63
%
0.31
646
3560
665
3731
1.88
46.24
8.7
10.0
94.06
94.07
%
0.00
665
3720
661
3717
1.88
45.61
8.7
9.9
1.33
1.29
%
0.46
661
3697
3119
25479
1.48
45.52
3.7
3.1
131.31
126.96
ug/l
0.33
2935
23845
2470
19273
1.49
45.45
3.6
3.6
2.37
2.35
mmol/l
3.96
2263
17518
1351
9271
1.59
45.08
2.1
1.9
—
—
—
0
0
1518
10707
1.56
44.95
4.3
3.9
226.46
473.31
ng/l
1.51
1157
8360
3468
28979
1.48
44.76
4.4
4.0
0.00
0.25
estimate
0.73
817
5712
897
5599
1.71
43.33
4.7
3.8
5.83
5.82
kpa
0.13
872
5464
267
1072
2.56
43.24
1.6
1.4
71.63
61.29
mmol/l
2.97
233
870
1009
6510
1.66
42.99
2.7
2.9
7.00
8.19
umol/l
0.94
871
5740
1294
8886
1.58
42.72
3.4
3.2
3.12
2.53
e6/l
1.05
644
4283
2584
20510
1.46
42.67
4.4
3.8
59.28
72.51
ng/l
0.16
1893
14308
5318
49116
1.86
42.46
8.2
6.5
40.11
39.25
mmol/mol
10.29
5087
46065
3397
28461
1.46
41.87
4.4
4.0
0.00
0.00
estimate
1.34
868
5923
634
3626
1.84
41.26
4.3
3.7
5.22
5.15
kpa
1.36
614
3483
2442
19260
1.46
41.22
3.8
3.5
7.44
7.45
mmol/l
0.05
2117
16288
3421
28779
1.45
40.71
4.4
4.0
2.78
4.01
estimate
0.24
881
6092
2357
18502
1.46
40.59
4.6
4.2
9.92
8.59
mg/mmol
0.55
1582
11430
865
5461
1.68
39.78
4.8
3.9
1.93
1.86
mmol/l
0.18
752
4804
4085
35667
1.47
39.14
4.0
3.4
54.38
48.37
u/l
3.20
3899
33501
475
2516
1.97
39.02
6.0
5.1
1.67
1.61
%
0.61
455
2365
1660
12237
1.50
39.00
1.9
1.8
1.12
1.25
mg/l
1.19
1304
9514
862
5482
1.67
38.45
2.3
2.3
0.22
0.21
g/l
3.36
812
5138
393
1965
2.07
37.91
3.7
3.0
25.06
24.86
mmol/l
0.42
386
1935
857
5468
1.66
37.69
2.7
2.5
68.70
48.97
u/l
0.30
746
4608
720
4390
1.73
37.50
4.2
4.2
1.23
1.23
mmol/l
0.41
664
3800
76
147
5.22
37.27
1.5
1.6
0.47
0.38
ug/l
0.70
54
104
2045
15865
1.44
36.35
1.8
1.7
20.13
20.32
nmol/l
0.20
1792
13463
5355
49980
1.79
35.47
6.1
5.3
6.04
5.94
mmol/l
7.46
5055
46084
2292
18219
1.42
35.36
3.9
3.5
49.76
47.71
mg/l
0.16
1575
11519
756
4775
1.67
34.36
2.5
2.7
66.04
66.38
g/l
0.63
695
4402
1490
10980
1.48
34.24
1.5
1.5
2.41
2.43
g/l
0.12
924
6794
5714
54638
2.56
34.16
31.2
21.5
79.36
77.09
umol/l
3.78
5698
54042
531
3049
1.82
33.85
3.9
3.5
2.25
1.89
mmol/l
1.53
398
2281
270
1229
2.25
33.03
1.4
1.4
91.22
27.56
e6/l
0.57
184
897
1349
9805
1.49
33.03
3.2
3.0
1.18
1.11
e6/l
0.21
716
5218
272
1248
2.24
32.64
1.4
1.5
1739.21
1121.65
e6/l
0.45
205
971
786
5113
1.62
31.61
7.8
7.8
9.77
9.83
mmol/l
0.07
751
4911
423
2314
1.89
31.41
6.4
5.4
0.84
0.88
%
1.05
404
2174
282
1346
2.15
30.67
3.6
3.2
8.18
8.16
kpa
0.09
277
1316
944
6485
1.54
29.89
4.2
4.7
230.85
243.04
u/l
2.31
890
6173
1635
12553
1.42
29.33
1.4
1.3
1.23
1.74
u/ml
1.26
427
3408
183
739
2.52
29.31
2.0
1.3
19.70
29.65
u/l
4.33
165
607
713
4640
1.61
28.45
3.5
3.2
4.65
4.54
kpa
0.74
693
4518
32
5
64.30
27.92
4.3
1.0
3.25
2.62
mu/l
—
32
5
854
5871
1.53
26.70
3.9
4.3
26.18
22.83
ug/l
0.11
698
4762
4672
42867
1.44
26.57
28.0
20.4
13.82
13.64
%
17.53
4649
42318
1096
7938
1.47
26.55
1.4
1.4
525.32
529.36
titre
0.02
233
1730
552
3425
1.67
26.53
8.1
6.9
25.09
24.52
mmol/l
3.08
531
3269
980
6946
1.49
26.47
1.9
1.8
—
—
—
0
0
1899
15181
1.37
26.11
3.9
3.4
0.75
0.16
estimate
0.59
684
4739
1923
15404
1.37
26.11
3.2
3.0
0.05
0.05
0.03
37
359
241
1153
2.14
26.07
3.4
3.1
90.38
89.94
%
0.57
236
1123
281
1424
2.02
26.06
1.3
1.3
522.63
547.72
mg/l
0.39
267
1354
635
4106
1.61
25.89
1.7
1.7
—
—
—
0
0
145
556
2.65
25.85
1.5
1.5
—
—
—
0
0
1833
14612
1.37
25.52
2.9
2.8
351.49
340.28
umol/l
4.76
1635
12916
733
4932
1.56
25.17
3.0
2.7
71.98
69.90
e9/l
0.85
542
3590
666
4384
1.59
25.17
2.8
2.9
10.22
10.53
g/l
1.13
616
4039
417
2429
1.77
25.16
4.9
3.4
25.28
25.29
mmol/l
0.01
400
2350
1440
11065
1.40
24.98
3.0
3.0
2.47
2.45
mmol/l
4.59
1312
9929
43
71
6.09
24.97
1.6
1.8
—
—
—
0
0
70
176
4.01
24.94
1.5
1.5
14.66
15.36
pmol/l
0.40
60
151
112
387
2.93
24.33
1.3
1.2
34.50
35.43
mmol/l
0.16
105
336
413
2435
1.75
23.88
2.0
1.9
38.76
39.64
u/l
0.38
369
2182
547
3477
1.63
23.84
3.5
3.2
128.87
129.26
g/l
0.14
520
3374
225
1086
2.11
23.80
1.7
2.0
1.03
0.86
nmol/l
2.01
202
930
403
2362
1.76
23.79
2.5
2.3
4.19
4.21
g/l
0.27
365
2177
403
2363
1.76
23.75
2.5
2.3
7.39
7.43
g/l
0.16
363
2176
402
2361
1.75
23.55
2.5
2.3
3.61
3.71
g/l
0.75
365
2177
796
5557
1.50
22.89
3.3
3.5
—
—
—
0
0
3574
31726
1.32
22.83
3.1
2.9
—
—
—
0
0
307
1679
1.87
22.75
7.5
6.0
1.27
1.32
mmol/l
0.45
274
1477
909
6525
1.46
22.72
1.9
1.9
—
—
—
0
0
248
1264
2.00
22.65
1.2
1.3
3.66
3.78
mmol/l
1.03
231
1192
340
1931
1.81
22.32
2.2
1.8
—
—
—
0
0
5635
54255
1.90
22.16
15.6
12.6
27.26
26.18
u/l
2.38
5540
52751
360
2098
1.76
21.66
2.3
2.0
—
—
—
0
0
377
2230
1.74
21.53
2.5
2.3
2.87
2.91
g/l
0.33
339
2046
349
2024
1.77
21.35
2.4
2.3
9.70
10.23
g/l
1.53
309
1823
335
1945
1.77
20.41
3.1
3.5
48.28
79.38
mg/l
0.56
280
1655
29
39
7.47
20.34
3.2
2.7
250.02
99.53
pmol/l
—
9
15
334
1943
1.76
20.21
3.1
3.5
36.23
54.99
mg/l
1.37
280
1653
1171
9013
1.37
19.40
1.8
1.7
1094.32
1164.24
nmol/l
1.90
927
6869
5145
48688
1.45
19.23
4.9
4.4
1.42
1.29
mmol/l
25.53
4807
44898
5432
51989
1.58
19.12
6.7
5.9
2.63
2.71
mmol/l
10.44
5143
48555
5728
55697
2.05
18.15
35.5
25.2
257.05
251.63
e9/l
7.85
5668
54635
302
1762
1.75
18.10
1.5
1.4
249.81
275.62
ug/g
1.41
169
1049
5728
55704
2.05
18.03
35.3
25.1
91.00
91.21
fl
3.04
5712
55149
5338
50980
1.50
18.01
5.8
5.1
1.39
1.47
mmol/l
43.36
5041
47498
5729
55719
2.05
18.00
35.7
25.3
134.37
135.00
g/l
2.58
5711
55180
5728
55708
2.04
17.96
36.1
25.6
40.34
40.81
%
1.56
5711
55126
5728
55709
2.04
17.94
35.4
25.1
4.49
4.48
e12/l
1.02
5654
54464
297
1729
1.76
17.94
3.1
3.3
3.97
2.82
ratio
0.31
166
965
5728
55714
2.04
17.86
35.5
25.2
7.15
6.70
e9/l
21.13
5655
54455
509
3401
1.54
17.80
1.7
1.7
—
—
—
0
0
406
2575
1.62
17.76
1.6
1.7
1.63
1.55
g/l
0.95
358
2225
937
7062
1.39
17.46
2.3
2.4
128.38
135.42
ug/g
0.27
741
5652
132
586
2.28
17.27
2.6
3.5
10.20
10.58
mmol/l
0.51
132
577
508
3427
1.53
16.98
1.7
2.0
1.13
1.33
g/l
2.26
469
3158
424
2749
1.58
16.92
1.5
1.5
—
—
—
0
0
5355
51266
1.49
16.88
5.9
5.2
4.52
4.65
mmol/l
17.62
5094
48069
235
1301
1.84
16.80
3.3
3.0
1.49
1.59
mmol/l
1.00
224
1259
606
4278
1.46
16.20
3.2
3.0
193.61
180.53
ng/l
0.34
564
3912
212
1164
1.85
15.58
9.0
7.1
10.88
11.29
mmol/l
1.12
193
1035
419
2762
1.56
15.54
2.4
2.2
0.10
0.30
estimate
0.31
144
875
212
1165
1.85
15.54
9.0
7.1
105.04
105.10
mmol/l
0.07
193
1036
261
1535
1.73
15.24
2.0
2.0
3.20
7.63
iu/l
0.64
98
636
2460
21453
1.25
15.22
4.3
3.9
0.86
0.26
estimate
0.38
714
4895
329
2060
1.63
15.16
2.5
2.3
0.46
0.91
g/l
2.73
279
1784
287
1749
1.67
14.71
2.4
2.2
0.00
0.03
g/l
2.80
256
1582
2611
22999
1.24
14.53
2.1
1.9
1.47
1.36
mmol/l
8.86
2214
19316
410
2736
1.54
14.39
4.7
3.9
46.87
47.69
%
0.26
401
2692
818
6218
1.37
14.25
1.8
1.8
1.51
1.47
%
0.76
712
5446
277
1693
1.67
14.05
2.4
2.2
0.00
0.00
g/l
-0.00
240
1490
113
516
2.21
13.90
1.1
1.1
—
—
—
0
0
1858
15816
1.26
13.85
4.6
4.2
0.00
0.00
estimate
0.46
818
5505
260
1575
1.68
13.65
2.4
2.3
0.00
0.00
g/l
-0.00
240
1489
78
308
2.55
13.30
2.0
2.1
7.91
8.21
mmol/l
0.29
78
308
622
4577
1.40
13.16
2.9
2.5
0.28
0.46
e6/l
2.23
602
4381
72
275
2.64
13.13
1.8
1.5
—
—
—
0
0
195
1102
1.80
13.11
3.5
4.5
2.62
2.55
mmol/l
0.13
133
760
195
1103
1.79
13.07
3.5
4.5
5.03
5.02
kpa
0.08
190
1088
196
1111
1.79
13.04
3.5
4.5
8.70
8.55
kpa
0.45
191
1095
322
2081
1.58
13.04
3.2
3.6
306.50
2697.99
u/ml
1.10
273
1798
252
1540
1.66
12.81
1.4
1.5
23.06
15.13
iu/ml
—
5
35
269
1676
1.63
12.68
2.9
3.4
1.54
1.56
mg/l
0.18
249
1539
178
992
1.82
12.54
1.5
1.6
0.72
0.77
g/l
0.32
136
770
246
1507
1.66
12.40
3.2
3.3
1.39
1.94
index
1.21
128
771
1373
11417
1.26
12.23
1.8
1.7
9146257.87
35979104.59
pmol/l
2.71
1159
9564
297
1913
1.58
12.21
1.6
1.7
—
—
—
0
0
120
591
2.05
12.21
1.1
1.1
—
4.29
—
0
8
295
1913
1.57
11.79
2.4
2.7
—
—
—
0
0
712
5448
1.35
11.77
2.3
2.2
0.02
0.01
estimate
0.33
178
1109
245
1523
1.64
11.68
2.0
2.0
11.54
11.74
mg/l
0.13
223
1422
1267
10491
1.26
11.61
1.4
1.3
35.37
31.17
iu/ml
0.49
384
3184
305
2001
1.55
11.58
2.3
2.2
413.60
623.85
ug/l
0.79
290
1901
185
1072
1.75
11.46
3.7
3.2
7.46
7.50
mmol/l
0.06
175
1039
1185
9749
1.27
11.44
1.3
1.3
10.90
12.08
u/ml
0.23
460
3800
352
2390
1.50
11.40
1.5
1.6
5.64
15.45
iu/ml
—
7
62
273
1753
1.58
11.39
1.6
1.7
0.25
0.24
g/l
1.27
249
1664
250
1575
1.61
11.30
1.6
1.7
—
—
—
0
0
82
361
2.29
11.09
2.5
1.8
126.83
113.72
ng/l
0.30
82
361
291
1909
1.55
11.07
4.4
3.8
25.20
24.88
mmol/l
1.10
275
1760
417
2946
1.45
11.05
3.2
2.9
1.41
1.22
%
2.92
411
2926
508
3721
1.40
11.00
1.2
1.2
146.92
142.73
u/ml
0.07
159
1384
64
253
2.55
10.96
1.3
1.3
48.00
65.89
%
—
6
35
331
2253
1.50
10.61
2.3
1.9
1.76
2.24
ug/l
0.47
295
2020
114
582
1.98
10.56
4.0
3.6
58.01
57.65
%
0.05
90
501
202
1231
1.66
10.44
2.2
2.8
31.10
34.22
umol/l
1.23
184
1121
275
1807
1.55
10.40
1.5
1.7
1.24
1.20
g/l
1.13
253
1719
158
908
1.76
10.12
4.1
3.6
1.42
1.62
%
0.32
135
812
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
273
1807
1.54
10.00
2.9
3.2
0.40
0.34
iu/ml
1.21
162
995
562
4254
1.35
9.93
1.6
1.5
—
—
—
0
0
214
1343
1.62
9.87
2.3
2.3
133.45
128.53
g/l
2.03
158
1041
590
4507
1.34
9.82
3.2
2.7
67.50
66.36
ml/min/173m2
0.18
290
1890
149
850
1.77
9.80
1.1
1.1
1133.65
13547.75
iu/ml
0.48
29
173
252
1657
1.54
9.53
2.2
2.6
3.82
3.57
g/l
1.85
240
1578
194
1201
1.64
9.47
1.4
1.5
—
—
—
0
0
1845
16182
1.20
9.45
6.3
5.6
1.95
2.78
ug/l
8.16
1707
14692
79
380
2.09
8.68
1.1
1.1
—
—
—
0
0
123
690
1.80
8.61
1.2
1.1
—
—
—
0
0
238
1583
1.52
8.57
2.4
2.5
185.15
194.82
%
0.94
227
1511
510
3911
1.33
8.26
2.6
2.5
13.22
21.98
au/ml
2.47
33
413
231
1545
1.52
8.12
2.3
2.1
10669.72
5064.28
u/l
0.85
58
604
83
418
2.00
8.09
1.1
1.1
37.56
41.49
mg/l
0.54
72
347
239
1612
1.50
8.08
1.2
1.2
81.25
146.86
titre
0.95
16
153
120
683
1.77
8.03
2.5
2.2
0.75
0.56
mmol/l
0.19
115
658
86
441
1.96
7.97
1.3
1.3
2.11
2.16
mmol/l
0.12
79
411
250
1711
1.48
7.87
1.4
1.3
—
—
—
0
0
246
1680
1.48
7.83
1.4
1.3
—
—
—
0
0
313
2243
1.42
7.73
1.6
1.6
0.33
0.31
mg/l
0.18
136
1046
471
3608
1.33
7.69
1.4
1.3
46.61
56.70
au/ml
0.33
21
253
249
1718
1.47
7.54
2.1
2.3
95.84
93.06
%
1.19
238
1655
191
1248
1.55
7.51
3.3
3.6
787.25
681.04
u/ml
0.06
173
1140
1131
9655
1.21
7.42
3.6
3.3
0.79
0.76
ug/l
0.31
811
6375
79
405
1.96
7.36
1.1
1.1
247.46
269.56
mg/l
0.61
71
349
65
313
2.09
7.19
1.4
1.4
1.37
1.26
nmol/l
0.35
54
227
288
2061
1.42
7.19
1.6
1.6
18.21
17.19
u/ml
0.10
47
475
105
596
1.78
7.14
1.3
1.2
48.81
61.14
u/l
2.43
95
527
465
3595
1.32
7.13
1.3
1.3
154.54
229.12
u/ml
2.25
439
3345
396
2992
1.35
7.11
2.8
3.8
107.48
64.45
u/ml
0.24
380
2885
118
694
1.71
7.09
1.2
1.1
—
—
—
0
0
15
19
7.91
7.09
1.0
1.0
107.29
78.00
pmol/l
—
7
10
42
169
2.50
7.06
1.0
1.1
—
—
—
0
0
120
710
1.70
7.06
2.3
2.3
31.85
32.47
pg
0.78
120
705
207
1396
1.50
7.05
1.3
1.3
—
—
—
0
0
70
350
2.01
7.02
1.4
1.2
84.57
89.97
u/l
0.22
61
299
160
1021
1.58
7.00
1.2
1.3
24.39
40.00
u/l
1.67
146
889
1477
12983
1.18
6.97
4.9
4.5
21.48
21.90
%
0.49
756
6418
215
1466
1.48
6.94
1.4
1.6
—
—
—
0
0
311
2273
1.39
6.89
1.3
1.3
0.24
1.31
u/ml
3.34
23
193
1512
13337
1.18
6.83
3.8
3.8
0.11
0.16
—
9
141
63
307
2.06
6.78
1.2
1.2
0.56
0.59
ratio
0.33
34
176
161
1054
1.54
6.34
1.3
1.3
—
—
—
0
0
161
1054
1.54
6.34
1.3
1.3
—
—
—
0
0
66
337
1.97
6.28
1.3
1.2
22.53
24.36
u/l
0.12
55
281
61
303
2.02
6.27
1.1
1.1
1.26
1.17
u/l
0.20
23
141
200
1374
1.47
6.26
1.1
1.1
11.37
5.34
eliau/ml
0.45
23
156
115
698
1.66
6.20
1.8
2.0
31.75
23.51
ug/l
0.35
115
688
128
799
1.62
6.18
6.8
6.5
12.49
11.98
mg/l
0.58
115
753
210
1468
1.45
6.02
4.4
4.1
3.80
3.89
mmol/l
2.25
210
1455
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
54
261
2.08
5.99
1.1
1.1
—
—
—
0
0
249
1798
1.40
5.97
1.5
1.5
0.11
6.62
iu/ml
0.95
49
332
59
296
2.00
5.92
1.1
1.1
—
—
—
0
0
123
770
1.61
5.89
1.5
1.4
—
—
—
0
0
84
476
1.78
5.82
1.2
1.2
115.60
106.86
pmol/l
0.73
84
476
65
341
1.92
5.75
7.0
6.7
12.38
131.95
ug/l
1.09
37
213
183
1258
1.47
5.74
1.6
1.5
110.30
173.26
pmol/l
2.03
177
1231
77
435
1.78
5.42
1.2
1.3
8.81
9.06
mmol/l
0.19
70
415
185
1294
1.44
5.33
1.4
1.5
—
—
—
0
0
111
697
1.60
5.30
2.2
2.4
1.26
1.30
g/24h
0.06
62
413
102
630
1.63
5.21
1.6
1.6
57.64
58.02
%
0.03
64
387
136
899
1.52
5.20
1.4
1.5
—
—
—
0
0
211
1519
1.40
5.19
1.5
1.6
—
—
—
0
0
171
1187
1.45
5.14
5.1
5.9
260.50
1783.92
iu/ml
0.64
14
176
184
1308
1.42
4.89
1.2
1.3
22.37
42.98
u/ml
2.37
18
143
122
799
1.54
4.89
1.1
1.1
122.20
116.39
%
1.20
109
722
312
2412
1.31
4.86
1.6
1.8
6.19
6.75
iu/ml
0.16
60
573
179
1269
1.42
4.83
1.3
1.7
—
—
—
0
0
93
574
1.63
4.79
1.4
1.3
1.50
1.53
nmol/l
0.12
81
519
171
1205
1.43
4.78
2.0
1.6
—
—
—
0
0
550
4564
1.23
4.74
2.5
2.3
5.48
7.86
ug/l
2.14
490
4058
224
1659
1.36
4.68
1.3
1.3
2.13
4.79
u/ml
0.71
21
155
61
337
1.82
4.68
1.3
1.6
10.88
6.01
u/l
0.69
54
297
81
486
1.68
4.67
1.6
1.5
38.54
31.79
%
0.76
51
292
67
382
1.76
4.63
1.1
1.0
—
0.62
—
0
5
29
121
2.40
4.62
1.1
1.3
—
—
—
0
0
35
160
2.19
4.54
1.2
1.2
6.61
11.89
pmol/l
—
8
59
137
935
1.48
4.54
2.5
2.9
5139.90
1168.04
u/ml
—
10
56
207
1524
1.37
4.51
1.5
1.4
—
—
—
0
0
20
70
2.86
4.48
1.2
1.0
—
—
—
0
0
35
161
2.18
4.48
1.1
1.1
88.11
89.88
%
0.13
18
90
52
278
1.88
4.44
1.7
1.9
—
—
—
0
0
52
278
1.88
4.44
1.7
1.9
—
—
—
0
0
52
278
1.88
4.44
1.7
1.9
—
—
—
0
0
52
278
1.88
4.44
1.7
1.9
—
—
—
0
0
60
336
1.79
4.42
1.7
1.5
5.83
6.46
u/l
0.13
48
274
222
1661
1.35
4.37
1.3
1.3
10.01
6.98
u/ml
0.23
26
248
80
488
1.65
4.36
1.3
1.6
2.40
4.10
ug/l
1.82
68
410
194
1424
1.37
4.32
1.8
1.6
13998.37
10724.37
e6/l
0.63
134
977
75
451
1.67
4.32
1.2
1.2
80.00
178.93
titre
—
7
84
10
16
6.26
4.29
1.2
1.3
34.10
37.78
umol/24h
—
10
16
48
253
1.90
4.28
2.1
2.4
—
—
—
0
0
62
356
1.75
4.22
1.1
1.1
6.31
13.11
nmol/l
0.49
16
71
157
1118
1.42
4.19
1.4
1.4
—
—
—
0
0
34
160
2.13
4.14
1.1
1.3
90.78
89.71
%
0.05
18
90
77
472
1.64
4.13
1.6
1.7
—
—
—
0
0
77
472
1.64
4.13
1.6
1.7
—
—
—
0
0
77
472
1.64
4.13
1.6
1.7
—
—
—
0
0
523
4381
1.21
4.13
2.0
2.0
—
—
—
0
0
122
831
1.48
4.12
1.1
1.1
—
—
—
0
0
117
1700
0.68
4.10
1.1
1.1
0.63
0.63
ratio
0.01
21
235
81
505
1.61
4.07
6.1
5.3
238.81
56.70
u/ml
0.76
28
155
47
251
1.88
4.05
1.1
1.1
—
—
—
0
0
37
182
2.04
4.03
1.1
1.3
—
—
—
0
0
223
1693
1.33
4.01
1.3
1.3
—
—
—
0
0
109
730
1.50
4.01
1.5
1.4
—
—
—
0
0
74
454
1.64
3.97
1.2
1.2
—
—
—
0
0
86
548
1.58
3.96
1.2
1.2
—
—
—
0
0
186
1377
1.36
3.96
1.3
1.3
2.20
4.49
u/ml
—
9
88
114
774
1.48
3.93
1.1
1.1
1.51
1.52
g/l
0.07
107
700
341
2746
1.26
3.91
1.0
1.1
—
—
—
0
0
47
256
1.84
3.83
1.9
2.3
105.91
140.55
umol/l
0.54
22
138
126
878
1.44
3.82
1.1
1.1
0.29
0.82
—
5
31
14
44
3.19
3.77
1.0
1.0
—
—
—
0
0
569
4847
1.19
3.77
2.1
2.1
—
—
—
0
0
106
716
1.49
3.77
1.5
1.4
—
—
—
0
0
468
5556
0.83
3.71
1.9
2.0
3.56
3.47
ratio
0.84
358
4281
163
1196
1.37
3.69
2.2
2.4
184.86
105.80
ug/min
0.63
91
724
14
39
3.60
3.69
1.0
1.1
—
—
—
0
0
72
448
1.61
3.68
1.2
1.2
—
—
—
0
0
78
498
1.57
3.60
3.4
2.9
—
—
—
0
0
333
4075
0.81
3.58
1.6
1.7
3.43
3.48
mmol/l
0.34
228
2810
31
150
2.07
3.56
1.1
1.1
—
—
—
0
0
74
468
1.59
3.56
1.2
1.2
—
—
—
0
0
74
468
1.59
3.56
1.2
1.2
—
—
—
0
0
32
157
2.04
3.54
1.1
1.1
—
—
—
0
0
26
118
2.21
3.50
1.3
1.4
1.23
1.17
mmol/l
1.90
26
118
190
1442
1.33
3.48
1.1
1.2
—
—
—
0
0
142
1030
1.39
3.47
1.5
1.7
—
—
—
0
0
76
487
1.57
3.47
1.2
1.1
—
—
—
0
0
122
864
1.42
3.43
1.4
1.2
1.76
3.92
u/ml
3.14
46
297
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
23
100
2.31
3.42
1.2
1.2
64.83
76.82
%
—
6
28
31
153
2.03
3.39
1.1
1.1
—
—
—
0
0
342
2803
1.23
3.39
1.9
2.1
—
—
—
0
0
43
238
1.81
3.37
1.2
1.1
83.47
321.06
ng/l
1.12
15
63
37
195
1.90
3.37
1.3
1.3
0.32
0.30
g/l
0.55
26
159
19
76
2.50
3.37
1.2
1.2
—
—
—
0
0
48
275
1.75
3.36
3.9
4.2
—
—
—
0
0
51
298
1.72
3.34
1.3
1.3
134.49
136.15
nmol/l
0.10
51
298
31
154
2.02
3.34
1.3
1.3
277.99
428.74
ug/l
0.19
15
70
104
720
1.45
3.31
1.5
1.4
—
—
—
0
0
94
639
1.48
3.29
2.6
2.2
20.32
22.92
mg/l
0.29
38
229
56
338
1.66
3.27
1.5
1.5
85.80
81.06
umol/l
0.40
56
338
80
528
1.52
3.23
1.3
1.3
—
—
—
0
0
186
1428
1.31
3.17
1.1
1.2
—
—
—
0
0
1006
9069
1.13
3.14
1.7
1.5
—
—
—
0
0
13
44
2.96
3.13
1.1
1.1
—
—
—
0
0
29
145
2.00
3.09
1.6
1.9
34.56
51.41
u/l
0.36
24
139
6
8
7.51
3.05
3.5
9.9
—
—
—
0
0
53
323
1.65
3.01
1.2
1.1
88.58
82.61
u/l
0.18
48
289
22
101
2.18
2.92
1.3
1.2
91.00
82.30
%
—
7
30
141
1055
1.34
2.90
1.2
1.2
248.66
276.90
u/ml
0.53
85
653
137
1022
1.35
2.88
1.3
1.3
205.71
391.29
titre
—
7
85
28
143
1.96
2.84
1.1
1.1
—
—
—
0
0
330
2752
1.21
2.81
3.7
3.3
1.02
1.02
ratio
0.96
299
2489
97
687
1.42
2.79
1.6
1.4
—
—
—
0
0
19
84
2.27
2.76
1.5
1.5
6.99
385513.87
nmol/l
0.72
11
69
96
682
1.41
2.73
1.6
1.4
—
—
—
0
0
104
750
1.39
2.71
1.2
1.6
—
—
—
0
0
26
132
1.97
2.69
1.1
1.1
—
—
—
0
0
96
684
1.41
2.69
1.6
1.4
—
—
—
0
0
80
552
1.46
2.66
1.7
1.8
—
—
—
0
0
145
1106
1.32
2.65
1.3
1.5
—
—
—
0
0
64
424
1.52
2.60
1.2
1.2
—
—
—
0
0
179
1409
1.28
2.59
1.1
1.1
3.58
3.98
0.23
15
186
114
843
1.36
2.57
1.4
1.2
6.51
4.10
u/ml
0.50
55
371
8
20
4.00
2.56
5.9
5.2
590.75
371.95
umol/l
—
8
20
16
68
2.36
2.55
1.2
1.2
—
—
—
0
0
196
1572
1.26
2.45
1.3
1.3
—
—
—
0
0
14
57
2.46
2.44
1.1
1.1
—
—
—
0
0
74
513
1.45
2.43
3.7
3.4
11.62
13.30
index
1.08
47
296
11
268
0.41
2.42
1.3
1.3
—
—
—
0
0
16
70
2.29
2.41
1.3
1.2
44.00
53.52
%
—
10
29
18
83
2.17
2.40
1.9
2.0
—
—
—
0
0
83
590
1.41
2.39
1.7
1.8
—
—
—
0
0
278
2321
1.21
2.39
1.8
2.0
—
—
—
0
0
14
58
2.42
2.36
1.0
1.4
—
—
—
0
0
74
518
1.43
2.33
1.4
1.4
283.84
338.97
u/l
0.61
67
499
15
65
2.31
2.31
1.1
1.1
—
—
—
0
0
9
28
3.22
2.30
7.3
5.3
—
—
—
0
0
73
511
1.43
2.30
1.2
1.3
—
—
—
0
0
4397
42965
1.09
2.29
29.1
21.1
331.26
332.11
g/l
7.75
4384
42747
18
85
2.12
2.28
1.9
2.0
—
—
—
0
0
78
554
1.41
2.27
3.7
3.8
—
—
—
0
0
27
150
1.80
2.19
1.1
1.1
—
—
—
0
0
29
165
1.76
2.18
1.7
1.6
9.70
8.90
ug/l
0.40
29
165
110
833
1.33
2.18
1.2
1.2
38.67
6.49
u/ml
—
6
36
8
24
3.34
2.18
1.0
1.0
—
—
—
0
0
20
101
1.98
2.15
1.8
2.0
19.38
17.49
umol/l
0.29
20
101
99
743
1.34
2.09
5.7
5.4
351.41
356.93
umol/l
0.15
92
656
54
364
1.49
2.09
1.4
1.4
—
—
—
0
0
14
62
2.26
2.07
1.1
1.1
—
—
—
0
0
55
373
1.48
2.07
1.3
1.2
—
—
—
0
0
41
263
1.56
2.00
1.2
1.1
—
—
—
0
0
54
368
1.47
1.99
1.3
1.2
—
—
—
0
0
128
1618
0.79
1.97
1.6
1.6
980.88
1009.86
mu/l
0.11
107
1332
99
751
1.32
1.97
1.7
1.5
33.01
32.56
g/l
0.13
90
683
7
21
3.34
1.96
1.0
1.1
0.00
0.49
u/ml
—
7
21
16
77
2.08
1.96
12.4
12.7
5.10
5.57
mmol/l
0.45
16
77
127
1003
1.27
1.88
1.4
1.4
141.10
152.95
au/ml
0.57
39
286
56
390
1.44
1.87
2.1
2.4
644.95
637.57
ml
0.04
42
262
52
357
1.46
1.87
1.4
1.4
—
—
—
0
0
28
166
1.69
1.87
1.3
1.2
—
—
—
0
0
21
114
1.85
1.86
2.1
3.4
105.00
132.87
ng/l
0.21
13
50
9
34
2.65
1.86
1.0
1.1
—
—
—
0
0
44
294
1.50
1.81
1.3
1.1
—
—
—
0
0
34
215
1.58
1.78
1.2
1.2
—
—
—
0
0
43
288
1.50
1.76
1.2
1.6
—
—
—
0
0
43
288
1.50
1.76
1.2
1.6
—
—
—
0
0
64
463
1.39
1.75
1.2
1.2
—
—
—
0
0
86
653
1.32
1.74
1.6
1.5
1310.48
3638.84
e6/l
0.98
62
452
64
464
1.38
1.73
1.0
1.1
—
—
—
0
0
95
732
1.30
1.73
1.3
1.6
—
—
—
0
0
115
910
1.27
1.71
1.0
1.1
4.27
4.26
u/ml
0.00
55
473
90
690
1.31
1.70
1.0
1.1
2.32
4.02
u/ml
1.09
33
300
59
425
1.39
1.67
3.3
2.7
25.93
29.82
mg/l
0.33
39
311
10
40
2.50
1.66
1.6
6.6
—
—
—
0
0
6
19
3.16
1.66
1.2
1.2
—
—
—
0
0
6
19
3.16
1.66
1.0
1.1
—
—
—
0
0
96
746
1.29
1.65
1.0
1.1
2.29
3.30
u/ml
0.56
40
372
84
641
1.31
1.65
1.0
1.1
0.19
0.22
u/ml
0.06
21
217
14
69
2.03
1.64
1.1
1.1
—
—
—
0
0
80
607
1.32
1.64
10.7
15.4
7.75
7.22
mmol/l
0.40
70
509
280
2429
1.16
1.63
1.2
1.4
—
—
—
0
0
44
302
1.46
1.62
1.0
1.2
—
—
—
0
0
50
352
1.42
1.62
1.4
1.6
—
—
—
0
0
185
1552
1.20
1.61
1.3
1.3
228.10
217.75
miu/ml
0.14
67
706
35
230
1.52
1.59
3.1
3.4
1.69
1.28
%
0.30
35
230
56
409
1.37
1.49
1.0
1.0
830.16
724.46
ng/l
0.79
43
278
62
461
1.35
1.48
1.3
1.6
—
—
—
0
0
53
385
1.38
1.46
1.6
1.6
—
—
—
0
0
137
1654
0.82
1.46
1.5
1.5
—
—
—
0
0
47
335
1.41
1.45
1.4
1.6
—
—
—
0
0
56
412
1.36
1.44
1.0
1.0
29.95
42.28
ng/l
2.58
42
283
17
97
1.75
1.34
1.0
1.4
—
—
—
0
0
55
410
1.34
1.32
1.0
1.0
243.05
323.01
ng/l
2.65
44
286
124
1026
1.21
1.30
3.5
3.3
0.83
0.81
nmol/l
0.16
100
819
108
882
1.23
1.29
1.0
1.1
1.43
1.01
u/ml
0.22
43
377
104
846
1.23
1.29
1.0
1.1
0.69
1.34
u/ml
1.88
47
426
130
1087
1.20
1.24
4.0
3.5
28.79
27.86
mg/l
0.12
91
743
8
36
2.22
1.24
1.0
1.1
—
—
—
0
0
66
512
1.29
1.22
1.5
1.4
136684.07
84112.16
e6/l
0.23
42
340
12
63
1.91
1.22
1.2
1.1
—
—
—
0
0
50
373
1.34
1.22
1.3
1.5
—
—
—
0
0
69
875
0.79
1.20
1.5
1.5
1.14
1.14
ratio
0.00
38
515
25
164
1.53
1.20
3.3
3.8
10.31
10.15
kpa
0.10
25
164
25
164
1.53
1.20
3.3
3.8
5.13
4.87
kpa
0.47
25
164
33
230
1.44
1.19
1.1
1.1
103.50
94.07
%
0.67
22
179
6
26
2.31
1.18
1.8
1.3
917.70
471.85
nmol/l
—
6
26
35
247
1.42
1.18
1.5
1.4
—
—
—
0
0
35
247
1.42
1.18
1.5
1.4
—
—
—
0
0
705
6577
1.08
1.18
5.3
5.0
31.83
32.39
%
0.67
509
4357
35
248
1.41
1.16
2.3
2.0
24.67
236.57
ug/min
—
9
61
30
207
1.45
1.14
1.9
2.2
—
—
—
0
0
30
207
1.45
1.14
1.9
2.2
—
—
—
0
0
33
232
1.42
1.14
1.9
1.7
41.23
39.97
g/l
0.80
33
232
43
317
1.36
1.14
1.1
1.1
1.11
1.06
ratio
0.81
34
255
37
266
1.39
1.14
1.4
1.4
—
1248823.00
—
0
13
88
715
1.23
1.14
1.1
1.1
5.79
3.27
eliau/ml
0.48
45
309
73
581
1.26
1.13
1.6
1.4
41825.05
70870.10
e6/l
0.62
43
317
60
466
1.29
1.12
1.3
1.6
—
—
—
0
0
30
208
1.44
1.12
1.9
2.2
—
—
—
0
0
7
30
2.33
1.12
10.4
9.3
—
—
—
0
0
19
119
1.60
1.11
1.6
1.4
22.57
23.87
%
0.06
14
99
70
875
0.80
1.10
1.5
1.5
0.91
0.95
ratio
0.50
39
515
70
875
0.80
1.10
1.5
1.5
1.12
1.17
ratio
0.17
39
518
35
251
1.40
1.10
1.3
1.7
1.37
3.46
u/field
1.35
24
176
5
21
2.38
1.09
14.0
10.0
103.20
106.38
g/l
—
5
21
24
160
1.50
1.09
1.3
1.2
36.51
39.17
g/l
0.38
17
72
24
160
1.50
1.09
1.2
1.2
—
—
—
0
0
14
81
1.73
1.08
1.1
1.1
—
—
—
0
0
28
193
1.45
1.08
1.6
1.5
65.91
64.11
%
0.10
23
157
22
144
1.53
1.08
1.6
1.3
38.81
33.42
%
0.25
16
95
69
549
1.26
1.08
1.4
1.4
6.26
6.31
mmol/l
0.06
64
517
127
1078
1.18
1.06
1.1
1.1
0.80
2.22
u/ml
3.49
62
576
58
453
1.28
1.06
1.1
1.5
1.06
1.17
promille
0.23
45
362
27
186
1.45
1.05
3.3
2.0
1.18
1.83
ratio
3.04
27
177
30
212
1.42
1.03
1.1
1.1
—
—
—
0
0
10
178
0.56
1.03
3.2
1.7
—
—
—
0
0
9
47
1.92
1.02
1.2
1.2
6.18
6.03
mmol/l
—
9
47
70
864
0.81
1.01
1.5
1.4
—
—
—
0
0
79
645
1.23
1.00
1.3
1.3
7.68
7.34
mmol/l
0.48
71
570
55
431
1.28
0.99
1.2
1.3
0.42
1.31
u/ml
1.52
31
250
24
164
1.47
0.99
1.5
1.3
38.37
52.24
%
0.79
18
140
13
212
0.61
0.97
1.2
1.5
—
—
—
0
0
47
363
1.30
0.95
3.0
2.8
238.47
215.92
e6/l
0.29
34
312
60
479
1.26
0.94
3.5
3.1
170.34
38.10
mg/l
0.84
44
354
51
400
1.28
0.93
2.4
1.9
1.13
1.57
u/field
0.54
30
209
46
356
1.29
0.92
2.7
2.7
642.29
507.59
e6/l
0.51
31
289
47
365
1.29
0.92
1.3
1.4
—
—
—
0
0
6
29
2.07
0.89
2.8
3.3
—
—
—
0
0
31
228
1.36
0.88
1.1
1.1
189.75
187.97
iu/ml
0.01
31
228
68
557
1.22
0.87
1.5
1.5
—
—
—
0
0
1313
12634
1.05
0.86
4.4
4.2
1.02
1.14
kg/l
0.50
929
8465
8
44
1.82
0.85
3.1
2.8
—
—
—
0
0
18
120
1.50
0.85
8.0
7.5
5.07
5.49
kpa
0.85
18
120
12
72
1.67
0.85
1.0
1.1
—
—
—
0
0
17
112
1.52
0.84
1.1
1.0
33.72
34.77
iu/ml
0.04
17
112
102
874
1.17
0.82
1.5
1.7
—
—
—
0
0
6
33
1.82
0.79
1.0
1.0
2.23
4.71
u/ml
—
6
21
92
1074
0.85
0.78
1.5
1.4
—
—
—
0
0
21
148
1.42
0.77
1.7
1.5
21.04
22.92
%
0.12
21
136
80
941
0.85
0.75
1.5
1.5
61.58
59.69
ug/l
0.13
65
774
28
209
1.34
0.75
2.4
2.8
0.63
0.61
mmol/l
0.64
28
209
28
209
1.34
0.75
1.1
1.1
—
—
—
0
0
65
777
0.83
0.74
1.5
1.6
—
—
—
0
0
9
55
1.64
0.73
1.1
1.3
—
—
—
0
0
14
92
1.52
0.72
1.5
2.6
16.38
14.84
ml/dl
1.26
14
86
11
68
1.62
0.71
1.0
1.1
—
—
—
0
0
5
26
1.92
0.70
1.0
1.1
9.59
8.44
mmol/l
—
5
26
12
77
1.56
0.68
3.9
3.2
140.96
27.70
mg/l
—
5
13
7
42
1.67
0.68
1.0
1.1
—
—
—
0
0
9
59
1.53
0.68
1.0
1.1
—
—
—
0
0
69
584
1.18
0.68
2.4
2.4
28.93
30.45
iu/ml
—
9
66
30
231
1.30
0.67
1.3
2.9
—
—
—
0
0
7
43
1.63
0.66
1.6
1.2
66.43
1863.62
u/l
—
7
37
5
28
1.79
0.66
1.0
1.0
0.00
0.16
u/ml
—
5
28
10
62
1.61
0.65
1.0
1.0
—
—
—
0
0
34
269
1.27
0.63
1.1
1.1
1187.76
1489.48
miu/ml
0.84
34
269
48
576
0.83
0.60
1.4
1.5
61.61
60.60
ug/l
0.06
48
576
85
743
1.15
0.58
1.1
1.1
2.34
2.83
—
9
124
6
36
1.67
0.56
1.2
1.6
358.17
336.83
umol/24h
—
6
36
6
36
1.67
0.56
1.2
1.3
—
—
—
0
0
6
36
1.67
0.56
7.2
4.8
—
—
—
0
0
6
38
1.58
0.54
1.7
2.0
—
—
—
0
0
16
116
1.38
0.54
1.1
1.1
—
—
—
0
0
16
118
1.36
0.50
2.9
2.5
2796.44
67.58
ug/l
0.46
16
118
29
234
1.24
0.49
2.0
2.3
58.64
52.50
umol/l
0.32
22
203
13
93
1.40
0.48
5.8
7.1
10.78
10.50
%
0.21
13
93
11
76
1.45
0.48
1.1
2.2
—
—
—
0
0
29
235
1.24
0.48
4.1
4.8
6196.96
64.89
mg/l
0.48
23
174
42
360
1.17
0.41
1.2
1.4
94.00
64.17
titre
—
5
24
5
33
1.52
0.41
1.2
2.4
2.36
2.71
mg/l
—
5
33
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
0
17
0.00
0.40
0.0
1.5
—
48.18
—
0
11
31
259
1.20
0.40
28.4
28.5
96.40
112.15
ug/l
1.09
25
213
49
427
1.15
0.39
1.2
1.6
21.40
20.91
u/ml
—
5
79
10
71
1.41
0.39
1.1
1.0
—
—
—
0
0
17
133
1.28
0.38
1.0
1.1
—
—
—
0
0
37
430
0.86
0.37
1.3
1.2
—
—
—
0
0
41
358
1.15
0.34
1.0
1.1
12.35
18.05
u/ml
0.95
12
150
69
625
1.11
0.33
1.2
1.2
—
—
—
0
0
14
110
1.27
0.31
1.1
1.2
—
—
—
0
0
7
55
1.27
0.30
1.0
1.0
—
—
—
0
0
59
534
1.11
0.29
2.1
2.0
11.55
7.49
umol/l
0.59
44
381
97
900
1.08
0.29
1.1
1.1
21.72
16.15
au/ml
0.21
18
212
8
106
0.75
0.29
1.0
1.6
0.51
0.48
e9/l
—
8
106
62
680
0.91
0.28
1.6
1.8
—
—
—
0
0
33
289
1.14
0.28
1.2
1.2
—
—
—
0
0
5
74
0.68
0.26
1.8
1.8
—
—
—
0
0
13
160
0.81
0.26
1.8
1.2
—
—
—
0
0
9
74
1.22
0.25
1.1
1.9
—
—
—
0
0
822
8386
0.98
0.25
1.5
1.5
—
—
—
0
0
29
255
1.14
0.24
2.0
1.6
31.34
29.38
umol/l
0.42
29
239
25
218
1.15
0.23
1.5
1.7
4.12
483.29
pmol/l
—
5
36
37
333
1.11
0.22
1.4
1.4
127.25
190.36
pmol/l
1.11
37
333
0
10
0.00
0.21
0.0
1.1
—
1.36
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
23
201
1.14
0.21
2.6
2.4
111.28
149.62
nmol/l
1.22
18
175
10
80
1.25
0.20
1.3
1.3
—
—
—
0
0
19
164
1.16
0.20
1.0
1.0
10.97
11.70
u/ml
—
10
115
26
231
1.13
0.19
1.3
1.2
10.46
10.02
mm/h
0.06
26
231
20
175
1.14
0.18
1.3
1.4
84.42
126.40
nmol/l
1.37
12
128
68
639
1.06
0.17
3.3
2.9
13.44
13.20
%
1.28
68
631
13
110
1.18
0.17
1.1
1.3
0.51
95.57
mg/l
—
7
75
5
67
0.75
0.17
1.0
1.1
—
—
—
0
0
5
68
0.74
0.17
1.0
1.1
10.56
8.09
u/ml
—
5
68
9
83
1.08
0.14
3.8
6.0
—
2070.67
—
0
6
619
6283
0.98
0.14
8.1
6.7
—
—
—
0
0
15
133
1.13
0.12
1.5
1.3
—
—
—
0
0
13
114
1.14
0.11
1.1
1.2
—
—
—
0
0
21
191
1.10
0.11
2.2
1.8
14311.33
18375.68
e6/l
—
9
99
184
1886
0.97
0.11
1.4
1.4
—
—
—
0
0
15
167
0.90
0.10
1.1
1.1
—
—
—
0
0
5
45
1.11
0.09
1.8
1.8
—
—
—
0
0
172
1686
1.02
0.08
1.6
1.8
—
32.21
—
0
6
9
102
0.88
0.06
1.6
1.6
—
—
—
0
0
41
398
1.03
0.04
1.1
1.1
8.91
8.66
iu/ml
0.03
12
114
21
201
1.04
0.03
1.1
1.5
—
—
—
0
0
13
122
1.07
0.02
2.2
1.9
3.47
1.97
ug/l
—
8
67
13
122
1.07
0.02
1.1
1.1
—
17.33
—
0
6
16
168
0.95
0.02
1.4
1.4
18.02
13.09
g/l
1.20
11
124
27
277
0.97
0.01
6.9
6.1
31.29
126.29
u/ml
—
7
52
189
1883
1.00
0.00
1.5
1.7
6.19
4.32
mg/l
0.80
149
1406
23
224
1.03
0.00
2.4
2.1
6514.38
4208.09
e6/l
0.13
13
157
18
175
1.03
0.00
3.5
3.5
14.64
8.30
mg/l
0.56
13
138
15
154
0.97
0.00
3.3
2.8
—
108.77
—
0
31
32
317
1.01
0.00
2.5
2.6
43.17
41.75
%
0.20
21
171
5
49
1.02
0.00
1.2
1.1
24.20
14.63
u/l
—
5
49
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
6
66
0.91
0.00
2.5
3.8
27.33
41.92
umol/l
—
6
55
6
69
0.87
-0.00
2.8
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
72
0.97
-0.00
1.1
1.1
—
—
—
0
0
5
56
0.89
-0.00
1.0
1.1
—
—
—
0
0
6
68
0.88
-0.00
1.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_ENDOCRINE_OTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_ENDOCRINE_OTH | 1.509 [1.35, 1.69] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.134 |
During the follow-up period (1.1.1998 — 31.12.2019), 1632 out of 11377 females with CD2_BENIGN_ENDOCRINE_OTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_ENDOCRINE_OTH | 1.447 [1.28, 1.63] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 1537 out of 7702 males with CD2_BENIGN_ENDOCRINE_OTH died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_ENDOCRINE_OTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.12% | 0.273% |
| 5 | 0.818% | 1.473% |
| 10 | 2.041% | 3.653% |
| 15 | 4.03% | 6.922% |
| 20 | 6.935% | 11.57% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_ENDOCRINE_OTH – Benign neoplasm of other and unspecified endocrine glands
GWS hits: 4
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data